Development of antibody technology to identify natural killer cell surface antigens in Xenopus Laevis by Minter, Ralph
Durham E-Theses
Development of antibody technology to identify
natural killer cell surface antigens in Xenopus Laevis
Minter, Ralph
How to cite:
Minter, Ralph (1999) Development of antibody technology to identify natural killer cell surface antigens in
Xenopus Laevis, Durham theses, Durham University. Available at Durham E-Theses Online:
http://etheses.dur.ac.uk/4598/
Use policy
The full-text may be used and/or reproduced, and given to third parties in any format or medium, without prior permission or
charge, for personal research or study, educational, or not-for-profit purposes provided that:
• a full bibliographic reference is made to the original source
• a link is made to the metadata record in Durham E-Theses
• the full-text is not changed in any way
The full-text must not be sold in any format or medium without the formal permission of the copyright holders.
Please consult the full Durham E-Theses policy for further details.
Academic Support Office, Durham University, University Office, Old Elvet, Durham DH1 3HP
e-mail: e-theses.admin@dur.ac.uk Tel: +44 0191 334 6107
http://etheses.dur.ac.uk
Development of Antibody Technology to Identify Natural Killer 
Cell Surface Antigens in Xenopus Laevis 
Ralph Minter 
Natural killer (NK)-like lymphocytes have recently been identified in thymectomised 
(Tx) Xenopus which are capable of spontaneous cytotoxicity towards the MHC-
deficient, allogeneic thymus tumour cell line B 3 B 7 . This Thesis describes attempts to 
raise antibodies to Xenopus NK cell surface antigens by phage display and hybridoma 
technology. 
The phage display technique was optimised for raising antibodies to novel, cellular 
antigens in a trial run using the Xenopus thymus tumour cell line B 3 B 7 . Having isolated 
a phage antibody which was shown by flow cytometry to bind B 3 B 7 cells, the 
technique was then used to try and raise antibodies to Xenopus NK cells. Isolation of 
an NK-specific phage antibody was not achieved but phage antibody XL-6 was raised, 
which bound an antigen on Xenopus lymphocytes. Phage antibody XL-6, and soluble 
scFv derived from this, were able to identify a putative mature T cell population in the 
thymus and may be specific for an amphibian homologue of the mammalian leukocyte 
common antigen CD45. 
Hybridoma technology was used to isolate three monoclonal antibodies, 1F8, 4D4 and 
1G5, which were shown by flow cytometric analysis to identify a putative NK cell 
population in control and Tx Xenopus. Following immunomagnetic purification, 1F8-
positive spleen cells from control and Tx animals were shown to kill the MHC-
deficient tumour target B 3 B 7 , confirming that this antibody was specific for Xenopus 
NK cells. Western blotting experiments showed that 1F8, 4D4 and 1G5 identified a 
doublet of protein bands at 72 and 74 kilodaltons in Xenopus gut lymphoid lysates. 
Initial attempts to isolate cDNA encoding a Xenopus NK cell surface antigen through 
inimunoscreening a Xenopus gut cDNA expression library with antibody 1G5 were 
unsuccessful as was an attempt to clone a Xenopus homologue of the mammalian NK 
receptor NKR-P1 by PCR. 
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CHAPTER 1 
General Introduction 
This Chapter comprises a review of recent research into mammalian natural killer 
(NK) cells and examines evolutionary aspects of NK cells highlighted by the study of 
lower vertebrates. An analysis of the use of comparative models in biology is included 
which introduces the benefits of the amphibian Xenopus laevis as an immunological 
model. Finally, the technique of phage display is presented as a novel means of raising 
antibodies. 
1.1 Natural Killer Cells 
1.1.1 The Importance of Natural Killer Cells 
NK cells are now widely accepted as a population of lymphocytes, distinct from T and 
B cells, which play a crucial role in innate resistance to viral infection and 
tumourigenesis. Their importance as a first line of defence lies in their ability to effect 
rapid cytotoxic responses without prior sensitization. Recent research into NK cells has 
not only emphasised their effector role in innate immunity but has also highlighted 
additional regulatory functions in the acquired immune response. The unique niche 
occupied by NK cells in cellular immunity has prompted much investigation into the 
precise events which trigger NK activity. This increased understanding of NK activity 
is now beginning to be used for therapeutic benefit. 
1.1.2 Discovery and Early Findings 
Early work in several invertebrate species, most notably in the earthworm Lumbricus, 
identified populations of large, circulating cells with numerous dark-staining granules 
(Cooper, 1969). Initially these cells were shown to elicit cytotoxic responses in tissue 
graft rejection (Cooper, 1969) but were later found to be capable of spontaneous 
killing (Suzuki and Cooper, 1995). 
One of the first demonstrations of spontaneous cytotoxicity in humans occurred when 
leukaemic blasts removed from a patient were shown in a chromium release assay to 
be lysed by lymphocytes from family members (Rosenberg et al., 1972). In a control 
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assay, peripheral blood cells removed from the non-leukaemic identical twin of the 
patient were not lysed thus eliminating the possibility of lysis due to histocompatibility 
differences. Further investigation showed that the spontaneously cytotoxic 
lymphocytes did not display the surface antigens characteristic of T cells or B cells 
(Ozer et al., 1979). This new type of lymphocyte activity became known as 'natural 
killer' or 'NK' activity and the lymphocytes responsible were termed NK cells. 
Early work on human NK cells showed that morphologically the majority are large 
granular lymphocytes with a high cytoplasm to nucleus ratio and numerous azurophilic 
granules (Timonen et al., 1981). In comparison to mature T and B cells, they are 
relatively short lived and may survive only a few days in circulation (Trinchieri, 1989). 
Studies on the distribution of human NK cells have shown that they typically comprise 
10-15% of the lymphocyte population of peripheral blood and are also found in the red 
pulp of the spleen (Timonen and Saksela, 1980; Timonen et al., 1981). NK cells have 
been identified in the liver and mucosal tissues such as the gastrointestinal tract 
(Timonen and Saksela, 1980; Timonen et al., 1981). In the gastrointestinal tract, they 
are found scattered throughout the lamina propria at the base of the crypts and in the 
Peyer's patches of the ileum (Hogan et al., 1985; Kummer et al., 1995). 
1.1.3 NK CeU Effector Functions 
NK cells have been shown to exhibit innate cytotoxicity towards vhaUy-infected cells 
and tumour cells as well as bacteria and other pathogens. Unlike CD8+ cytotoxic T 
lymphocytes (CTL's), NK cells do not require cognate interaction with antigenic 
peptides in association with the class I major histocompatibihty complex (MHC) in 
order to be activated (Trinchieri, 1989). In fact the binding of MHC class I by NK cells 
has been shown to transmit inhibitory signals to NK cells as shown by experiments 
where class I-deficient tumour cells, susceptible to NK lysis, are protected by the 
expression of transfected class I genes (Quillet et al, 1988). This finding led to the 
formulation of the 'missing self theory which predicts a surveillance role for NK cells 
in search of cells which fail to express self class I MHC (Ljunggren and Karre, 1990). 
The elimination of such targets by NK cells would complement the activity of CTL's 
which are unable to destroy class I-deficient cells. 
In addition to the non-MHC restricted cytotoxicity described above, NK cells are 
important mediators of antibody-dependent cellular cytotoxicity (ADCC). In ADCC, 
NK cells recognise the Fc portion of antibody molecules bound to the surface of target 
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cells and consequently lyse the antibody-coated cells. In both cases, the mechanism of 
lysis appears to be similar and involves the release of preformed cytolytic granules in 
close proximity to the plasma membrane of the cell being lysed (Trinchieri, 1989). 
Important among the components released are perforins which insert into the 
membrane as monomers and then polymerise to form pores which allow osmotic lysis 
of the target cell (Joag et al., 1989). The pores also allow NK-released granzymes to 
enter the target cell and trigger apoptosis (Robertson and Ritz, 1990). In addition, the 
surface expression of Fas ligand (FasL) and soluble release of TNF-related apoptosis-
inducing ligand (TRAIL) by NK cells trigger apoptosis upon binding to their respective 
ligands Fas and DR4 or DR5 on target cells (Oshimi et al., 1996; Wiley et al., 1995; 
MacFarlane et al., 1997). Release of soluble tumour necrosis factor a (TNF-a) is also 
a major factor in NIC-mediated cell lysis (Joag et al., 1989). 
1.1.3.1 NK Responses to Viral Infection 
The importance of NK cells in the early regulation of viral infections has been well 
demonstrated with murine cytomegalovirus (MCMV) and herpes simplex virus (HSV) 
infection of mice. Suckling mice with low levels of NK activity are more susceptible to 
infection with these viruses and yet resistance can be induced by adoptive transfer of 
purified NK cells (Bukowski et al., 1985). Alternatively, resistant strains of mice 
treated with reagents that inhibit NK activity become more susceptible to viral 
infection (Welsh, 1986). NK cells have been shown to inhibit MCMV infections in 
mice with severe combined immunodeficiency (SCID), which lack functional T and B 
cells, although these mice do not completely eradicate the virus. This emphasises the 
role of the NK cell in controlling the levels of replicating virus in the first few days of 
infection before the antigen-specific T cell response eradicates the virus at a later stage 
(Biron et ah, 1983). 
The important anti-viral effects of NK cells are further highlighted by the rare case of a 
patient completely deficient in NK activity who suffered a series of severe viral 
infections, including varicella zoster virus, human cytomegalovirus and HSV (Biron et 
al., 1989). 
Human NK cells are capable of recognising and lysing virally-infected cells directly as 
demonstrated by in vitro killing assays (Santoli et al., 1978). The recognition step is 
not fully understood but could be due to downregulation of class I M H C expression by 
the virus (Brutkiewicz and Welsh, 1995), or the presence of viral peptides in the 
binding groove of class I interfering with the transmission of a negative signal to the 
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NK cell (Chadwick et al., 1992). There has also been some evidence to suggest that 
purified glycoproteins from several viruses can augment the cytolytic activity of NK 
cells in vitro and in vivo (Harfast et al., 1980; Casali et al., 1980; Arora and Houde, 
1988). 
The ability of activated NK cells to secrete interferon-y (TFN-y) is also strongly linked 
to anti-viral activity. IFN-y has been shown to induce the production of the free radical 
nitric oxide (NO) from macrophages which in turn has a direct inhibitory effect on 
viral replication (Nathan, 1992; Karupiah et al., 1993). 
1.1.3.2 NK Responses to Bacteria and Other Parasites 
Human NK cells have been shown to directly ki l l both gram positive and gram 
negative bacteria in vitro (Garcia-Penarrubia et al., 1989). They can also lyse cells 
infected with Salmonella typhimurium, Mycobacterium avium or Shigella flexneri in 
vitro (Klimpel et al., 1986; Katz et. al., 1990; Griggs and Smith, 1994). However, the 
evidence in vivo seems to suggest that the production of cytokines, particularly IFN-y, 
is the most important contribution of NK cells to bacterial clearance. The prevention of 
NK cell IFN-y production in SCH) mice decreases the resistance to the pathogen 
Listeria monocytogenes (Tripp et al., 1994). The IFN-y mediated regulation of 
bacterial infection appears to be linked with production of the free-radical NO by 
macrophages and other cells (Glesch and Kaufmann, 1991; Beckerman et al., 1993). 
Direct killing of the fungus Cryptococcus neoformans and the protozoa Toxoplasma 
gondii and Trypanosoma cruzi by NK cells has also been shown in vitro (Hidore and 
Murphy, 1989; Hauser and Tsai, 1986; Hatcher and Kuhn, 1982). However, as with 
bacterial infections, it appears that in vivo the production of IFN-y by NK cells is far 
more important for innate resistance to parasites than direct cytotoxic activity (Scott 
and Trinchieri, 1995). 
1.1.3.3 NK Responses to Tumours 
There is now considerable evidence that NK cells play a crucial role in the elimination 
of tumour metastases in the blood (Whiteside and Herberman, 1995; Vujanovic et al., 
1996). Early experiments showed that NK cells rapidly destroy tumour cells in the 
bloodstream of animal models (Riccardi et al., 1980; Barlozzari et al, 1983) and these 
finding are borne out in human cancer patients where a link has been established 
between low levels of NK activity and high levels of metastasis (Whiteside and 
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Herberman, 1994). This seems to apply to both haematological cancers, such as 
leukaemia, and solid tissue cancers such as breast cancer (Pross and Lotzova, 1993; 
Strayer et al., 1986). 
The cytolytic ability of NK cells is clearly important in the elimination of tumour cells 
and studies in vitro have shown that NK cells are capable of inducing necrosis, through 
the release of perforin, and apoptosis in tumour cell targets (Vujanovic et al., 1994; 
Young, 1989; Whiteside et al., 1998). NK-derived cytokines may also play a part in 
slowing the growth of tumours and increasing their susceptibility to lysis by other 
effector cells (Whiteside and Herberman, 1992). 
NK recognition of tumour cells is only poorly understood at the moment, although it 
has been shown that many tumour cell lines which make good targets for NK-mediated 
cytolysis have reduced expression of class I M H C on their cell surface (Harel-Bellan, 
1986; Storkus, 1987). 
The ability of NK cells to control tumour metastases has been investigated as a means 
of therapy for cancer patients. Two methods which have demonstrated anti-tumour 
effects in animal models are the activation of endogenous NK cells and adoptive 
transfer of activated NK cells (Whiteside et al., 1998). Unfortunately, the small 
number of clinical trials carried out in humans have been performed on patients in the 
advanced stages of metastasis and have not shown a clear therapeutic effect (Whiteside 
et al., 1998). However, a greater understanding of NK cell biology is likely to facilitate 
better design of NK-mediated therapies. 
1.1.4 The Regulatory Role of NK Cells 
NK cells were once thought to be merely effectors of innate cytotoxic responses and to 
interact only with the non-specific cells of the immune system. However, it has 
recently been suggested that NK cells have an additional, regulatory role in acquired 
immune responses. Although this regulatory role is poorly understood, there are 
several examples of NK cells being involved in the development of antigen-specific T 
and B cell responses. 
NK cells were shown to be crucial for the differentiation of active CTL's in a mixed 
lymphocyte culture reaction (Kos and Engleman, 1995). Furthermore, it appeared that 
direct contact between NK cell and T cell was required for CTL development as NK-
derived soluble factors could not elicit the same response. Separate experiments have 
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also shown NK cells to be required for the development of tumour-specific CTL's 
(Kurosawa et al., 1995). 
NK cells are also thought to participate in the humoral response to T cell independent 
(TI) antigens associated with bacterial and viral infection. NK cell production of DFN-y 
was required for antibody secretion by B cells in response to TI antigens in vitro 
(Snapper et al., 1996). Evidence has also been found in vivo for an NK cell 
involvement in B cell responses to TI antigens (Wilder et al., 1996). 
In addition, the production of IFN-y by NK cells was shown to favour the development 
of T helper type 1 (Thl) cells in the mouse following injection of leishmanial antigens 
(Scharton and Scott, 1993; Romagnani, 1992). Depletion of NK cells in both human 
and mouse studies has been shown to interfere with the IFN-y-mediated development 
of Thl clones (Manetti et al., 1993; Afonso et al., 1994). However NK cells are not 
always required for the development of Thl cells and it is thought that they may be 
more important in response to antigens which induce a strong EL-4 response in the 
absence of adjuvant (Trinchieri and Scott, 1995). 
Although the regulatory role of NK cells has yet to be clearly defined, evidence does 
seem to suggest that NK cells play a crucial part in certain antigen-specific T and B 
cell responses. 
1.1.5 Surface Receptors on NK Cells 
Studies of surface molecules on NK cells have been complicated by the fact that many 
are also expressed on related cells, most notably T cells. For example the molecule 
CD56, which is present on more than 95% of human NK cells, is also present on a 
small population of T cells (Ritz et al., 1988). Significantly the T cells which express 
CD56 are, like NK cells, capable of non-MHC restricted cytotoxicity which suggests a 
strong developmental relationship between NK cells and T cells (Lanier et al., 1986a). 
As a result of this close relationship, NK cells have become defined as much by the 
absence of T cell receptor (TCR) and CD3 expression as by the presence of 'NK-
specific' molecules such as CD56. 
Despite the problems resulting from this close relationship with T cells, a number of 
NK cell surface molecules have been discovered in recent years which have enabled 
greater understanding of the ways in which NK responses are switched on and off. 
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1.1.5.1 Inhibitory NK cell Receptors 
Inhibition of NK cell activity occurs as a direct result of interaction with self MHC 
class I molecules (Shimizu and DeMars, 1989; Storkus et al., 1989). As mentioned 
previously this infers a role for NK cells in searching for and lysing cells which lack 
normal expression of class I MHC, such as some tumour cells and virally infected cells 
(Ljunggren and Karre, 1990). The inhibitory receptors on NK cells which bind to 
MHC class I molecules have been extensively studied in humans and rodents. 
The predominant inhibitory receptors in humans, known collectively as killer cell 
inhibitory receptors (KIR's), are members of the immunoglobulin (Ig) superfamily. 
These can be divided into the KJR2D and KIR3D subfamilies, which have two and 
three extracellular Ig-like domains respectively (reviewed in Lanier, 1998a). KIR's are 
generally expressed as monomers but one isoform, known as KTR3DL-NKAT4, can 
appear as a disulpMde-linked homodimer (Pende et al., 1996; Dohring et al., 1996a). 
Different KIR's are specific for different class I MHC molecules, for example the 
KIR2D and KIR3D subfamilies bind HLA-C and HLA-B ligands respectively, whereas 
the KIR3DL-NKAT4 binds only HLA-A molecules (Moretta et al., 1993; Litwin et al., 
1994; Pende et al., 1996; Dohring et al., 1996a). This ligand-binding diversity of KIR 
molecules is generated by alternative splicing of messenger RNA (mRNA) and allelic 
polymorphism of the 12 estimated KTR genes located on chromosome 19 (Dohring et 
al., 1996b; Selvakumar et al., 1997). Different KIR's are expressed on overlapping 
subsets of NK cells which produces a diverse repertoire of receptors for MHC class I 
(Moretta et al., 1990). In addition, KIR molecules are also expressed on a subset of 
CTL's, again emphasising the similarities between NK cells and some T cells (Mingari 
et al., 1997). 
The mechanism of inhibition through KIR molecules is linked to the presence of 
immunoreceptor tyrosine-based inhibitory motifs (ITIM's) in the cytoplasmic domain. 
Al l inhibitory KIR molecules contain two ITIM's which, after phosphorylation, recruit 
Sffi-containing tyrosine phosphatase-1 (SHP-1) or SHP-2 (Burshtyn et al., 1996; 
Campbell et al., 1996; Fry et al., 1996). The exact pathway for inhibition has not yet 
been defined but it is apparent that SHP-1, and possibly SHP-2, are required (reviewed 
in Vivier and Daeron, 1997). 
Surprisingly, the major inhibitory molecules on murine NK cells, known as the Ly-49 
family, are structurally unrelated to the human KIR molecules. Instead, they are C-type 
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lectin-like receptors, which form disulptide-linked homodimers in the plasma 
membrane (Mason et al., 1995; Stoneman et al., 1995). Despite this fundamental 
difference in structure, there are many striking similarities between KIR and Ly-49 
receptors. Ly-49 proteins are encoded by a family of nine genes (Brown et al., 1997) 
in which diversity is achieved by allelic polymorphism and alternative splicing of 
mRNA (Smith et al., 1994; Silver et al., 1996). Different Ly-49 receptors have 
specificities for different MHC class I ligands, and are expressed on overlapping 
subsets of NK cells to produce a diverse repertoire (Brennan et al., 1994). Ly-49 can 
also be expressed on a subset of T cells (Chan and Takei, 1989). Finally, and perhaps 
most significantly, Ly-49 molecules possess ITIM's in their cytoplasmic domain which 
recruit SHP-1 in order to inhibit NK cells (Nakamura et al., 1997). 
A third set of inhibitory receptors are the CD94/NKG2 heterodimers which are present 
on human, mouse and rat NK cells, as well as a subset of T cells in humans (reviewed 
in Lanier, 1998a). These heterodimers are, like the murine Ly-49 proteins, members of 
the C-type lectin superfamily (Lazetic et al., 1996). The CD94 subunit appears to be 
invariant and acts primarily as a chaperone to transport NKG2 to the cell surface 
(Lazetic et al., 1996), whereas NKG2 is encoded by a family of four genes, designated 
NKG2A, NKG2C, NKG2E and NKG2D/F (Houchins et al., 1991). CD94/NKG2A is 
the best studied of these heterodimers and possesses two ITTM sequences in the 
cytoplasmic domain of the NKG2A subunit, consistent with its role as an inhibitory 
receptor (Houchins et al., 1997). Recent studies have shown that CD94/NKG2A is 
specific for the non-classical class I molecule HLA-E (Braud et al., 1998a). HLA-E is 
an unusual molecule in that it requires binding of a leader peptide of a classical class I 
molecule before it can be expressed on the cell surface (Braud et al., 1998b). As a 
result it has been proposed that HLA-E can be used by NK cells to detect events that 
disrupt the synthesis or transport of classical class I molecules (Lanier, 1998b). 
The question of why the predominant inhibitory NK receptors of rodents are C-type 
lectins while in humans they are Ig-like molecules has yet to be answered. One theory 
is that the CD94/NKG2 system, which is present in rodents and humans, evolved first. 
These receptors detect more general deficiencies in class I expression which might 
result from certain viral infections (Wiertz et al., 1997). As an improvement to this 
system, the Ly-49 receptors in mouse and the KIR molecules in humans may have 
evolved to provide greater specificity and sensitivity (Lanier et al., 1998). 
The recent progress in molecular characterisation of inhibitory receptors has facilitated 
the discovery of several novel Ig-like molecules which can inhibit NK cells. These 
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include the p49 molecule expressed on human NK cells and a subset of T cells 
(Cantoni et ah, 1998) and the murine gp49 which is expressed on NK cells and mast 
cells (Rojo et al., 1997; Wang et al., 1997). The human p49 protein is inhibited 
specifically by HLA-G1 molecules expressed on the human trophoblast during 
pregnancy (Ponte et al., 1999). The relative importance of these new inhibitory 
receptors, compared to the existing KIR's, has yet to be demonstrated. 
1.1.5.2 Activating Receptors on NK cells 
In contrast to the current understanding of inhibitory receptors on NK cells, there are 
many gaps in the knowledge about receptors which activate NK cells. Despite an 
intensive search, no predominant receptor which is highly antigen specific, equivalent 
to the TCR of T cells or the surface Ig of B cells, has been found on NK cells. Instead 
the search has highlighted an array of activating receptors with an ability to bind fairly 
broad ranges of targets. 
One of the best studied activating receptors on NK cells is the low affinity receptor for 
IgG, known as CD16 or FcyRm. CD16 is expressed on most mouse and human NK 
cells as well as on activated monocytes and a subset of T cells (Lanier et al., 1986b; 
Phillips et al., 1991). Following ligation to the Fc portion of an IgG molecule, CD16 
becomes associated with the y subunit of the high affinity IgE receptor (FceRI-y) or the 
C, subunit of CD3 in human NK cells (Lanier et al., 1991). Both FcsRI-y and the £ 
subunit possess immunoreceptor tyrosine-based activation motifs (ITAM's) in their 
cytoplasmic domains and these are consequently phosphorylated by src-family tyrosine 
kinases (Salcedo et al., 1993). This begins a cascade of biochemical events which 
leads to secretion of cytokines and activation of ADCC mechanisms (Perussia et al., 
1984; Anegon et al., 1988). CD16 is thought only to be involved in cytotoxic 
responses to antibody-coated targets (ADCC) and not in any other NK-mediated 
cytotoxicity. 
The NKR-P1 family of proteins are members of the C-type lectin superfamily and have 
been primarily studied in rodents although a human homologue has also been found 
(Lanier et al., 1994). They are expressed as disulpMde-linked homodimers on the 
surface of most NK cells and a subset of T cells (Chambers et al., 1989; Giorda et al., 
1990). Monoclonal antibodies (mAb's) to NKR-P1 are able to induce a rise in 
intracellular Ca + + levels in NK cells, indicative of activation, and trigger cytotoxic 
responses and cytokine production (Chambers et al., 1989; Ryan et al., 1991; Arase et 
al., 1996). The triggering mechanism of NKR-P1 is probably related to a motif in the 
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cytoplasmic region, also found on CD4 and CD8, which can interact with the src-
family kinase p56 l c k and thus initiate signal transduction (Turner et al., 1990; Campbell 
& Giorda, 1997). In addition, NKR-P1 interacts with the molecule FceRI-y (Arase et 
aL, 1997) and this association may be equally important as FceRI-y has been shown to 
play a role in signal transduction from other receptors, such as CD16 (Lanier et al., 
1991). The ligand for the NKR-P1 receptors is unknown although recombinant NKR-
Pl has been shown to bind certain synthetic carbohydrates which may be expressed on 
tumour and lymphoblastoid cells (Bezouska et al., 1994). 
The KIR, Ly-49 and CD94/NKG2 families of inhibitory receptors which bind class I 
MHC molecules all have variants which do not express ITIM's and have the ability to 
activate rather than inhibit NK cells. When bound by the appropriate class I ligand, the 
activating KIR receptor p50 has been shown to increase Ca + + levels in NK cells and 
induce cytotoxic responses (Moretta et al., 1995). The ability to be activated upon 
binding class I MHC is in agreement with the observation that rat and mouse NK cells 
are capable of lolling MHC-mismatched donor cells (Ohlen et al., 1989; Rolstad et al., 
1997). The signal transduction mechanism of the activating forms of KIR, Ly-49 and 
CD94/NKG2 is probably due to the presence of a charged amino acid in the 
transmembrane domain (Houchins et al., 1991; Biassoni et al., 1996; Mason et 
al., 1996). This residue is thought to allow the binding of a small dimeric molecule 
known as DAP-12 which contains an IT A M in its cytoplasmic domain (Lanier et al., 
1998c). Once phosphorylated, DAP-12 is able to initiate a cascade of biochemical 
events which lead to NK cell activation (Lanier et al., 1998c). 
Many other membrane receptors have been linked to NK cell activation as mAb's 
against these molecules can stimulate NK-mediated lysis of target cells. These include 
the human CD2, CD44 and DNAM-1 molecules, mouse 2B4 and Ly6 and mouse and 
human CD69 which are all expressed on a variety of cells other than NK cells 
(reviewed in Long and Wagtmann, 1997). Also important in NK cytotoxicity are cell 
adhesion molecules which can allow conjugation to target cells prior to lysis. The most 
important of these are LFA1 (CD 1 la/CD 18) and CD2 which bind the respective 
ligands ICAM-1 (CD54) and LFA-3 (CD58) (reviewed in Robertson and Ritz, 1990). 
Some of these molecules are probably only co-stimulatory and thus unable to initiate 
NK cell activation alone. 
More recently, a number of novel activating receptors which show a high level of 
specificity for NK cells have been discovered. Two of these are the NKp44 and 
NKp46 molecules cloned from human NK cells, which are members of the 
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immunoglobulin superfamily (Pessino et al., 1998; Cantoni et al., 1999). Both are 
specifically expressed on NK cells and when cross-linked by mAb's are capable of 
inducing lysis of tumour cell targets (Sivori et al., 1997; Vitale et al., 1998). NKp44 
and NKp46 are similar in that they each contain a charged amino acid in their 
transmembrane domain which attract the signal transducing molecules DAP-12 and the 
C-subunit of CD3 respectively (Vitale et al., 1997). Homologues of both these 
receptors have been found in the mouse (Pessino et al., 1998; Biassoni et al., 1999) 
which implies a fundamental role in NK cell activation. 
Finally, a receptor which shows remarkable conservation through vertebrate evolution 
is the nonspecific cytotoxic cell receptor protein-1 (NCCRP-1), originally discovered 
on the surface of nonspecific cytotoxic cells (NCC) in teleost fish (Evans et al., 1988). 
NCC are the teleost equivalent of mammalian natural killer cells and display 
spontaneous cytotoxicity towards certain tumour cell targets (reviewed in Evans and 
Cooper, 1990). Monoclonal antibodies to NCCRP-1 were found to block NCC 
recognition and subsequent lysis of tumour targets (Evans et al., 1988). This trait was 
also apparent when the antibody was applied to human NK cells, although the high 
concentration of antibody required for an effect on human NK cells casts some doubt 
on these findings (Harris et al., 1991). Teleost NCCRP-1 has now been sequenced 
(Jaso-Friedmann, et al., 1997) and recent work suggests that it may be a type HI 
membrane receptor capable of recognising antigen (Evans et al., 1998). 
1.1.5.3 A Balance between Activating and Inhibitory Receptors 
It is clear that there are a large array of molecules expressed on NK cells which can 
trigger cytotoxicity in a fairly simple and nonspecific manner. Most of the ligands for 
activating receptors have yet to be identified but it is unlikely that they are highly 
specific (reviewed in Long and Wagtmann, 1997). In fact, some of these ligands are 
expressed on healthy cells which predicts a requirement for control mechanisms to 
prevent NK cells destroying self tissue. It would appear that this control is achieved 
through the more specific signals received via the various MHC class I-binding 
inhibitory receptors. These inhibitory receptors, through SHP-1, have been shown to 
block crucial steps in the transduction of activating signals and thus override 
potentially self-destructive cytotoxicity (Binstadt et al., 1996; Valiante et al., 1996). 
However, the inhibition is not absolute and it has been shown that inhibitory signalling 
through human KIR can be overcome using agonist mAb's to several activating 
receptors simultaneously (Lanier et al., 1997). This suggests that the responses of NK 
cells are held in check by a balance of positive and negative signalling events through 
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numerous receptors, with certain environments able to tip the balance towards a 
cytotoxic response. 
1.1.6 Evolutionary Studies of NK CeUs 
Although the vast majority of NK research has been performed in mammals, there is 
an increasing body of evidence to suggest that naturally cytotoxic cells are an 
important part of the immune systems of more primitive species. The importance of 
cytotoxic immune effectors may even stretch as far back through animal evolution as 
the invertebrates, as the earthworm displays some degree of spontaneous cytotoxicity 
towards tumour cell targets (Cossarizza et al., 1996). 
1.1.6.1 The Prevalence of Natural Cytotoxicity in Lower Vertebrates 
Of the lower vertebrate animals, naturally cytotoxic cells have been identified in fish, 
amphibians, reptiles and birds (Evans and Cooper, 1990; Ghoneum et al., 1990; Sherif 
and Elridi, 1992; Gobel et al., 1994). As mentioned previously, teleost fish have NCC, 
a population of lymphoid cells which are innately cytotoxic towards tumour cell 
targets (reviewed in Evans and Cooper, 1990). Strong evidence of the relatedness of 
these fish NCC to mammalian NK cells comes from the finding that an antibody to 
NCCRP-1 on fish NCC also binds specifically to human NK cells (Harris et al., 1991). 
Initial studies of amphibians highlighted the presence of naturally cytotoxic cells 
capable of lysing tumour cell targets (Ghoneum et al., 1990). Further study of the 
amphibian Xenopus laevis has shown that a non-T, non-B lymphoid cell population 
displays cytotoxicity towards an allogeneic, MHC-deficient thymus tumour target 
B 3 B 7 , which is strongly suggestive of NK activity in these animals (Horton et al., 
1996). 
Cytotoxic activity towards the NK-sensitive human tumour cell line K562, was 
observed in peripheral blood mononuclear cells of the snake Psammophis sibilans 
(Sherif and Elridi, 1992). Similar activity was found in spleen and thymus populations, 
and further work is required to attribute this killing to a reptilian equivalent of NK 
cells. 
In the chicken, candidate NK cells have been identified which, like mammalian NK 
cells, have been shown to lyse an NK-sensitive tumour cell line (Gobel et ah, 1994). 
These avian lymphoid cells are able to bind chicken IgG, suggesting the presence of Fc 
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receptors and an ability to kil l by ADCC (Gobel et al., 1994). They also lack 
expression of the TCR/CD3 complex on the cell surface, although they do express 
cytoplasmic CD3 and surface CD8, indicating that these cells have much in common 
with T cells (Gobel et al., 1994). 
1.1.6.2 Insights into the Evolution of Cytotoxic Lymphocytes 
Despite being acknowledged as two distinct populations of lymphocytes, NK cells and 
CTL do bear many striking similarities. T cell surface receptors such as CD2 and CD8 
can be expressed on NK cells and most of the NK-defining molecules, including 
CD16, CD56, KIR, Ly-49, CD94/NKG2 and NKRP-1, are expressed on subsets of 
CTL (reviewed in Lanier, 1998a). From a functional viewpoint, the subset of CTL 
which express these NK-defining molecules such as CD56 are, like NK cells, capable 
of non-MHC restricted cytotoxicity (Lanier et al., 1986a). In addition, both NK cells 
and CTL can be stimulated by the cytokines interleukin (IL)-2 or IL-12 (Smith, 1988; 
Kobayashi et al., 1988) and furthermore, extended culture of CTL with recombinant 
IL-2 increases the amount of non-MHC restricted cytotoxicity in these cells (Dianzani 
et al., 1989). 
Many of the proteins involved in signal transduction in T cells, namely the CD3 
chain, the tyrosine kinases p56 l c k and ZAP-70, phospholipase C, MAP kinase, p21 ras 
and SHP-1, are also utilised by NK cells (reviewed in Lanier, 1998a). The perforin-
dependent and Fas-mediated cytolytic effector mechanisms are also shared by both NK 
cells and CTL (Valiante and Parham, 1996). 
These similarities between NK cells and CTL, as well as the prevalence of NK cells in 
some very primitive organisms, have given rise to the idea that NK cells are the 
evolutionary fore-runners of cytotoxic T cells (Janeway, 1989). It is proposed that a 
primitive immune system would tend to consist of a few multi-specific effector cells, 
such as NK cells. The consequent acquisition by NK cells of clonally distributed, 
antigen-specific receptors, at some point in animal evolution, could conceivably have 
turned them into cytotoxic T cells (Janeway, 1989). 
1.2 Comparative Studies in Biology 
The study of comparative animal models allows the identification of biological 
phenomena which are conserved throughout animal evolution. In the case of 
comparative immunology, where such phenomena are intrinsically linked to the 
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survival of the animal, the conservation of these features strongly underlines their 
immunological significance. 
1.2.1 The Xenopus laevis Comparative Model 
As an immunological model for the investigation of NK cells, the amphibian Xenopus 
laevis offers certain advantages over other animal models. Firstly, the Xenopus 
immune system is the best characterised of the lower vertebrates and shows a high 
level of similarity with the immune systems of mammals. Al l the important lymphoid 
organs are present, including thymus, spleen, liver, kidney and gut-associated 
lymphoid tissue (Plytycz and Bigaj, 1983; Katagiri and Tochinai, 1987). B and T cells, 
including T-helper and T-cytotoxic subsets, have been identified (Horton, 1994) as 
have the equivalents of MHC class I and class I I (Du Pasquier et al., 1989). In 
addition, Xenopus possesses three types of antibody molecules: IgM, IgY, a likely 
precursor of mammalian IgG and IgE, and IgX, a possible equivalent of mammalian 
IgA (Du Pasquier et al., 1989). 
A second advantage of studying Xenopus lies in the ability to remove the thymus 
during the initial stages of histogenesis in the early larval development of the animal 
(Horton and Manning, 1972). These early-thymectomised (Tx) animals develop into 
healthy adults in which virtually no functional T cells can be identified (Horton et al., 
1998a). The many similarities between CTL and NK cells can sometimes make it 
difficult to attribute cytotoxic responses to one cell type or the other and it is therefore 
advantageous to be able to remove T cells. Xenopus thus offer a unique 
environment in which to study NK cells free of any T cell complications. In addition, 
the physical removal of the thymus also means that Tx Xenopus are not hindered by 
any of the congenital defects associated with athymic nude rodents (Horton et al., 
1998a). 
Thirdly, the identification of features which are conserved in the immune systems of 
vertebrates underlines their fundamental importance in immunology, as shown by the 
discovery of MHC, CTL and B cells in many lower vertebrates (reviewed in Horton 
and Ratcliffe, 1996). In the case of NK cell receptors, the studies of rodents and 
humans have drawn a rather confusing picture involving many different receptor 
families, some of which do not appear to be shared between the different species. By 
characterising the receptors found in the NK cells of lower vertebrates, it may be 
possible to identify which ones are conserved in all NK cells. The conservation of such 
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receptors throughout the evolution of vertebrates would certainly indicate their 
fundamental importance in NK cell function. 
Finally, the study of comparative immunology offers insights into the evolution of the 
immune system. As mentioned above, it is thought that NK cells are the evolutionary 
forerunners of CTL. By studying the immune systems of more primitive species it may 
be possible to compile evidence for a common lymphoid progenitor. 
1.3 Phage Display Technology 
1.3.1 The Uses of Specific Antibodies 
Specific antibodies to cell surface antigens have proven invaluable tools for the study 
of NK cells. When used in conjunction with flow cytometry they provide accurate 
quantification of NK cell numbers in different lymphoid organs. Application of 
specific antibodies to immunocytochemical staining of tissue sections allows the 
identification of the specific distribution of NK cells in various organs. Using magnetic 
cell sorting or flow cytometric cell sorting they allow purification of NK cells from 
mixed lymphoid populations, enabling functional and molecular studies to be 
performed on purified populations of cells. Furthermore, i f they are specific for an 
important receptor on the NK cell surface, they permit isolation of that protein which 
can lead to cloning of the relevant gene. In some cases the antibodies even have 
agonist or antagonist properties which allow detailed analysis of activatory or 
inhibitory signals. 
Up to now, these antibodies have been produced using classical hybridoma 
technology, whereby B-cells taken from an animal immunised with NK cell antigens 
are fused in vitro to myeloma cells using polyethylene glycol. These hybridoma's can 
be cultured in vitro and cloned by limiting dilution. Because each hybridoma results 
from the fusion of a single plasma cell to a myeloma cell, it wil l only secrete 
monospecific antibodies. 
In recent years an alternative technology, known as phage display, has emerged which 
is also capable of isolating monospecific antibodies to antigens of choice. 
15 
1.3.2 Phage Display 
1.3.2.1 The Bacteriophages 
Bacteriophages, or 'phages' are a diverse family of viruses which infect bacteria. They 
do so because they are unable to replicate independently and require the bacterial 
replication machinery for this purpose. The filamentous bacteriophage M13, the vector 
of choice in phage display, is shaped like a long fibre about 6nm in diameter and 900-
1900nm in length (Prescott et al., 1990). It specifically infects male (F+) E.coli cells 
by attaching to the tip of the F pilus. Following replication, progeny phage are 
extruded through the pili, leaving the host cell intact (Prescott et al., 1990). 
1.3.2.2 The Concept of Phage Display 
The human B cell population of a healthy individual expresses approximately 10 
different antibodies, each with a distinct specificity for antigen (reviewed in Rolink 
and Melchers, 1993). This diversity is a result of variation in the amino acid sequence 
of complementarity determining regions (CDR's) within the variable heavy (VH) and 
variable light (VL) chains of the antibody molecule, which combine to form the 
antigen binding site. Using the polymerase chain reaction (PCR) it is possible to 
amplify DNA sequences which encode the VH and V L regions and express them in 
bacteria, whereupon they retain the ability to bind antigen (Skerra and Pluckthun, 
1988). 
By cloning large numbers of VH and V L regions and recombining them at random, a 
diverse library of antibody fragments can be generated. In phage display, this library is 
usually expressed on the surface of the filamentous bacteriophage M l 3 by fusion to 
either gene in or gene VOL, which encode phage coat proteins (reviewed in Winter et 
al., 1994). In this way, each recombinant phage is like a monoclonal antibody as it 
expresses a single antibody fragment with a distinct specificity for antigen. Phage 
antibody libraries can be panned against antigen and those individual phage which 
bind the antigen can be specifically eluted and re-amplified for further panning. Over 
successive rounds of panning the original library becomes enriched for those phage 
with a higher affinity for the antigen. Once individual phage antibodies have been 
isolated which show specificity for a given antigen, it is possible to increase their 
binding affinity by site-directed mutation to levels comparable with hybridoma-derived 
antibodies (Schier et al., 1996). 
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1.3.2.3 The Advantages and Disadvantages of Phage Display 
The most significant feature of phage display is that each recombinant phage is a 
replicating unit containing the DNA sequence which encodes its surface antibody. This 
direct link between DNA sequence and protein function enables vast phage libraries, 
containing as many as 101 0 different specificities, to be screened by successive rounds 
of panning against antigen in as little as two weeks (Griffiths and Duncan, 1998). 
Classical hybridoma technology, on the other hand, usually allows the screening of a 
few hundred clones over the course of several months (Harlow and Lane, 1988). 
The immunisation stage prior to hybridoma production imposes a certain degree of 
selection pressure on the B cell population. For instance, B cells will not be stimulated 
to differentiate into antibody-producing plasma cells i f an antigen is not immunogenic. 
Alternatively, B cells wil l be deleted i f they produce antibodies to conserved epitopes 
which are expressed in the animal's own tissues. This places some constraint on the 
specificities which are obtainable through the hybridoma technique. Such selection 
pressures do not exist in the phage display system. By artificially recombining 
different V H and VL regions or rearranging sequences within the CDR's of the VH 
and VL chains it is possible to generate novel binding specificities in vitro (Nissim et 
al., 1994). This may offer a significant advantage when trying to raise antibodies to 
non-immunogenic, conserved or rare antigens. 
The ability to manipulate antibody fragments in vitro offers other advantages. As 
mentioned earlier, it is possible to increase the binding affinity of selected clones by 
site-directed mutagenesis. Production of soluble antibody fragments from bacteria can 
also be easily achieved and it is possible to introduce peptide tags which enable simple 
purification, detection or dimerisation of fragments (reviewed in Krebber et al., 1997). 
DNA encoding these fragments can also be stored indefimtely at -80°C in a stable form 
which can be revived without any loss of function. Conversely, viable hybridoma cells 
can be difficult to revive after freezing and can also accumulate mutations which 
eventually interfere with the production of functional antibodies (Harlow and Lane, 
1988). 
Despite the many advantages of phage display, it should be stressed that it is still a 
developing technique. Many of the reports of successful and rapid isolation of specific 
phage antibodies have used highly purified, 'known' proteins as antigen whereas in 
reality many researchers wish to raise antibodies to 'unknown' antigens in their native 
conformation, such as cell surface proteins. Currently phage display is relatively poor 
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at raising antibodies to such antigens due to difficulties in the selection process. 
However, a great deal of research is being made into improving selection strategies and 
tailoring phage display to the task of raising useful antibodies to novel, cellular 
antigens (reviewed in Griffiths and Duncan, 1998). 
1.4 Aims and Objectives 
The aim of this project was to investigate NK cells in the amphibian Xenopus laevis by 
three strategies: 
1. The optimisation of protocols to construct and screen phage display libraries against 
whole, live Xenopus cells with a view to raising phage antibodies to NK-enriched 
lymphocyte preparations from Tx Xenopus. 
2. Using hybridoma-derived antibodies recently raised to cell surface determinants on 
Xenopus NK cells (Horton et al., manuscript submitted) it was intended that molecular 
characterisation of N K cell receptors could be conducted using Western blotting and 
immunoprecipitation. Subsequently, it was envisaged that sequence information could 
be gained from the purified protein with a view to designing degenerate PCR primers 
and cloning the relevant gene(s). Attempts could also be made at isolating the relevant 
gene(s) by immunoscreening cDNA expression libraries cloned from Xenopus 
lymphoid organs. Any sequence information gained could be entered into BLAST 
search algorithms to try and find homology with NK proteins in other species. 
3. By designing degenerate PCR primers to conserved sequences found in mammalian 
NK receptors, attempts were to be made to isolate Xenopus homologues of these NK-
related genes. 
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CHAPTER 2 
Generation of Phage Display Antibodies to the 
Xenopus Tumour Cell Line B 3 B 7 
A trial run was conducted using the Xenopus tumour cell line B 3 B 7 to evaluate the 
ability of phage display to produce specific antibodies to cellular epitopes. The 
intention of this work was to assess the performance of phage antibodies and soluble 
antibody fragments in different immunological assays such as flow cytometry and 
Western blotting. 
2.1 Introduction 
2.1.1 Phage Display Libraries 
Antibody libraries cloned from both naive and immunised animals have been used 
successfully in the isolation of specific phage antibodies (Huse et al., 1989; Vaughan 
et al., 1996). Of these, the immune libraries have the advantage that the majority of 
cloned VH and VL regions encode antibodies against the immunogen which means 
that relatively small (105 clone) libraries can be panned successfully (Huse et al., 
1989; Clackson et al., 1991). These V H and VL regions have also undergone affinity 
maturation during immunisation which in turn increases the affinity of the phage-
displayed antibodies (Griffiths and Duncan, 1998). For these reasons it was decided 
that libraries cloned from immunised mice would be used in this study. 
The PCR primers required to amplify all known mouse VH and VL regions have been 
published (Krebber et al., 1997). These primer sequences were obtained by combining 
previously published primers sets which were designed to amplify mouse V H and VL 
regions (Kettlebrough et al., 1993; 0rum et al., 1993; Zhou et al., 1994). The 
optimised set incorporates all VH and VL sequences found in a comprehensive 
collection of mouse immunoglobulin data (Kabat et al., 1991). 
The most frequently used phage display vectors are phagemids, which are bacterial 
plasmids containing a bacteriophage origin of replication. Antibody fragments can be 
cloned into phagemids directly upstream of a sequence encoding an M l 3 phage coat 
protein, usually coat protein I I I (cpIQ). This allows expression of antibody fragments 
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as fusions to M13 coat proteins in a suitable E.coli host cell (Hoogenboom et al., 
1991). Wild type, also known as helper, M13 bacteriophage can infect and replicate in 
the same host cell which allows incorporation of the fusion protein into the coat of the 
progeny phage. By fusing antibody fragments to cpHI, up to five copies of the antibody 
will be expressed on the surface of the recombinant phage particle (Barbas et al., 
1991). Because the phagemid DNA also contains an M13 origin of replication it can 
also be packaged inside each recombinant phage. Upon re-infection of E.coli, 
recombinant phage are unable to propagate and the phagemid DNA reverts to 
replication as a plasmid. An overview of the production of recombinant M l 3 phage 
particles is shown in Figure 2.1. 
Although complicated in theory, the use of phagemid vectors has been preferred in 
recent years for their higher cloning efficiency compared with direct cloning into 
phage vectors (Huse et al., 1989; McCafferty et al., 1990). In this way, phagemids 
facilitate the construction of larger, more diverse libraries (Griffiths and Duncan, 
1998). 
The two types of antibody fragment used in phage display are single chain variable 
fragments (scFv's) and Fab fragments. ScFv's are formed by linking VH and VL 
regions together to form a single polypeptide, whereas Fab fragments consist of larger 
portions of heavy and light chains which are expressed separately and associate in the 
bacterial periplasm (Winter and Milstein, 1991). The smaller size of scFv fragments 
makes them easier to express in bacteria leading to greater stability of libraries during 
bacterial culture. The phage display system used in this study (Krebber et al., 1997) 
utilises scFv fragments fused to cpHI of bacteriophage M l 3 for expression on the 
phage surface. 
2.1.2 Phage Display Panning Strategies 
The Xenopus lymphoid cell line B 3 B 7 was derived from an animal which had 
developed a tumour of the thymus (Du Pasquier and Robert, 1992). Its lack of class I 
MHC expression (Du Pasquier et al., 1995) has made it an excellent target for assaying 
natural killer cell activity in Xenopus (Horton et al., 1996). For this reason, and 
because it can be continuously cultured in vitro, B 3 B 7 cells were chosen to test the 
efficacy of phage display panning for raising specific antibodies. 
As mentioned in Chapter 1, the majority of successful phage panning strategies have 
been conducted using purified protein antigens coated onto plastic tubes (Marks et al., 
1991). The main drawback of this approach is that only antigens which have already 
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been characterised by other methods may be used for panning. In addition, phage 
antibodies raised in this way often fail to bind native protein (Griffiths and Duncan, 
1998). In order to try and raise phage antibodies to novel proteins in their native 
conformation, this study used whole B 3 B 7 cells to immunise the mice from which the 
phage display library was cloned. This library was then panned on whole, live B3B7 
cells and flow cytometry was used for the detection of bound phage. Similar methods 
have been described elsewhere which have been successful in raising phage antibodies 
to novel cellular epitopes (De Kruif et al., 1995; Watters et al., 1997). 
2.2 Materials and Methods 
2.2.1 General Materials and Methods 
Except where indicated, all chemicals and biological reagents were obtained from 
Sigma Chemical Company Ltd or BDH Ltd and were 'Analar' or the best grade 
available. 
2.2.1.1 Buffers 
Amphibian phosphate 0.11M NaCl, 8mM Na 2HP0 4, 1.5mM KH 2 P0 4 (pH7.6) 
buffered saline (APBS) 
DNA loading buffer 0.25% bromophenol blue, 40% (w/v) sucrose in ddH 20 
FACS buffer APBS + 0.1% bovine serum albumin (BSA) + 0.1% NaN 3 
Phosphate buffered 0.14M NaCl, 6mM Na 2HP0 4, 1.5mM KH 2 P0 4 , 2.6mM 
Protein loading buffer 50mM Tris HC1 (pH6.8), lOOmM dithiothreitol (DTT), 2% 
sodium dodecyl sulphate (SDS), 0.1% bromophenol blue, 
10% glycerol 
saline (PBS) KC1 (pH7.4) 
SDS-PAGE running 
buffer 
0.25M Tris, 0.5M Glycine, 1% SDS (pH8.3) 
TAE 40mM Tris acetate, ImM Emylenediammetetraacetic acid 
(EDTA) (pH7.7) 
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TBS lOmM Tris HC1 (pH7.5), 150mM NaCl 
2.2.1.2 Sterilisation Procedure 
Al l glassware, plasticware and other equipment required for aseptic work was 
autoclaved for 15 minutes at 120°C, 15 psi. Solutions were either autoclaved or filter 
sterilised through Q.2ym filters before use. 
2.2.1.3 General DNA Manipulations 
Quantification of DNA or RNA solutions 
DNA or RNA solutions were diluted with nuclease-free water (Promega) and the 
absorbance at 260nm measured on a Beckman DU7500 spectrophotometer. An A 26o of 
1.0 is equivalent to 50^ig/ml of double stranded DNA or 40|ig/ml of RNA. 
For very dilute DNA solutions, quantification was achieved by visual comparison to 
DNA of known concentration after agarose gel electrophoresis, staining with ethidium 
bromide and exposure to UV light. Standards of known concentration were derived 
from a dilution series of linearised plasmid pUC19. 
Restriction digestion of DNA 
Restriction digests were normally performed in a volume of 50jJ. The DNA to be 
digested was adjusted to approximately ljj.g/10jil before addition of 0.1 volumes of the 
manufacturer's lOx digestion buffer and 1-2 units of restriction enzyme per lOjol 
volume. Samples were incubated at 37°C for 2-3 hours, with the exception of the 
restriction enzyme Sfil which required incubation at 50°C for 2-3 hours. 
Agarose gel electrophoresis 
For separation of DNA fragments according to size, agarose gel electrophoresis was 
employed. 0.5g (1%) or lg (2%) agarose (Gibco) was dissolved in 50ml TAE buffer 
by heating in a microwave for 1 minute. Ethidium bromide was added to a final 
concentration of 0.5ng/ml before pouring the molten agarose into gel formers and 
allowing to set. Gels were immersed in TAE buffer containing 0.5p.g/ml ethidium 
bromide in electrophoresis tanks. 0.2 volumes DNA sample loading buffer were added 
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to each sample prior to loading into the wells. Gels were electrophoresed for 2 hours at 
lOV/cm and DNA bands visualised under long wave UV light (320nm). 
Polyacrylamide gel electrophoresis (PAGE) 
In some cases, DNA samples were separated by PAGE. 1mm thick gels were cast 
using the Bio-Rad Mini-Protean n protein gel apparatus. Al l glass plates used for 
casting gels were cleaned with 100% ethanol prior to use. A 10% separating and 4% 
stacking gel were prepared as follows: 
10% Separating 4% Stacking 
30% Acrylamide 3.33ml 0.67ml 
(29.2% acrylamide, 0.2% bisacrylamide) 
Distilled water 6.42ml 4.20ml 
5 Ox TAE buffer 0.20ml 0.10ml 
10% ammonium persulphate 0.05ml 0.025ml 
N,N,N' ,N ' -tetramethy lemylenechamine 0.005ml 0.005ml 
(TEMED) 
Total: 10ml Total: 5ml 
3.8ml of the separating gel mixture was pipetted into the gel casting apparatus, 
overlaid with 200(il isopropanol and left for 1 hour to set. The isopropanol was poured 
off and 1ml of the stacking gel mixture was pipetted on top of the separating gel and 
the comb inserted. After 1 hour, the cast gel was placed into the electrophoresis tank 
and immersed in TAE buffer. 0.2 volumes DNA sample loading buffer was added to 
each sample prior to loading into the wells. Gels were electrophoresed for 1.5 hours at 
20V/cm then soaked in TAE buffer containing 0.5jxg/ml ethidium bromide for 30 
minutes and DNA bands were visualised under long wave UV light (320nm). 
Purification of DNA from agarose gels using silica fines 
The DNA band of interest was excised from a 1% agarose gel using a straight-edged 
razor blade. The excised piece of agarose was placed in an eppendorf tube, weighed, 
and 3 volumes of sodium iodide stock solution (6M sodium iodide, 0.1M sodium 
sulphite in ddH 20) were added. The tube was incubated at 50°C for 5 minutes to allow 
the agarose to melt. lOjxl silica fines (50% w/v in ddH 20), generously donated by Prof. 
N . Robinson of Newcastle University, was added and the tube incubated for 15 
minutes at 50°C, mixing every 3 minutes to keep the silica fines in suspension. The 
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silica fines were pelleted by spinning at 15000rpm for 5 seconds, the supernatant was 
removed and replaced with 500ul 70% ethanol. This wash step was repeated before 
removing as much 70% ethanol as possible by pipetting and allowing the rest to 
evaporate for 2 minutes at RT. The silica fines were eluted by resuspending in lOjxl 
ddH 20 and incubating for 5 minutes at 50°C. After spinning at 15000rpm for 5 
minutes, the supernatant containing the DNA was transferred to another tube and 
stored at -20°C. 
Preparation of plasmid DNA 
Small scale purification of plasmid DNA from 1.5ml overnight cultures of E.coli was 
carried out using the Genie DNA Extraction Kit (Helena Biosciences). The cultures 
were spun in eppendorfs for 30 seconds at 15000rpm to pellet the E.coli cells which 
were then resuspended in 150|il Solution I (50mM glucose, lOmM EDTA (pH8.0), 
25mM Tris HC1 (pH8.0). 150|il Solution I I (0.2M NaOH, 2% (w/v) SDS) was added to 
lyse the cells before addition of Solution HI (3M Potassium acetate, 0.1% (v/v) glacial 
acetic acid). The tubes were spun at 15000rpm for 5 minutes to pellet the precipitated 
protein and genomic DNA. The supernatant was added to 200jil DNA Binding Resin 
and the plasmid DNA captured by spinning at 15000rpm for 30 seconds in the columns 
provided. Captured DNA was washed once in 500^1 70% ethanol before being eluted 
in 50fjl ddH 20 and stored at -20°C. 
Ligation reactions 
DNA fragments with compatible cohesive ends produced by restriction enzyme 
digestion were ligated together using T4 DNA ligase (MBI Fermentas). A molar ratio 
of vector to insert DNA of 3:1 was used in each ligation in a total volume of \0\A. 
Added to each reaction were 0.1 volumes of lOx ligation buffer (Boehringer 
Mannheim) and 4 units T4 DNA ligase. Ligation reactions were incubated for 3-4 
hours at 14°C. 
2.2.1.4 General Protein Manipulations 
SDS-PAGE 
Denatured proteins were separated according to size by SDS-PAGE. 1mm thick gels 
were cast and electrophoresed using the Bio-Rad Mini-Protean I I protein gel apparatus. 
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Al l glass plates used for casting gels were cleaned with 100% ethanol prior to use. A 
10% separating and 4% stacking gel were prepared as follows: 
10% Separating 4% Stacking 
30% Acrylamide 3.33ml 0.67ml 
(29.2% acrylamide, 0.2% bisacrylamide) 
Distilled water 3.61ml 2.80ml 
1.5M Tris HC1 (pH8.8) 2.50ml -
0.5M Tris HC1 (pH6.8) - 1.25ml 
2% SDS 0.50ml 0.25ml 
10% ammonium persulphate 0.05ml 0.025ml 
TEMED 0.005ml 0.005ml 
Total: 10ml Total: 5ml 
3.8ml of the separating gel mixture was pipetted into the gel casting apparatus, 
overlaid with 200^1 isopropanol and left for 1 hour to set. The isopropanol was poured 
off and 1ml of the stacking gel mixture was pipetted on top of the separating gel and 
the comb inserted. After 1 hour, the cast gel was placed into the electrophoresis tank 
and immersed in SDS gel running buffer. 0.2 volume protein sample loading buffer 
was added to each sample which was then boiled for 3 minutes to denature the protein. 
Standard protein size markers were included for comparison and all samples were 
loaded into wells and the gel electrophoresed at 200V for 45 minutes. 
Coomassie staining of protein gels 
Following electrophoresis, gels were incubated for 1 hour at RT in 20ml protein stain 
solution (0.25g Coomassie blue, 45ml methanol, 45ml distilled water, 10ml glacial 
acetic acid) on a rocker platform. Gels were then transferred to 20ml de-stain solution 
(45ml methanol, 45ml distilled water, 10ml glacial acetic acid) and incubated for 
several hours, or until the background was clear and protein bands were visible. 
Western blotting 
Transfer of proteins from polyacrylamide gels to nitrocellulose was carried out using 
the Bio-Rad Trans-Blot® Electrophoretic Transfer cell. Following separation of 
proteins by SDS-PAGE, gels were placed in 50ml transfer buffer (25mM Tris, 192mM 
glycine, 20% methanol) and soaked for 15 minutes to remove SDS. The gel was placed 
on top of a piece of nitrocellulose (Schleicher and Schuell) and sandwiched between 4 
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sheets of 3MM paper (Whatman). The gel sandwich was placed between two fibre 
pads (Bio-Rad) before assembling in the transfer cell and immersing in an 
electrophoresis tank filled with transfer buffer. 30V was applied to the transfer cell 
overnight. To check for transfer of proteins, nitrocellulose filters were stained in 20ml 
Ponceau red stain (0.2% Ponceau S, 3% trichloroacetic acid in distilled water) and de-
stained in 20ml 5% acetic acid in distilled water. 
2.2.2 Phage Display Library Construction 
2.2.2.1 Bacterial Strains 
The strains of Escherichia coli used for recombinant antibody expression were as 
follows:-
XLl-Blue endAl, hsdKll (r k-m k+), sw/?E44, thi-l, recAl, gyrA96, relAl, 
A(lac), [F'proAB, lacl q, lacZAM15, TnlO (Tef)] 
JM83 thiA, lac-, proAB, xyl, ara, mtl, rpsL (<|>80 lacZ AM 15), X-
2.2.2.2 Bacterial Growth Media 
The media used for growing bacteria were made up as follows:-
2xYT medium: 
16g Trypticase peptone (Becton-Dickinson) 
lOg Yeast extract (Oxoid) 
5g NaCl 
Made up to 1 litre with distilled water 
(For 2xYT agar, 15g agar (Gibco) was added) 
(For 2xYT soft-agar, 7.5g agar (Gibco) was added) 
This solution was autoclaved before use. 
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NE (non-expression) medium: 
2xYT broth or 2xYT agar was made up, autoclaved and allowed to cool 
before the addition of 0.05 volumes of 20% glucose and 25p.g/ml 
chloramphenicol 
LE (low expression) medium: 
2xYT broth or 2xYT agar was made up, autoclaved and allowed to cool 
before the addition of 0.05 volumes of 20% glucose, 25(ig/ml 
chloramphenicol and 0.5mM isopropyl-8-D-thiogalactoside (IPTG) 
(Melford laboratories) 
Expression medium: 
2xYT broth or 2xYT agar was made up, autoclaved and allowed to cool 
before the addition of 25|ig/ml chloramphenicol. 
2.2.2.3 Immunisation of Mice with Xenopus B 3 B 7 Tumour Cells 
Two Balb/C mice were each given two intra-peritoneal injections of lx lO 7 B 3 B 7 
tumour cells in 0.25ml PBS over a twenty day period. After the second injection, a test 
bleed was performed on the mice to confirm the reactivity of the serum to B 3 B 7 cells 
by flow cytometry (data not shown). Two weeks after the second injection, the mice 
were killed by cervical dislocation and the spleens were dissected out. 
2.2.2.4 Isolation of Total RNA from the Spleen of Immunised Mice 
A l l tubes in contact with RNA were previously treated with 'RNase AWAY' 
(Molecular Bio-Products, San Diego) to remove RNA degrading enzymes. RNase-free 
tips (Molecular Bio-Products, San Diego) were used for pipetting all solutions 
containing RNA. 
Splenocytes were flushed from the dissected mouse spleen using a hypodermic needle 
attached to a syringe containing phosphate buffered saline (PBS). The spleen cells 
were washed with 50ml PBS and then spun down in a 50ml Falcon tube for 5 minutes 
at 2000rpm. The supernatant was removed carefully and replaced with 8ml of TRI 
reagent (Sigma) before vortexing for 3-4 minutes to resuspend the cell pellet. The tube 
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was left to stand for 10 minutes at RT to lyse the spleen cells. 1.6ml of water saturated 
chloroform:isoamylalcohol (24:1) was added and the tube shaken for 15 seconds, then 
left to stand for 15 minutes at RT. The tube was spun for 5 minutes at 5000rpm and the 
upper aqueous layer, containing the RNA was transferred to eppendorf tubes in 900^1 
aliquots, taking care to avoid the DNA-containing interface. 600fj! of isopropanol was 
added to each tube and the tubes were mixed and then left to stand for 1.5 hours to 
allow the RNA to precipitate. The eppendorfs were spun at 12,000g for 15 minutes in 
a micro-centrifuge and the supernatant discarded carefully before resuspending the 
RNA pellet in 1ml 70% ethanol. These tubes were again spun at 12,000g for 15 
minutes before removing the supernatant carefully and allowing the RNA pellet to dry 
for 5 minutes at RT. The pellet was resuspended in 200JJ1 nuclease-free water and the 
amount of RNA was quantified using a UV spectrophotometer, as described in Section 
2.2.2.5 RT-PCR Amplification of V H and V L DNA Fragments 
The VH and VL forward and reverse primer sets used for the amplification of mouse 
V H and V L regions are described in Appendix 1. Two separate RT-PCR reactions 
were performed in RNase-free eppendorf tubes to amplify V H and VL fragments: 
The tube was heated to 65°C for 15 minutes, then placed onto ice before addition of 
the following components: 
The samples were overlaid with mineral oil and the following RT-PCR reaction was 
performed in a Perkin Elmer thermal cycler: 
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2.2.1.3 
lOOngRNA 
Nuclease-free water 
lOx PGR buffer (Boehringer Mannheim) 
lOmM dNTP's (Gibco) 
40 units RNase inhibitor (Promega) 
0.1M Dithiothreitol (Gibco) 
lOfigBSA 
V H or VL reverse primer mix 
5^1 
71^1 
10|xl 
2^1 
1^ 1 
0.5|il 
5^d 
2pl 
5 units Taq polymerase (Boehringer Mannheim) I j j l 
200 units Superscript I I Reverse Transcriptase (Gibco) l^ i l 
V H or VL forward primer mix 2\A 
48°C 1 hour 1 cycle [Reverse transcriptase reaction] 
92°C 3 minutes 1 cycle [Denaturation] 
92°C 1 minute [Denaturation] 
63°C 
58°C 
30 seconds 
50 seconds 
• 7 cycles 
[Annealing] 
[Annealing] 
72°C 1 minute [Elongation] 
92°C 1 minute - [Denaturation] 
63°C 30 seconds > 30 cycles [Annealing] 
72°C 1 minute [Elongation] 
2.2.2.6 Splicing by Overlap Extension (SOE)-PCR to Join V H and V L DNA 
The following components were added to an eppendorf tube:-
lOng V H DNA 2]ol 
lOng VL DNA 2(il 
lOx PCR buffer (Boehringer Mannheim) 5 pi 
lOmM dNTP's (Gibco) 1^ 1 
5 units Taq polymerase (Boehringer Mannheim) 1^ 1 
ddH 20 37jJ 
The tubes were overlaid with mineral oil and incubated in a Perkin Elmer thermal 
cycler as follows: 
92°C 
92°C 
63°C 
58°C 
72°C 
3 minutes 
1 minute 
30 seconds 
50 seconds 
1 minute 
1 cycle 
• 2 cycles 
[Denaturation] 
[Denaturation] 
[Annealing] 
[Annealing] 
[Elongation] 
The primers required to amplify the ful l length scFv fragments (see Appendix 1) were 
then added: 
ScFor 
ScBack 
l j i l 
29 
The remainder of the SOE-PCR reaction was then carried out: 
92°C 1 minute [Denaturation] 
[Annealing] 
[Elongation] 
63°C 30 seconds 23 cycles 
72°C 1 minute 
2.2.2.7 Ligation and Transformation Reactions 
The scFv insert and pAKlOO phage display vector (see Appendix 2) were both 
digested with Sfil for 2-3 hours at 50°C and then purified from agarose using silica 
fines. Ligation reactions were performed as described in Section 2.2.1.3. The reaction 
volume was then made up to 50|il with ddH 20 and 500|il n-butanol was added to 
precipitate the DNA. The tube was vortexed for 5 seconds and then spun at 15000rpm 
for lOminutes. The supernatant was removed and the DNA pellet resuspended in 15|il 
water. 
The precipitated ligation reaction was added to 40^1 electrocompetent XL 1-Blue E.coli 
in an electroporation cuvette (Flowgen). A Bio-Rad Gene Pulser™ was used to apply 
10000 volts/cm to the cuvette for approximately 4.5 milliseconds and the bacteria were 
then transferred to 200jol 2xYT medium and incubated for 1 hour at 37°C. Aliquots of 
this were then plated onto NE agar and incubated overnight at 37°C. Transform ants 
were collected into 2xYT medium and stored at -80°C in 40% glycerol. 
2.2.2.8 R F L P Analysis of scFv Sequences 
scFv sequences were amplified by PCR from individual colonies of bacteria 
harbouring the scFv-containing phagemid pAKlOO. Colony PCR's were performed in 
20JJ1 volumes, made up as follows: 
1 Ox PCR buffer (Boehringer Mannheim) 2^1 
lOmM dNTP's (Gibco) 0.5ul 
ScFor 0.5ul 
ScBack 0.5ul 
Taq polymerase (Boehringer Mannheim) 0.2|j.l 
ddH 20 16.3^1 
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A nichrome wire was sterilised by passing through a flame, then touched on a bacterial 
colony and used to transfer bacteria to the PCR reaction tube. The PCR reaction was 
overlaid with mineral oil and subjected to the following cycles in a Perkin Elmer 
thermal cycler. 
94°C 
52°C 
68°C 
68°C 
1 minute 
1 minute 
2 minute 
7 minutes 
30 cycles 
1 cycle 
[Denaturation] 
[Annealing] 
[Elongation] 
[Elongation] 
HaeHI digestion was carried out on lOjxl of the completed PCR reaction in a total 
volume of 20|il (as described in Section 2.2.1.3). Digested samples were analysed by 
agarose gel electrophoresis or PAGE. 
2.2.2.9 Rescue and Titration of Phage-scFv's 
The phagemid-scFv library which had been transformed into E.coli strain XLl-Blue 
was retrieved from storage at -80°C and grown at 37°C in 50ml NE medium to an 
optical density at 550nm (OD 5 5 0 ) of 0.5 (determined by spectrophotometry). 101 1 
VCSM13 helper bacteriophage (Stratagene) and 25\A 1MIPTG were added and the 
culture incubated at 37°C without agitation for 15 minutes. A further 100ml LE 
medium was added and the culture shaken for 10 hours at 30°C. 2 hours after 
infection, 30f4.g/ml kanamycin was added. Following incubation, bacteria were pelleted 
by centrifugation at 5000rpm for 10 minutes and the supernatant removed to fresh 
tubes. 1/6 volume of 20% polyethylene glycol (PEG) 8000, 2.5M NaCl was added and 
tubes left to stand for 15 minutes at RT to allow phage particles to precipitate. Phage 
were pelleted by centrifugation at 5000rpm for 10 minutes and resuspended in 15ml 
APBS. 1/6 volume of 20% PEG 8000, 2.5M NaCl was added and the tubes left to 
stand for 15 minutes at RT, before spinning at 5000rpm for 10 minutes. Phage were 
resuspended in 1ml FACS buffer and spun at 15000rpm for 5 minutes to pellet any 
debris. The supernatant was transferred to a new tube and stored at 4°C. 
A dilution series of recombinant phage particles was titred by incubating briefly with 
XLl-Blue to allow infection, then plating the XLl-Blue on NE agar and counting the 
numbers of chloramphenicol-resistant colony forming units (CFU's) which arose from 
phagemid infection. A 5ml culture of XLl-Blue was grown overnight at 37°C in 2xYT 
containing 10|j,g/ml tetracycline. A tenfold dilution series of the phage (down to a 
dilution of 10"11) was performed in 10|jl volumes of water. Each dilution was added to 
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a 40|xl aliquot of the X L 1-Blue overnight culture and incubated at 37°C without 
agitation for 15 minutes. XL 1-Blue cells were then plated onto NE agar and incubated 
overnight at 37°C. 
2.2.2.10 Amplification and Titration of Wild-Type (Helper) M13 Phage 
5ml 2xYT containing lOjig/ml tetracycline was inoculated with XLl-Blue and 
incubated overnight at 37°C. 500|il of the overnight culture was added to 17ml 2xYT 
(plus 10ng/ml tetracycline) and grown to an O D 5 5 0 of 1. 1011 VCSM13 helper phage 
were added and the flask left to stand at 37°C for 30 minutes. The flask was then 
shaken overnight at 30°C, with 30ug/ml kanamycin added 2 hours after the addition of 
helper phage. Following overnight culture, the XLl-Blue cells were pelleted by 
spinning at 5000rpm for 10 minutes and the supernatant transferred to a fresh tube and 
heated to 65°C for 15 minutes. The supernatant was then distributed in 1ml aliquots to 
sterile eppendorf tubes and the phage precipitated with 1/6 volume 20% PEG 8000, 
2.5M NaCl (as in Section 2.2.2.9). Purified helper phage were then resuspended in 
FACS buffer and stored at 4°C. 
A dilution series of helper phage particles was titred by incubating briefly with X L l -
Blue to allow infection, then mixing the XLl-Blue with molten 2xYT soft-agar and 
plating on 2xYT agar and counting the numbers of plaque forming units (PFU's) 
which arose from phage infection. A 5ml culture of XLl-Blue was grown overnight at 
37°C in 2xYT containing 10jj,g/ml tetracycline. A tenfold dilution series of the phage 
(down to a dilution of 10"11) was performed in IOJJI volumes of water. Each dilution 
was added to a 40ul aliquot of the XLl-Blue overnight culture and incubated at 37°C 
without agitation for 15 minutes. XLl-Blue cells were then added to 3ml molten 2xYT 
soft-agar (pre-heated to 55°C) and immediately plated on 2xYT agar and incubated 
overnight at 30°C. 
2.2.3 Phage Display Panning on Xenopus cells 
2.2.3.1 Culture of Xenopus Tumour Cell Line B 3 B 7 
The Xenopus tumour cell line B 3 B 7 was grown in 50ml tissue culture flasks (Falcon) in 
10ml tumour medium in 5% C 0 2 at 27°C. The lids of the flasks were only loosely 
tightened to permit gaseous diffusion. Every 2-3 days the cells were subcultured by 
removing 1ml to a new flask containing 8ml fresh tumour medium. Tumour medium 
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was prepared by diluting 400ml serum-free medium to amphibian strength with 
distilled water. The medium was supplemented with 8% supernatant from the Xenopus 
A6 kidney cell line (Rafferty, 1969), 2% decomplemented foetal calf serum (FCS) 
(First Link) and 200ng/ml kanamycin (Gibco). Serum-free medium contains 500ml 
Iscove's medium (Gibco), 5ml lOOx non-essential amino acids (Gibco), 50ng/ml 
penicillin/streptomycin (Gibco), 5 i^g/ml insulin, 50mM mercaptoethanol and 1.5ml 
10% Primatone (Roche). 
2.2.3.2 Preparation of Xenopus Spleen Lymphocytes and Red Blood Cells 
Outbred Xenopus laevis were used for these studies and were bred and reared under 
standard conditions (Horton and Manning, 1972). Prior to dissection, animals were 
heavily anaesthetised in 3-amino-benzoic acid ethyl ester (MS222). Spleens were 
dissected out with forceps and micro-scissors and placed in 3.5cm petri dishes (Costar) 
in 3ml FACS buffer. The spleens were teased apart to release splenocytes into the 
FACS buffer which was then transferred to a 15ml Falcon centrifuge tube (Becton 
Dickinson). After pipetting to break up clumps of cells, debris was allowed to settle 
and the supernatant carefully pipetted on top of 3ml 1.077 density Ficoll (Amersham-
Pharmacia) in a fresh 15ml tube. This tube was centrifuged at 4°C for 5 minutes at 
250g and lymphocytes removed from a tight band above the Ficoll layer to a new 15ml 
tube. The red blood cells (RBC's) which had pelleted below the Ficoll layer were also 
transferred to a new 15ml tube. Both cell populations were resuspended in 5ml FACS 
buffer and centrifuged at 4°C for 10 minutes at 300g to pellet the cells. After removal 
of the supernatant, the cells were resuspended in 1ml FACS buffer and a 10|xl aliquot 
pipetted into a haemocytometer for counting cell numbers. Cells were either used 
directly or transferred to 24 well plates (Becton Dickinson) in 1ml tumour medium and 
incubated at 27°C in 5% C 0 2 for up to 3 days. 
2.2.3.3 Panning the Phage-ScFv Library by Subtractive Isolation 
1 x 101 0 of the 'anti-B 3B7' phage-scFv library and 1 x 10 1 0 wild type phage (control) in 
lml FACS buffer were each added to eppendorf tubes containing lx lO 6 RBC's and 
incubated for 2 hours at 4°C with rotation. The cells were spun down at 3,400 rpm for 
2 minutes and the supematants were transferred to tubes containing lx lO 6 B 3 B 7 cells 
and incubated for 2 hours at 4°C with rotation. After incubation, lOOul was removed 
for flow cytometric analysis (also called fluorescence-activated cell sorting (FACS) 
analysis; see Section 2.2.3.6). The remaining 900jil was spun down at 3,400 rpm for 1 
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min and the supernatant removed and replaced with 1ml FACS buffer. This wash step 
was repeated a further 6 times to remove unbound phage. 
Bound phage were eluted by adding lOOul 0.1M glycine/HCl pH2.2 to the pelleted 
cells and incubating at RT for 10 minutes. Cell debris was then spun down at 6,900 
rpm for 1 min and the supernatant neutralised with lOOul lOmM Tris HC1 pH8.0. 2jxl 
was removed at this point to test for elution titres (Section 2.2.3.4). The remainder of 
the eluted phage was added to 500pl of overnight cultured XLl-Blue and incubated at 
37°C for 30 rninutes without shaking. The XLl-Blue were then added to 50ml of NE 
medium and grown at 37°C to an O D 5 5 0 of 0.5 before preparation of phage as 
described in Section 2.2.2.9. The same protocol was employed in all subsequent 
rounds of panning. 
2.2.3.4 Testing Enrichment by Elution titres 
The 1:100 dilution of eluted recombinant phage and eluted wild type phage (control) 
were further diluted in 3 tenfold dilutions down to 10"6 in 10|xl volumes. The phage 
were titred by infection of XLl-Blue and counting subsequent CFU's for recombinant 
phage (as described in Section 2.2.2.9) and by counting PFU's for wild type phage (as 
in Section 2.2.2.10). 
2.2.3.5 Testing Enrichment by R F L P Analysis 
Individual scFv sequences were amplified by PCR from colonies of phagemid-
transformed bacteria after each round of panning (as in Section 2.2.2.8). HaeHI 
digestion and analysis by agarose gel electrophoresis or PAGE were also performed as 
described in Section 2.2.2.8. 
2.2.3.6 Testing Enrichment by Flow Cytometric (FACS) Analysis 
For flow cytometric analysis, the 100fil aliquots of B 3 B 7 cells removed from the 
recombinant library phage and wild type phage panning steps (Section 2.2.3.3) were 
each washed three times in 1ml of fresh FACS buffer, with spins performed at 300g 
for 10 rninutes at 4°C. The 2 aliquots of cells were resuspended in 400ul of FACS 
buffer and each transferred to 2 wells of a 96-well microtitre plate (Becton Dickinson). 
The following is an overview of the antibody incubations performed in separate wells 
prior to FACS analysis:-
34 
B 3 B 7 cells plus 
library phage 
rabbit anti-M13 antibody F I T C conjugated goat 
anti-rabbit Ig antibody 
B3B7 cells plus 
library phage 
no rabbit anti-M13 antibody F I T C conjugated goat 
anti-rabbit Ig antibody 
B3B7 cells plus 
wild type phage 
rabbit anti-M13 antibody F I T C conjugated goat 
anti-rabbit Ig antibody 
B3B7 cells plus 
wild type phage 
no rabbit anti-M13 antibody F I T C conjugated goat 
anti-rabbit Ig antibody 
Both the detecting antibodies were adsorbed with a 1:20 dilution of filter-sterilised 
Xenopus serum prior to incubation with B 3 B 7 cells. The rabbit anti-M13 antibody was 
used at a working dilution of 1:1000 and applied to the cells in a 50JJ1 volume before 
incubating on ice for 30 minutes. The cells were then washed three times in 200 ,^1 
F A C S buffer, with spins performed at 300g for 10 minutes at 4°C. The F I T C 
conjugated goat anti-rabbit Ig antibody was diluted to 1:160 and applied to the cells in 
a 50^1 volume before incubating on ice in the dark for 30 minutes. The cells were then 
washed three times in 200|ud FACS buffer, with spins performed at 300g for 10 
minutes at 4°C, before resuspending in 500j±l F A C S buffer for flow cytometric 
analysis. 
Flow cytometry was performed using a Coulter Epics® X L - M C L flow cytometer in 
conjunction with the Epics® X L - M C L and E X P O software for data analysis. F I T C 
fluorescence on cells was detected by the fluorescence 1 (FL1) sensor, which detects 
light with a wavelength of between 505 and 545nm. Background levels of fluorescence 
were set at 2% using the control sample in which the anti-M13 antibody was omitted. 
2.2.4 Manipulations of Individual Phage Antibodies 
2.2.4.1 Isolation and Rescue of Individual Phage Antibodies 
For growing up individual phage antibodies, a colony of XLl-Blue E.coli bearing the 
phagemid-scFv of interest was used to inoculate 50ml N E medium and the culture was 
grown at 37°C until the O D 5 5 0 reached 0.5. The recombinant phage-scFv's were then 
grown up, rescued, purified and titred as in Section 2.2.2.9. 
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2.2.4.2 Single and Dual Stain FACS Analysis 
The protocol for labelling cells with phage for F A C S analysis was the same for B 3 B 7 
cells, splenocytes and red blood cells. In each case, 5xl0 5 cells were incubated with 
l x l O 1 0 phage-scFv's for 1 hour on ice. The method for labelling with antibodies and 
for F A C S analysis was then exactly as described in Section 2.2.3.6. 
For dual stain analysis, the cells were first labelled with phage as described above, 
washed three times in F A C S buffer and transferred to a 96 well plate. The rabbit anti-
M13 antibody, adsorbed on 1:20 Xenopus serum and then diluted 1:1000, was applied 
to the cells in a 50ul volume as before except that included in this 50(il volume was 
the co-staining mouse mAb 8E4, at a dilution of 1:30, or 2B1 at a dilution of 1:15 (For 
details of md-Xenopus mAb's see Appendix 3). The cells were washed three times in 
F A C S buffer and the goat anti-rabbit Ig F I T C , adsorbed on Xenopus serum and diluted 
to 1:160, was then added and the cells incubated on ice in the dark for 30 minutes. The 
cells were washed three times in F A C S buffer containing 1:100 filter-sterilised normal 
rabbit serum before detection of the co-staining antibody with phycoeiythrin (PE)-
conjugated rabbit anti-mouse Ig antibody (DAKO), adsorbed on Xenopus serum and 
diluted 1:20. Three further washes in F A C S buffer were carried out before 
resuspending the cells in 500jil F A C S buffer and analysing on the flow cytometer. 
The F I T C fluorescence was detected by the FL1 sensor and the PE fluorescence was 
detected by the FL2 sensor which detects light at 560 to 590nm. The control for F I T C 
fluorescence was the same as described above (Section 2.2.3.6). The control for PE 
fluorescence was to run a sample in which the co-staining mouse mAb had been 
omitted, but the PE-conjugated rabbit anti-mouse Ig included. 
2.2.4.3 Western Blotting of Phage Particles to Detect scFv Fusion Proteins 
10 1 0 phage particles in 20pl APBS were added to 4jil protein sample loading buffer 
and boiled for 3 minutes to denature the protein. Samples were subjected to SDS-
P A G E and transferred to nitrocellulose as described in Section 2.2.1.4. All the 
following manipulations of the nitrocellulose filters were carried out at R T on a rocker 
platform. After staining with Ponceau S to confirm protein transfer (as in Section 
2.2.1.4), the protein molecular weight size markers were marked in pencil and the 
Ponceau stain washed off by incubating the nitrocellulose in 50ml TBS for 10 minutes. 
The filter was then transferred to 50ml blocking solution (5% non-fat dried Marvel 
milk, 0.02% Tween 20 in TBS) for a further 10 minutes. This solution was then poured 
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off and replaced with a further 50ml blocking solution and left to incubate for 2 hours. 
Following blocking, the filters were incubated for 2 hours in lOmls blocking solution 
supplemented with ljjg/ml anti-FLAG mAb (Kodak), which detects a short peptide 
incorporated into the scFv protein. The filters were then washed three times in 20ml 
blocking buffer before transferring to lOmls blocking solution containing a 1:20000 
dilution of horseradish peroxidase (HRP)-conjugated goat anti-mouse IgG antibody. 
After two hours incubation, filters were washed three times in TBS and then 
transferred to a 10ml solution containing lOOmM Tris HC1 (pH8.5), 1.25mM luminol, 
0.2mM p-coumaric acid and 0.1% hydrogen peroxide for 1 minute in a dark room. 
Filters were blotted to remove excess moisture then placed on 3MM paper, covered 
with cling film and exposed to blue-sensitive X-ray film (Fujifilm) inside a film 
cassette for 5 minutes. Films were developed using a Compact X4 X-ray film 
processor (X-Ograph). 
2.2.4.4 Use of Individual Phage Antibodies to Probe Western Blots of B 3B 7CeU 
and Spleen Lymphocyte Lysates 
7 1 
1x10 B 3 B 7 cells and 1x10 spleen lymphocytes were washed twice in APBS before 
being resuspended in lOOjil lysis buffer (l%NP-40, 150mM NaCl, 50mM Tris HC1 
(pH8.0), ImM MgCb, ImM phenylmethane sulphonyl fluoride (PMSF), lug/ml 
leupeptin and ljxg/ml pepstatin A). The cells were lysed on ice for 30 minutes then 
spun at 15000rpm for 3 minutes to remove insoluble material. 20|il aliquots of the 
supernatant were added to 4^1 protein sample loading buffer and the samples subjected 
to SDS-PAGE and transferred to nitrocellulose (as in Section 2.2.1.4). Nitrocellulose 
filters were probed using the same conditions as those described in Section 2.2.4.3 
with the following exceptions. The primary antibody was either the phage antibody or 
wild type M13 phage at a concentration of 101 1 phage per ml of blocking buffer. Phage 
were detected using a mouse anti-M13 antibody (1:1000), followed by an HRP-
conjugated goat anti-mouse IgG antibody (1:20000). 
2.2.5 Manipulation of Soluble Antibody Fragments 
2.2.5.1 Production of Soluble ScFv's From E.coli Strain JM83 
DNA encoding the single chain variable fragment (scFv) was isolated from the 
phagemid vector pAKlOO following restriction digestion with the enzyme Sfil and gel 
purification of the DNA (Section 2.2.1.3). The scFv was cloned into the expression 
vector pAK400 (see Appendix 2), which had also been digested with Sfil, using the 
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ligation protocol described in Section 2.2.1.3. Ligation reactions were transformed into 
the non-suppressor E.coli strain JM83. Transformed colonies were grown at 30°C in 
50ml expression medium to an OD 6 0o of 1.5. The cells were pelleted by centrifugation 
at 6000 rpm for 20 minutes at 4°C and the supernatant removed. The cells were 
resuspended in 1ml 30mM Tris HC1 (pH8.0), 20% sucrose, transferred to an eppendorf 
tube and shaken on ice for 10 minutes. Centrifugation at 15000rpm for 10 minutes was 
used to pellet the cells again and the supernatant was discarded. The cells were 
resuspended in 600ul 5mM MgS0 4 and shaken on ice for 10 minutes. The tube was 
spun at 15000rpm for 10 minutes and the supernatant (the osmotic shock fluid 
containing scFv proteins) was stored at 4°C. 
2.2.5.2 Purification of Soluble ScFv's using the Ni-NTA Spin Kit (Qiagen) 
The purification of scFv's was permitted by the incorporation of a sequence encoding 
a polyhistidine tag sequence at the 3' end of the scFv DNA (see Appendix 2). The 
purification was performed using Ni-NTA spin columns (Qiagen) using the method 
enclosed with the kit. Briefly, spin columns were equilibrated by adding 600^1 wash 
buffer (50mM NaH 2PO 4(pH8.0), 300mM NaCl, 50mM imidazole), spinning at 
2000rpm for 2 minutes at 4°C and discarding the excess liquid. 600ul osmotic shock 
fluid (described in Section 2.2.5.1) was added, the column was spun again, using the 
same spin conditions, and the flow-through was saved for analysis. The column was 
washed twice with wash buffer and the flow-through was saved each time for analysis. 
Finally, the scFv's were eluted by adding 200jil elution buffer (50mM N a H 2 P 0 4 
(pH8.0), 300mM NaCl, 250mM imidazole), spinning again and transferring the eluate 
to a fresh tube. Purified scFv protein was verified by SDS-PAGE analysis and then 
stored at -20°C. 
2.2.5 J FACS Analysis of Soluble ScFv's 
For analysis of soluble scFv labelling of Xenopus cells, 3xl0 5 cells (either B 3 B 7 or 
spleen lymphocytes) were incubated with lpig/ml soluble scFv in 50pl FACS buffer on 
ice for 30 minutes. The cells were washed three times in 200^1 F A C S buffer before 
adding 50^1 F1TC conjugated rabbit anti-mouse Ig antibody (DAKO), adsorbed on 
Xenopus serum and diluted 1:20, and incubating on ice in the dark for 30 minutes. 
Cells were washed three times in 200jxl F A C S buffer before resuspending in 500ul 
F A C S and analysing on the flow cytometer. 
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2.3 Results 
23.1 Construction of the 0-6387 Phage Display Library 
2.3.1.1 Amplification of the VH and VL Fragments by RT-PCR 
Following immunisation with B 3 B 7 cells, RNA was isolated from the spleens of the 
mice as described in Section 2.2.2.4 and two separate RT-PCR reactions were set up 
for the amplification of V H and V L DNA (Section 2.2.2.5). A tenth of each completed 
RT-PCR reaction was analysed by agarose gel electrophoresis (see Figure 2.2). The 
presence of DNA bands at the predicted sizes of 386-440bp for V H and 375-402bp for 
V L (Krebber et al., 1997) indicated that RT-PCR reactions were successful. V H and 
V L bands were excised from agarose gels and the DNA purified using silica fines, as 
described in Section 2.2.1.3. 
23.1.2 Joining of the VH and VL Regions by PCR 
The primers designed by Krebber et al incorporate short complementary sequences 
into the V H and V L fragments which allow them to be joined using splicing by overlap 
extension (SOE)-PCR. Using V H and V L DNA purified from agarose, an SOE-PCR 
reaction was set up in a I O O J J I volume (As described in Section 2.2.2.6). After 
completion of the reaction, I O J J I was removed for electrophoretic analysis (Figure 2.3). 
A band of around 800bp was seen which indicated that pairs of V H and V L DNA 
fragments had been joined together to form scFv-encoding DNA fragments. The band 
corresponding to the scFv DNA was excised from the gel and purified using silica 
fines. 
2.3.1.3 Cloning of the scFv DNA into the Phagemid Vector pAKlOO 
The phagemid vector pAKlOO, which was used for the cloning of scFv sequences, 
contains a chloramphenicol resistance gene that enables selection of bacteria which 
harbour the phagemid (Krebber et al., 1997). The pAKlOO vector also has two 
different restriction sites which are both recognised by the restriction endonuclease 
Sfil. These two Sfil restriction sites are also incorporated into the SOE-PCR primers, 
which permits directional cloning of scFv's into pAKlOO (Krebber et al., 1997). 
Separate Sfil restriction digests were performed on the pAKlOO vector and scFv inserts 
and the digested DNA was gel purified using silica fines. A ligation reaction was set 
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up with a molar ratio of vector to insert of 3:1. Control reactions were also carried out 
with vector alone to account for vector religation. Ligation mixtures were precipitated 
to remove buffer salts and electroporated into E.coli strain X L 1-blue (see Section 
2.2.2.7). Around 1000 chloramphenicol-resistant transformants resulted from a ligation 
reaction containing lOOng of vector and 25ng of insert. Less than 5 transformants per 
lOOng of vectors were due to vector religation. 
By performing a series of ligation reactions, a library of approximately 1x10s scFv's 
was transformed into E.coli and stored in glycerol at -80°C. 
23.1.4 Diversity of the scFv Library 
In order to verify the presence of scFv sequences in the transformant E.coli, ten 
individual colonies were used in separate 20^1 'colony-PCR' reactions to re-amplify 
their scFv sequences (Section 2.2.2.8). 10^1 of each reaction was examined by 
electrophoresis (Figure 2.4a). In addition, the diversity of the scFv sequences was 
assessed by digesting the other lO^il of P C R product with the frequent-cutting 
restriction endonuclease HaeDI. The digested DNA was separated on a 2% agarose gel 
to allow analysis of restriction fragment length polymorphisms (RFLP's) (see Figure 
2.4b). All ten randomly picked colonies contained scFv inserts and all ten gave 
different R F L P profiles suggesting that the library contained a diverse repertoire of 
scFv sequences. 
2.3.2 Panning the a-B 3B 7 Library 
Prior to parming, the phagemid-scFv library in E.coli was expressed on the surface of 
recombinant phage by infecting the E.coli with helper phage in a 50ml overnight 
culture. Following purification, the recombinant phage library had a titre of 5x l0 1 2 
CFU/ml. 
To remove non-specific phage-scFv's which might otherwise be enriched during 
panning, a method known as subtractive isolation was used (Van Ewjik et al., 1997). 
This involved pre-incubation of the recombinant phage with a population of adsorber 
cells, in this case Xenopus erythrocytes, before each round of panning on B 3 B 7 cells. 
Following incubation with phage, the B 3 B 7 cells were washed extensively to remove 
non-specific phage before eluting the specifically bound phage in a solution of low pH. 
Eluted phage were used to re-infect E.coli strain XLl-blue and consequently cultured 
and converted to phage-scFv's for further rounds of panning. 
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Three different strategies were used to test the effectiveness of panning in enriching 
the phage library for binders to B 3 B 7 cells. Firstly, the phage eluted from B 3 B 7 cells 
after each round of panning was titred to check for any increase due to selection of 
binding phage. Secondly, R F L P analysis was used on scFv's from various stages of 
panning to observe whether certain scFv sequences were being selected over others. 
Thirdly, flow cytometry was used during each round of panning to analyse the B3B7 
cells for phage bound to the cell surface. 
2.3.2.1 Testing for Enrichment by Elution Titres 
After each round of panning, an aliquot of the eluted phage was serially diluted and 
each dilution was titred. As a control for phage sticking non-specifically to cells, wild 
type M13 phage were panned in parallel to recombinant phage-scFv's and their elution 
titres were checked for comparison. The results (Table 2.1) show that over 3 rounds of 
panning there is an increase in the number of recombinant phage eluted from the cells 
whereas the elution titre of the wild type phage did not increase during panning. This 
suggest that the increase observed with the recombinant phage is due to an enrichment 
of the initial phage library for phage scFv's with specificity for B 3 B 7 cells. 
2.3.2.2 Testing for Enrichment using RFLP Analysis of ScFv Sequences 
R F L P analysis was performed on twelve randomly isolated scFv sequences after each 
round of panning (see Figure 2.5). After one round of panning, minimal selection of 
scFv's is apparent as all 12 R F L P patterns are different. However, after a second round 
of panning, one particular R F L P pattern was recurrent in 8 of the 12 samples (lanes 5 
to 12) and after a further round of panning this pattern was present in all 12 lanes. This 
suggested that one scFv was being strongly selected by panning for its ability to bind 
B 3 B 7 cells. 
2.3.2.3 Testing for Enrichment by Flow Cytometry 
During each round of panning, an aliquot of B 3 B 7 cells which had been incubated with 
recombinant phage was analysed by flow cytometry for the presence of phage bound 
to the cell surface. The cells were incubated with a rabbit anti-M13 antibody, followed 
by a FITC-conjugated anti-rabbit Ig antibody. As a control for background 
fluorescence, an aliquot of B 3 B 7 cells was also incubated with wild type phage before 
addition of the same anti-M13 and anti-rabbit F I T C antibodies. The results (Figure 
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2.6) show that recombinant phage which had been panned three times on B 3 B 7 cells 
were able to bind approximately 90% of the B 3 B 7 cells whereas wild type phage 
showed only background levels of fluorescence. 
2.3.3 Analysis of Individual Phage Antibodies 
2.3.3.1 Flow Cytometric Testing of 5 Individual Phage Antibodies for their Ability 
to Bind B 3 B 7 Cells 
Following the success of panning, it was decided that individual panned phage were to 
be tested separately for their ability to bind B 3 B 7 cells. Using the R F L P profiles 
obtained after 2 rounds of panning (Figure 2.5b), five phage expressing different scFv 
sequences were prepared for flow cytometric analysis. The five phage antibodies 
corresponding to the scFv sequences in lanes 1-5 of Figure 2.5b were designated X L B -
1 to XLB-5 respectively (for Xenopus laevis B 3 B 7 ) . Flow cytometric analysis (Figure 
2.7) showed that phage antibodies XLB-1 to X L B - 4 were poor at binding B 3 B 7 cells 
whereas X L B - 5 , which was strongly selected during panning, bound around 90% of 
B 3 B 7 cells. 
2.3.3.2 Verification of ScFv Expression on Phage XLB-5 by Western Blotting 
In order to confirm that phage X L B - 5 was expressing surface scFv, 10 1 0 phage 
particles were subjected to SDS-PAGE and then blotted to nitrocellulose. As a control, 
the same number of wild type phage particles were included in the Western blot. 
ScFv's were detected by virtue of the fact that they express a four amino-acid ' F L A G ' 
sequence which is bound by an anti-FLAG mouse mAb. This mAb was detected by an 
HRP-conjugated goat anti-mouse IgG antibody, followed by chemiluminescent 
detection of positive bands. The result shown in Figure 2.8 confirms that recombinant 
phage X L B - 5 does indeed express the ScFv fusion to cpin which is detected at 48 kDa 
by the anti-FLAG mAb. Also detectable are copies of the soluble scFv at 28kDa which 
are not fused to cpHI. 
2.3.3.3 FACS Analysis of Phage XLB-5 on Different Xenopus Cell Types 
The specificity of phage X L B - 5 was tested by labelling Xenopus spleen lymphocytes 
and Xenopus red blood cells and analysing by flow cytometry. The histograms (Figure 
2.9) show that X L B - 5 phage bound a distinct sub-population of both red blood cells 
(60% labelled with XLB-5 ) and spleen lymphocytes (53% X L B - 5 positive). 
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2.3.3.4 Dual Stain Analysis of Phage XLB-5 on Xenopus Splenocytes 
Dual stain analysis of spleen lymphocytes was conducted using X L B - 5 phage in 
conjunction with the mouse mAb's 2B1 and 8E4. 2B1 is an w\x-Xenopus CD5 
antibody which binds T-cells and 8E4 is an mti-Xenopus IgM antibody which binds B -
cells. Figure 2.10 shows the dual-stain histograms which were performed on spleen 
lymphocytes from two separate animals. X L B - 5 phage appears to bind a large and 
distinct subset, equivalent to 80%, of CD5-positive Xewopzvs T-cells and a distinct sub-
population, around 67%, of IgM-positive Xenopus B-cells. 
2.3.3.5 Probing Western Blots of B 3 B 7 and Spleen Lymphocyte Lysates with Phage 
XLB-5 
In order to identify the antigen bound by phage antibody X L B - 5 , Western blots of 
B 3 B 7 and spleen cell lysates were probed with phage antibody X L B - 5 , and wild type 
phage as a control. Detection was achieved using a mouse anti-M13 antibody, 
followed by an HRP-conjugated goat anti-mouse IgG antibody and chemiluminescent 
identification of protein bands. The result (Figure 2.11) shows that no specific protein 
band was identified by X L B - 5 , whereas the wild type phage displays some non-
specific background staining of Xenopus proteins. 
2.3.4 Production and Analysis of Soluble XLB-5 ScFv 
2.3.4.1 Purification of Soluble XLB-5 (sXLB-5) ScFv Fragments 
sXLB-5 was purified from E.coli JM83 cells using osmotic shock followed by His-tag 
purification using the Ni-NTA kit (Qiagen) as described in Sections 2.2.5.1 and 
2.2.5.2. The purity of sXLB-5 was confirmed by SDS-PAGE (Figure 2.12) which 
shows that the scFv had been successfully isolated from a complex mixture of E.coli 
proteins. 
2.3.4.2 FACS Analysis of sXLB-5 on B 3 B 7 Cells and Splenic Lymphocytes 
sXLB-5 was tested for its ability to bind B3B7 cells and splenic lymphocytes by flow 
cytometry (Section 2.2.5.3). Figure 2.13 shows that sXLB-5 is unable to bind B3B7 
cells but is able to bind a small population (9%) of splenic lymphocytes. 
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2.4 Discussion 
2.4.1 The Efficiency of Phage Display in Generating Antibodies to B 3 B 7 Cells 
The objective of the work detailed in this Chapter was to perform a 'trial run' of 
generating phage display antibodies to Xenopus cells, assessing whether it was 
possible to efficiently select phage antibodies which bound cellular epitopes displayed 
on B 3 B 7 Xenopus tumour cells. Using a method of subtractive isolation to remove 
general wa&rXenopus phage antibodies, 3 rounds of panning were performed on B3B7 
cells. Evidence from elution titres, R F L P and F A C S analysis strongly suggested that 
the original phage library, consisting of around 105 clones, became enriched for phage 
antibodies capable of binding to B3B7 cells. When five phage antibodies were isolated 
from the panned library and tested individually for their ability to bind B 3 B 7 cells, one 
of them, X L B - 5 , showed strong binding. The trial run was thus successful in raising a 
phage antibody which was able to bind to a surface epitope on the target cell. 
Furthermore, the scFv fusion to phage cpHI was detected in Western blots of phage 
X L B - 5 , suggesting that phage were binding through surface scFv molecules. 
Despite the success of panning in raising a single phage antibody X L B - 5 , it is often 
desirable to produce several antibodies to the target cell. The strong selection of X L B -
5 during 3 rounds of panning appears to have prevented selection of other, possibly 
lower affinity, phage antibodies to B 3 B 7 . The selection of higher affinity clones such 
as XLB-5 may have been favoured by the stringency of the wash conditions as every 
round of panning on B 3 B 7 cells included 7 x 1ml wash steps to remove non-
specifically bound phage prior to elution. Watters et al have reported that reducing the 
number of wash steps to 4 increases the number of specifically bound phage eluted 
during each round of panning. However, they also show in the same paper that using 
only 4 wash steps also increases the number of non-specifically bound phage which 
are eluted (Watters et al., 1997). Another study (De Bruin et al., 1999) reports that 
non-specifically eluted phage-scFv's can become enriched during amplification of the 
phage library between panning rounds if the encoded scFv offers growth advantages 
to the E.coli host. This could occur if, for example, a phagemid encodes an scFv which 
is not full-length. It was therefore decided that the more stringent wash conditions 
should continue to be used for future panning experiments. In addition the higher 
affinity phage antibodies selected by more stringent panning are likely to be of greater 
use when screening by F A C S analysis for antibodies which identify small sub-
populations of cells. It should be noted, however, that phage antibodies which produce 
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relatively poor results in F A C S analysis can display more convincing binding in other 
assays, such as immunocytochemistry (Palmer et al., 1997). 
One way to circumvent the problem of selecting only a small number of high affinity 
phage antibodies would be to screen a large number of phage antibodies, ie 50 to 100, 
after only 2 or 3 rounds of panning for their ability to bind the target cell. In addition 
to flow cytometric analysis, other assays, such as immunocytochemistry, could be used 
to increase the chance of detecting useful, lower affinity, phage antibodies. However, 
as the panning on B 3 B 7 cells was only intended as a trial run of phage display panning 
on Xenopus cells and due to the time-consuming nature of screening many phage 
antibodies, these modifications were not tested. 
2.4.2 Further Characterisation of Phage Antibody XLB-5 
Further flow cytometric testing of X L B - 5 on Xenopus splenic lymphocytes and red 
blood cells suggested that X L B - 5 bound a specific sub-population of both these cell 
types. These F A C S traces are indicative of specific binding as they feature distinct 
negative and positive peaks of fluorescence. In addition, X L B - 5 could be used in dual 
stain analysis, in conjunction with mouse mAb's 2B1 and 8E4, which identify 
Xenopus T cells and B cells respectively. The dual-stain traces further confirm that 
X L B - 5 is capable of highlighting a sub-population of Xenopus cells in the same way as 
hybridoma-derived mAb's to cell-surface structures. 
In order to probe the molecular nature of the antigen bound by X L B - 5 , Western blots 
were performed on both B 3 B 7 cells and spleen lymphocyte lysates, using X L B - 5 as the 
primary detecting antibody. Although phage antibodies have been used successfully in 
such assays (Nissim et al., 1994), X L B - 5 was unable to detect any specific protein 
bands. There is a strong possibility that this was due to the fact that X L B - 5 was raised 
against cell surface proteins in their native conformation. When the cell lysates were 
denatured, subjected to SDS-PAGE and blotted to nitrocellulose, the proteins were no 
longer in their native conformation and thus may have been unrecognisable to X L B - 5 . 
This problem may have been countered by immunoprecipitation of the X L B - 5 antigen 
from native lysates of B 3 B 7 protein, but the time consuming nature of such an 
experiment prevented it from being carried out. 
The production and purification of soluble X L B - 5 scFv was easily achieved after sub-
cloning of the scFv DNA into the high expression plasmid vector pAK400 (See 
Appendix 2). Surprisingly, the soluble, purified X L B - 5 scFv was incapable of binding 
B 3 B 7 cells and bound only -10% of Xenopus spleen lymphocytes instead of the -70% 
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bound by X L B - 5 phage. The only possible explanation for this change in binding 
specificity is that the soluble scFv molecule adopted a different conformation to the 
scFv/cpIII fusion protein expressed on the phage surface. 
The single and dual-stain F A C S traces of X L B - 5 phage on Xenopus spleen 
lymphocytes suggest an intriguing pattern of binding to subsets of both T-cells and B-
cells. In both cases, X L B - 5 appears to label 60 to 80% of cells. Unfortunately, X L B - 5 
also appears to bind to approximately 60% of red blood cells which suggests that it is 
not binding to a cell surface marker of major immunological interest. However, the 
ability of X L B - 5 to differentiate red blood cells, which are generally regarded as a 
fairly homogenous population, into 2 subsets is interesting and may be linked to the 
fact that amphibian red blood cells are nucleated and not perhaps as homogenous as 
mammalian RBC's . 
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Figure 2.1 An Overview of the Strategy for Production of Recombinant 
Ml3 Phage Expressing Surface ScFv's 
These diagrams illustrate the stages involved in the production of recombinant 
phage f rom an E.coli host containing a single scFv-encoding phagemid. The 
production of a library of recombinant phage would require a mixed population 
of E.coli host cells, each harbouring a different scFv-encoding phagemid. The 
diagrams are not drawn to scale. 
E. coli host cell 
o r i ^ 
scFv cpIII 
Phagemid 
scFv/cpIII 
fusion proteins 
A. The phagemid, containing the 
scFv DNA fused to the cplll gene 
and also the phage origin of 
replication (on), exists as a plasmid 
inside a male E.coli host with sex 
pili. The phagemid-containing host 
is only capable of producing the 
scFv/cpIII fusion proteins at this 
stage. 
r Phagemid 
Helper phage 
recombinant 
phage particles 
B. Upon infection of the host cell via 
the sex pili, the helper phage 
replicate and incorporate scFv/cpIII 
fusion proteins encoded by the 
phagemid. The resulting recombinant 
phage particles also incorporate the 
phagemid DNA due to the presence 
of the ori sequence. Recombinant 
phage are then extruded through the 
sex pili. N.B. It should be noted that 
wild type phage (lacking surface 
scFv) are extruded along with the 
recombinant phage. 
Phagemid 
C. The recombinant phage 
particle contains the phagemid 
DNA encoding the scFv/cpIII 
which it expresses on its surface. 
Upon re-infection of E.coli, the 
phagemid DNA reverts to the 
plasmid form, shown in part A. 
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Figure 2.2 V H and V L R T - P C R ' s 
1% agarose gel showing amplification of variable heavy (VH) and variable 
light (VL) chain D N A by RT-PCR. Template RNA was obtained f rom the 
spleens of mice immunised with B 3 B 7 cells. Lane 1 contains ^Pstl DNA 
markers. 
VH V L 
400bp 
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1% agarose gel showing the ability o f SOE-PCR to jo in V H and V L D N A 
fragments together to form scFv-encoding DNA fragments. V H and V L D N A 
are included for size comparison. Lane 1 contains APstI D N A size markers. 
VH V L SOE-PCR 
800bp scFv 
400bp 
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Figure 2.4 Diversity of ScFv Sequences in Library by R F L P Analysis 
10 scFv sequences were reamplified f rom the cx-B^B? phage library by PCR 
and analysed by gel electrophoresis (A). Following Haelll digestion, scFv 
fragments were run on a 2% agarose gel for analysis of RFLP's (B). Marker in 
lane 1 of both gels is M>stl DNA. 
A. 
B. 
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-
• 
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Table 2.1 Enrichment of Phage Binders during Panning on BgB^as 
assessed by Elution Titres 
The number of phage eluted from B 3 B 7 cells was recorded after each round of 
panning. Wild type (helper) phage were panned and titred in parallel as a 
control. Phage numbers are expressed as the total number of plaque forming 
units (PFU's) or colony forming units (CFU's) eluted from the cells. 
Elption i titre: wil d type Elution titre: recombinant 
phage (I W s ) : -phage (CFU's) 
Round 1 -100 -200 
Round 2 -300 -2000 
Round 3 -200 -100,000 
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Figure 2.5 Enrichment of Phage Binders as determined by R F L P 
Analysis of ScFv Sequences 
After each round of panning, 12 scFv sequences were amplified and digested 
with Haelll before separation on 2% agarose gels. M indicates iVPstl DNA. 
A. Round 1 
M l 2 3 4 5 6 M M 7 8 9 10 11 12 M 
B. Round 2 
M 1 2 3 4 5 6 M M 7 8 9 1011 12M 
d 
— ^—. . , i 1 - / 
L J 
C . Round 3 
M l 2 3 4 5 6 M 
^ ^ r * -
M 7 8 9 1011 12 M 
it -wj wjuw 
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Figure 2.6 Flow Cytometric Analysis of Phage during Panning 
During each round of panning, both wild type (WT) and recombinant phage 
were tested by flow cytometry for their ability to bind B 3 B 7 cells. Phage were 
detected by a rabbit anti-M13 antibody followed by a FITC-conjugated anti-
rabbit Ig antibody. The percentage of positively stained cells is indicated in the 
top-right corner of each histogram. 
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Figure 2.7 Flow cytometric Analysis of Five Individual Phage 
Antibodies following Panning 
Five different recombinant phage, isolated from the library which had been 
panned twice on B 3 B 7 cells, were tested individually by flow cytometry for 
their ability to bind B3B7. Phage were detected by a rabbit anti-M 13 antibody 
followed by a FITC-conjugated anti-rabbit antibody. 
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10 100 1000 
8% 
XLB-4 
Tfmr m r t n I I I I MM 1 100 1800 10 
92% 
XiLB-5 
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Figure 2,8 1 onfu matioii of ScFv/cpIII Fusion Protein on Phage XLB-5 
by Western Blotting 
1010 wild type (WT) and 1010 XLB-5 phage particles were separated by SDS-
PAGE and blotted to nitrocellulose. Blots were probed with a mouse mAb to a 
FLAG epitope expressed by the scFv, followed by an anti-mouse Ig antibody 
conjugated to horseradish peroxidase (HRP). Positive bands were detected by 
chemiluminescence. 
W T X L B - 5 
phage phage 
66kDa — 
45kDa — 
36kDa — 
29kDa — 
24kDa — 
20kDa — 
scFv/cpIII fusion 
protein 
scFv 
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Figure 2.9 Flow Cytometric Testing of XLB-5 onXehopus Red Blood 
Cells and Splenic Lymphocytes 
The specificity of XLB-5 was tested using flow cytometry on different 
Xenopus cell types. The first histogram (A) shows XLB-5 staining of red blood 
cells (RBC's) and'the second (B) shows XLB-5 staining of splenic 
lymphocytes. 
A . XL/B-5 
60% 
i i n rrrm I : l .1 I M i l l 
100 10 1OO0 
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Figure 2.10 Dual Stain Testing of XLB-5 Phage on Snlenocytes 
Spleen cells were dual-labelled by using XLB-5 (detected by FITC) in 
conjunction with phycoerythrin (PE) labelling of 2 antibodies to different 
Xenopus lymphocyte populations. The co-staining antibodies used were 2B1, 
an mii-Xenopus CD5 antibody which binds T-cells, and 8E4, an wnti-Xenopus 
IgM antibody which binds B-cells. The XLB-5 (FITC) fluorescence is 
measured on the X-axis of the histogram, while the PE fluorescence is shown 
on the Y-axis. The results shown on these histograms are gated for spleen 
lymphocytes. 
Spleen lymphocytes: 
I ' 1 I M i l l I . 1 I I I 
XLB-5 
Spleen lymphocytes: 
XLB-5 
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Figure 2.11 XLB-5 Phage as a Reagent in a Western Blot 
Protein lysates from B 3 B 7 cells and Xenopus spleen lymphocytes were 
separated by SDS-PAGE and transferred to nitrocellulose before being probed 
with XLB-5 phage (1011 per ml). Wild type (WT) phage (10 n per ml) were 
used in parallel as a control for non-specific binding. Bound phage were 
detected by a rabbit anti-M13 antibody, followed by an HRP-conjugated anti-
rabbit antibody. HRP activity was detected using chemiluminescence. 
116ka — 
66kDa — 
45kDa — 
36kDa — 
29kDa — 
24kDa — 
B 3 B 7 Spleen B 3 B 7 Spleen 
T 
XLB-5 
Phage 
~ " ~ v — 
W T 
Phage 
The WT phage control blot shown here is also displayed in Figure 3.14 as 
the experiments were performed at the same time. 
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Figure 2.12 His-tag Purification of Soluble XLB-5 (sXLB-5) 
Soluble XLB-5 scFv fragments, containing poly-histidine tag sequences, were 
purified from the periplasm of JM83 E.coli following osmotic shock of the 
cells. Ni-NTA spin columns (Qiagen) were used to specifically bind the poly-
histidine tag of the scFv fragments. Non-specifically bound proteins were 
washed away before elution of the scFv fragments. The following were 
analysed by SDS-PAGE: 
M Protein molecular weight markers 
1 Osmotic shock fluid 
2 Wash fluid 
3 Eluent containing scFv fragments 
66kDa 
45kDa 
36kDa 
29kDa 
24kDa 
20kDa 
14kDa 
tew* 
scFv 
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Figure 2.13 Flow cytometric testing of sXLB-5 on B3B7 cells smdXenopus 
spleen lymphocytes 
Purified, soluble XLB-5 scFv's were tested by flow cytometry for their ability 
to bind B 3 B 7 cells and spleen lymphocytes. ScFv's were detected by a FITC-
conjugated anti-mouse Ig antibody. 
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CHAPTER 3 
Attempts to Generate Phage Display Antibodies to 
Xenopus NK-like Cells 
Having shown in the previous Chapter that phage display technology is capable of 
raising specific phage antibodies to cellular epitopes on Xenopus B 3 B 7 cells, a similar 
panning protocol was used to try and raise antibodies to Xenopus NK-like cells. ScFv 
libraries were cloned from mice immunised with NK-enriched lymphocyte populations 
from thymectomised (Tx) Xenopus. Following panning to select phage binding to NK-
enriched splenocytes, phage antibodies of interest were isolated by flow cytometric 
screening on Xenopus splenocytes. 
3.1 Introduction 
3.1.1 NK-enriched Populations from Tx Xenopus 
In order to raise cell specific antibodies by hybridoma or phage display technology, it 
is useful to have pure preparations of these cells for the immunisation and screening 
stages. In the case of Xenopus NK cells, a degree of purification from total spleen 
mixtures is possible by depletion of other cell types. Firstly the problem of T-cell 
contamination can be removed by using spleen cells from Tx animals, which have been 
shown to lack functional T-cells (Horton et al., 1998b). In addition, immunomagnetic 
cell separation can be used to remove B cells and thrombocytes from the Tx spleen. 
The remaining cells, although not a pure Xenopus NK population, are highly enriched 
for NK cells. This has been verified by demonstrating effective spontaneous 
cytotoxicity of similar NK-enriched populations towards the MHC-deficient, 
allogeneic tumour target B 3 B 7 (Horton et al., 1998, Horton, T.L., pers. comm.). 
3.1.2 Phage Display Panning on Xenopus NK-enriched Cells 
The phage display panning protocol used in Chapter 2 was shown to be successful in 
selecting phage antibodies which bound whole, live cells. Flow cytometric testing of 
phage antibody XLB-5 on B 3 B 7 cells revealed a convincing and consistent binding 
ability, which was comparable with that of hybridoma-derived mAb's. As discussed in 
the previous Chapter, the B 3 B 7 panning protocol was thus successful in selecting phage 
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antibodies which bound with a high enough affinity to be useful in flow cytometric 
analysis. As a result, the protocol for panning on NK-enriched populations in this 
Chapter is based on the B 3 B 7 panning strategy. 
The ability of phage antibody XLB-5 to bind not only B 3 B 7 cells but also red blood 
cells, T-cells and B-cells suggested that it was binding to a common epitope expressed 
on many Xenopus cell types. To favour the production of phage antibodies to more 
specific epitopes on Xenopus cells, it is necessary to improve the negative selection 
step of the panning process so that non-specific phage antibodies are more effectively 
removed from the library. 
Another aspect of the trial run conducted on B 3 B 7 cells which requires improvement is 
the screening stage. Due to the limited number of antibodies screened after panning, 
only one phage antibody was isolated which showed strong binding to the target cell. 
By screening a larger number of phage antibodies from the panned library, it is hoped 
that several useful phage antibodies will be isolated. In addition, it will be necessary to 
optimise the VH and V L RT-PCR reactions in order to increase the size and diversity 
of the starter library. A further improvement is the incorporation of a proof-reading 
DNA polymerase enzyme into the PCR reactions to ensure the faithful copying of 
mouse VH and V L sequences and thus increase the percentage of scFv's in the starter 
library which encode functional proteins. 
3.2 Materials and Methods 
3.2.1 General Materials and Methods 
All the general materials and methods used in this Chapter are described in Section 
2.2.1, with the following exception: 
3.2.1.1 Thymectomy Operations on Xenopus laevis Animals 
Thymectomy operations were carried out by microcautery on 5 to 7 day old tadpoles 
by Dr J.D. Horton (as in Horton and Manning, 1972). When adult thymectomised 
animals were taken for dissection, the thymic region was examined to verify that no 
regeneration of the thymus had occurred. 
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3.2.2 Phage Display Library Construction 
The methods for phage display library construction were as described in Section 2.2.2, 
with the following exceptions: 
3.2.2.1 Preparation of NK-enriched Cells from Tx Xenopus for Immunisation 
Splenic lymphocytes were isolated from Tx animals, as described in Section 2.2.3.2., 
and incubated with B cell-specific mAb's, including the anti-IgM mAb 8E4 (see 
Appendix 3 for details) together with a cocktail of anti-light chain mAb's (Hsu et al., 
1991) on ice for 30 minutes. Following 3 washes with FACS medium, 5xl0 6 cells in 
80|jJ Hank's balanced salt solution (HBSS)(Gibco), diluted to amphibian strength and 
supplemented with 1% foetal calf serum, were added to 20jxl of MACS microbeads 
conjugated with goat anti-mouse IgG (Miltenyi Biotec). The cells and beads were 
incubated for 15 minutes at 4°C, and the mixture passed over a prewashed Mini-
MACS separation column placed in a separation unit (magnet). The non-adherent 
splenocytes, depleted of B cells, eluted from the column were then incubated with the 
thrombocyte-specific mAb XLH-1 (See Appendix 3 for details). Following three 
washes with FACS medium, the thrombocytes were removed by magnetic sorting 
using goat anti-mouse IgM microbeads. 
3.2.2.2 Immunisation of Mice with Xenopus 'NIC-enriched' Cells 
Two Balb/C mice were given three injections of 8xl0 5 NK-enriched cells, the first in 
complete Freund's adjuvant and the second and third in incomplete Freund's adjuvant, 
into the foot pad over a 10 day period. The mice were then dissected and the spleens 
were removed for RNA isolation. At the same time, the mouse sera were tested to 
confirm reactivity to Xenopus splenocytes. 
3.2.2.3 RT-PCR Amplification of VH and VL Fragments 
The amplification of VH and V L fragments from RNA was performed in a two-step 
reaction, with the first step being a general cDNA amplification using an oligo dT 
primer (Gibco) to reverse transcribe all messenger RNA's containing a poly-A tail, 
instead of the protocol described in Chapter 2 which used the reverse VH and V L 
primers at this stage. The second step was the specific amplification of VH and V L 
regions by PCR, using the VH and VL-specific primers listed in Appendix 1. 
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The cDNA amplification was performed in an RNase-free eppendorf tube as follows: 
400ng RNA 20}il 
Nuclease-free water (Promega) 65fil 
lOx Expand™ buffer (Boehringer Mannheim) lOpl 
lOmM dNTP's (Gibco) 2pl 
40 units RNase inhibitor (Promega) IJJI 
Oligo dT 1 2" 1 8 primer (Gibco) 2\A 
The tube was heated to 65°C for 15 minutes and then placed on ice before the addition 
of lul (200 units) Superscript II reverse transcriptase (Gibco). The tube was then 
incubated at 48°C for 1 hour. 
VH and VL fragments were amplified in separate eppendorf tubes as follows: 
cDNA from first reaction 10jd 
ddH20 31.5^1 
1 Ox Expand™ buffer (Boehringer Mannheim) 5 JJI 
lOmM dNTP's (Gibco) 1 jil 
VH or V L forward primer mix 1 pi 
VH or V L reverse primer mix 1 pi 
Expand™ Polymerase Mixture (Boehringer) 0.5jil 
The samples were overlaid with mineral oil and the following PCR reaction was 
performed in a Perkin Elmer thermal cycler: 
92°C 
92°C 
50°C 
72°C 
92°C 
63°C 
72°C 
3 minutes 
1 minute 
1 minute 
1 minute 
1 minute 
30 seconds 
1 minute 
1 cycle 
7 cycles 
y 30 cycles 
[Denaturation] 
[Denaturation] 
[Annealing] 
[Elongation] 
[Denaturation] 
[Annealing] 
[Elongation] 
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3.2.2.4 SOE-PCR 
The following components were added to an eppendorf tube: 
lOng VH DNA 2ul 
lOng V L DNA 2ul 
lOx Expand™ buffer (Boehringer Mannheim) 5 pi 
lOmM dNTP's (Gibco) lul 
Expand™ Polymerase Mixture (Boehringer) lul 
ddH20 37ul 
The tubes were overlaid with mineral oil and incubated in a Perkin Elmer thermal 
cycler as follows: 
92°C 3 minutes 1 cycle [Denaturation] 
92°C 1 minute [Denaturation] 
63°C 30 seconds [Annealing] 
> 2 cycles 
58°C 50 seconds [ [Annealmg] 
72°C 1 minute J [Elongation] 
The primers required to amplify the full length scFv fragments (see Appendix 1) were 
then added: 
ScFor lul 
ScBack lul 
The remainder of the SOE-PCR reaction was then carried out: 
92°C 1 minute ] [Denaturation] 
63°C 30 seconds > 23 cycles [Annealing] 
72°C 1 minute J [Elongation] 
3.2.3 Phage Display Panning on Tx Xenopus Spleen Lymphocytes 
Panning on Tx Xenopus splenic lymphocytes and FACS analysis during panning was 
carried out as described in Section 2.2.3, with the following exceptions: 
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3.2.3.1 Negative Panning on Xenopus Red Blood Cells 
1 x 1010 of the phage-scFv library and 1 x 1010 wild type phage (control) in 1ml FACS 
buffer were each added to eppendorf tubes containing 1 x 106 red blood cells and 
incubated for 1 hour at 4°C with rotation. The cells were centrifuged at 3,400 rpm for 
2 minutes and the supernatants were transferred to tubes containing another 1 x 10 red 
blood cells and incubated for a further hour at 4°C with rotation. Following this second 
incubation, the red blood cells were pelleted by centrifugation at 3,400 rpm for 2 
minutes and the phage supernatant was removed and saved for positive panning. 
3.2.3.2 Positive Panning on Tx Lymphocytes 
The cells used for positive panning were Tx splenic lymphocytes, which had been 
passed over Ficoll to remove red blood cells (As in Section 2.2.3.2). Due to the cost of 
multiple magnetic cell separations, removal of B cells and thrombocytes was not 
carried out on these cells during each round of positive panning. The phage 
supernatant which had been negatively panned on red blood cells was transferred to an 
eppendorf tube containing 1 x 106 Tx lymphocytes and the tube incubated for 2 hours 
at 4°C with rotation. 
3.2.4 Manipulations of Individual Phage Antibodies 
3.2.4.1 RFLP Analysis of scFv Sequences 
Following 3 rounds of panning, 48 individual scFv sequences were amplified by PCR 
and their RFLP profiles analysed as described in Section 2.2.2.8. 
3.2.4.2 Isolation and Rescue of Individual Phage Antibodies 
Following identification of 12 different scFv sequences by RFLP analysis, the 12 
respective phagemid-containing colonies oiE.coli strain X L 1-Blue were grown up in 
5Oral NE medium. The cultures were infected with M13 helper phage and the 
recombinant phage-scFv's rescued and titred as in Section 2.2.2.9 
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3.2.4.3 Identification of cpID/scFv Fusion Proteins by Western Blotting 
Recombinant phage were subjected to SDS-PAGE, transferred to nitrocellulose and 
probed for the presence of cpHI/scFv fusion proteins as described in Section 2.2.4.3. 
Instead of using the anti-FLAG mAb (Kodak), filters were probed directly with the 
HRP-conjugated goat anti-mouse IgG antibody (1:20000) and bands detected by 
chermluminescence. 
3.2.4.4 Production of Soluble scFv's from E.coli Strain JM83 
The cloning of scFv sequences into pAK400, transformation of E.coli strain JM83 and 
subsequent production of soluble scFv protein was carried out exactly as described in 
Section 2.2.5.1. Instead of purifying the scFv proteins using Ni-NTA spin columns 
(Qiagen), as described in Section 2.2.5.2, osmotic shock supernatants were used 
directly. 
3.2.4.5 Preparation of Lymphocytes from Xenopus Thymus, Liver and Peripheral 
Blood 
Prior to dissection, animals were heavily anaesthetised in 3-amino-benzoic acid ethyl 
ester (MS222). Thymuses and livers were exposed by removing the overlying skin and 
dissected out with forceps and micro-scissors and placed in 3.5cm petri dishes (Costar) 
in 3ml FACS buffer. The organs were teased apart to release cells into the FACS 
buffer which was then transferred to a 15ml Falcon centrifuge tube (Becton 
Dickinson). Peripheral blood was drawn off from the heart with a pipette and placed 
into a tube containing 3ml heparinised FACS buffer to prevent coagulation of red 
blood cells. Cell suspensions from thymus, liver and peripheral blood were then 
carefully pipetted on top of 3ml 1.077 density Ficoll (Amersham-Pharmacia) in a 
fresh 15ml tube. This tube was centrifuged at 4°C for 5 minutes at 250g and the 
lymphocytes removed from a tight band above the Ficoll layer to a new 15ml tube. The 
cells were resuspended in 5ml FACS buffer and centrifuged at 4°C for 10 minutes at 
300g to pellet the cells. After removal of the supernatant, the cells were resuspended in 
lml FACS buffer and a lOjjl aliquot pipetted into a haemocytometer for counting cell 
numbers. Cells were either used directly or transferred to 24 well plates (Becton 
Dickinson) in lml tumour medium and incubated at 27°C in 5% C 0 2 for up to 3 days. 
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3.2.4.6 Culture of B 3 B 7 Thymus Tumour and A6 Kidney Tumour Cell Lines 
Both the B3B7 and A6 tumour cell lines were cultured in tumour medium in a 5% C 0 2 
atmosphere as summarised in Section 2.2.3.1. 
3.2.4.7 Use of Soluble scFv's in Single and Dual Stain FACS Analysis 
Single stain FACS analysis with soluble scFv's was carried out exactly as described in 
Section 2.2.5.3 with gates set on lymphoid cell populations except in the analysis of 
RBC's or tumour cells. Background levels of FITC fluorescence were set at 2% using 
a control sample in which soluble scFv was omitted. 
For dual stain analysis, the cells were first labelled with scFv and rabbit anti-mouse Ig 
FITC antibody (DAKO) as described above. The cells were washed three times in 
FACS buffer containing 1:100 filter-sterilised normal mouse serum before incubating 
in the dark on ice for 20 minutes with 50^ 1 PE-conjugated mouse mAb. The PE-
conjugated mouse mAb's used and their working dilutions are listed in Appendix 3. As 
a control for PE fluorescence, a sample was incubated with PE-conjugated mouse 
immunoglobulins (DAKO) and used to set the background fluorescence marker to 2%. 
Three further washes in FACS buffer were carried out before resuspending the cells in 
500jil FACS buffer and analysing on the flow cytometer. 
In one dual stain experiment, using the anti-NK mAb 1F8 (described in Chapter 4), 
cells were first labelled with soluble scFv and rabbit anti-mouse Ig PE antibody 
(DAKO). The cells were washed three times in FACS buffer containing 1:100 filter-
sterilised normal mouse serum before incubating in the dark on ice for 20 minutes with 
50^ 1 FITC-conjugated 1F8, diluted 1:200. 
3.2.4.8 Use of Individual Phage Antibodies to Probe Western Blots of B 3 B 7 Cells 
and Spleen Lymphocyte Lysates 
Phage antibodies were used to probe lysates of B3B7 cells and spleen lymphocytes as 
described in Section 2.2.4.4. 
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3.3 Results 
3.3.1 Construction of the anti-NK Phage Display Library 
3.3.1.1 Amplification of VH and V L Regions by RT-PCR 
A two stage RT-PCR reaction was performed on RNA isolated from the spleens of the 
mice immunised with NK-enriched Xenopus lymphocytes (as described in Section 
3.2.2.3). Following the initial cDNA amplification, individual PCR reactions were 
performed using the Expand™ proof-reading DNA polymerase mixture (Boehringer 
Mannheim) to amplify VH and V L DNA. A tenth of each reaction was examined by 
agarose gel electrophoresis (Figure 3.1). The bright DNA bands visible at around 
400bp in each lane indicated that the VH and V L fragments were more efficiently 
amplified using this two stage method than the single step method used in Chapter 2 
(See Figure 2.2). 
3.3.1.2 Joining of VH and V L Regions by SOE-PCR 
The gel-purified VH and V L DNA fragments were assembled into scFv-encoding 
DNA fragments by SOE-PCR, again using the Expand™ proof-reading DNA 
polymerase mixture (Described in Section 3.2.2.4). A tenth of the reaction was 
analysed by agarose electrophoresis and a DNA band was visible at around 800bp, 
indicating that the VH and V L DNA had been assembled correctly (Figure 3.2). DNA 
bands corresponding to scFv sequences were gel-purified using silica fines (See 
Section 2.2.1.3). 
3.3.1.3 Cloning of the scFv DNA into Phage Display Vector pAKlOO 
ScFv sequences were cloned into the pAKlOO phagemid vector and transformed into 
E.coli strain XLl-Blue as described in Section 2.2.2.7. A series of ligation and 
transformation reactions were performed which resulted in the cloning of 
approximately 5 x 10s scFv sequences into the pAKlOO vector. Following 
transformation of the scFv-containing vectors into XLl-Blue, the library was stored in 
40% glycerol at -80°C. 
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3.3.1.4 Testing the Diversity of the Library by R F L P Analysis 
10 transformed colonies of X L 1-Blue containing cloned scFv's were picked to test the 
diversity of the scFv sequences in the library. ScFv sequences were amplified directly 
from the bacterial colonies by PCR and digested with the restriction endonuclease 
HaeDI as described in Section 2.2.2.8. Agarose gel electrophoresis of half the PCR 
reaction volume confirmed that the ten colonies picked contained scFv DNA (Figure 
3.3A). The HaeDI digested scFv DNA was also separated by electrophoresis on 
agarose (Figure 3.3B) and the profiles show that 9 of the 10 transformants examined 
contained different scFv sequences. 
3.3.2 Panning of the anti-NK Phage Display Library 
Following rescue of the recombinant phage-scFv library from E.coli using helper 
phage, two consecutive negative panning steps were carried out on Xenopus red blood 
cells before the positive panning on Tx splenocytes (Described in Section 3.2.3). The 
Tx spleen cells were washed extensively to remove non-specifically bound phage 
before elution of bound phage in a solution of low p R Eluted phage were used to re-
infect E.coli strain XLl-blue and consequently cultured and converted to phage-scFv's 
for further rounds of panning. 
3.3.2.1 Testing for Enrichment by Flow Cytometry 
To test whether panning was enriching the library for phage-scFv's with an ability to 
bind Xenopus spleen cells, flow cytometry was used during each round of panning to 
detect phage on the surface of cells (As described in Section 2.2.3.6). As a control for 
non-specific attachment of phage to cells, wild type M13 phage were subjected to the 
same panning conditions and also tested by flow cytometry. The results (Figure 3.4) 
show that recombinant phage-scFv's which had been panned three times on Tx spleen 
were able to bind 94% of the Tx spleen cells whereas wild type phage showed only 
background levels of fluorescence. 
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3.3.3 Analysis of Individual Phage Antibodies 
33.3.1 R F L P Analysis of 48 scFv Sequences from Recombinant Phage after Three 
Rounds of Panning on Tx Spleen Cells 
In order to assess the number of different phage antibodies contained within the 
panned library, 48 scFv sequences were amplified from randomly isolated phagemids 
by PCR (As described in Section 2.2.2.8). These scFv sequences were digested with 
the restriction endonuclease HaelH and the resulting RFLP profiles examined 
following agarose gel electrophoresis (See Figure 3.5). Examination of the RFLP 
patterns allowed segregation of the scFv's into 12 groups which were designated XL-1 
to XL-12 (for Xenopus lymphocyte). Some recurring patterns were observed, such as 
XL-4 and XL-6, both of which were present in 10 of the 48 samples tested (21% of 
samples). 
3.3.3.2 Flow Cytometric Testing of 12 Individual Phage Antibodies for their 
Ability to Bind Xenopus Spleen Cells 
The RFLP analysis of scFv sequences allowed 12 individual phage antibodies, called 
XL-1 to XL-12, to be isolated from the panned library. These 12 phage antibodies 
were screened by flow cytometry for their ability to bind splenocytes from control 
Xenopus. The histograms shown in Figure 3.6 show that each recombinant phage has 
an ability to adhere to a small percentage (between 6% and 20%) of the total spleen 
population. However, only the FACS trace corresponding to phage antibody XL-6 
shows a separate peak of positive fluorescence to suggest that it is binding specifically 
to a distinct subset of spleen cells. 
3.3.3.3 Verification of ScFv Expression on Phage XL-6 by Western Blotting 
In order to confirm that phage XL-6 was expressing surface scFv, 1010 XL-6 phage 
particles were subjected to SDS-PAGE and then blotted to nitrocellulose, as in Section 
2.2.4.3. As a control, the same number of wild type phage particles were included in 
the Western blot. ScFv/cpHI fusion proteins were detected directly using an HRP-
conjugated goat anti-mouse IgG antibody, followed by chemiluminescence. The result 
shown in Figure 3.7 confirms that recombinant phage XL-6 does indeed express the 
ScFv fusion to cpJH which is detected at 48 kDa. 
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333.4 Production of Soluble XL-6 ScFv 
After cloning the XL-6 scFv into the expression vector pAK400 and tramforming the 
plasmid into E.coli strain JM83, soluble scFv proteins were purified from bacterial 
cultures by osmotic shock (Described in Section 2.2.5.1). An aliquot of the osmotic 
shock supernatant was subjected to SDS-PAGE, blotted to nitrocellulose and probed 
with an HRP-conjugated goat anti-mouse IgG antibody, followed by 
chemiluminescence. The result shown in Figure 3.8 confirms that soluble XL-6 scFv 
was produced from the bacteria as a band is present at around 28 kDa. 
3.3.3.5 Comparison of Phage XL-6 and Soluble XL-6 Binding to Xenopus Spleen 
Cells by Flow Cytometry 
The XL-6 phage and soluble XL-6 scFv were both tested by flow cytometry for their 
ability to bind control Xenopus splenocytes. Figure 3.9 shows that both the phage-
bound and the soluble scFv fragments bind to approximately 95% of the total 
population of splenocytes. The XL-6 phage gives a broader peak of fluorescence than 
the soluble XL-6 scFv. 
33.3.6 Testing of Soluble XL-6 on Different Cell Types of Control Xenopus 
Having confirmed that the soluble XL-6 scFv retains the ability of the phage XL-6 to 
bind Xenopus splenocytes, the specificity of soluble XL-6 was tested by flow 
cytometry on various cell types of control Xenopus laevis. The results in Figure 3.10 
show that the XL-6 scFv does not bind to Xenopus red blood cells, B3B7 thymus 
tumour cells or the A6 Xenopus kidney tumour cell line (Rafferty, 1969). Cells derived 
from various lymphoid organs of control Xenopus laevis were also tested for binding 
of XL-6 scFv. The traces shown in Figure 3.10 reveal that XL-6 binds 82% of 
splenocytes, 74% of liver leukocytes, 24% of peripheral blood leukocytes (PBL) and 
22% of thymocytes. 
3.3.3.7 Dual Stain Testing of Soluble XL-6 on Splenocytes from Control Xenopus 
Dual stain analysis was carried out using soluble XL-6 in conjunction with PE-
conjugated mouse mAb's to Xenopus cell surface markers, as described in Section 
3.2.4.7. These mAb's and their specificities are listed in Appendix 3. The histograms 
(Figure 3.11) show that the cells bound by mAb's 2B1 (a-CD5) and D4-3, which are 
pan T cell markers, are also bound by the XL-6 scFv. The anti-CD8 mAb F17 also co-
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stained strongly with XL-6, as did the mAb D12.2, which was originally thought to 
identify a y5 T cell population (Ibrahim et al., 1991). The anti-jo, chain antibody D8, 
which binds all Xenopus B-cells, also co-stained with XL-6 although under half of the 
B-cells co-expressed the XL-6 antigen. 
3.3.3.8 Single and Dual Stain Testing of Soluble XL-6 on Immunomagnetically-
Sorted Populations of Splenocytes from Tx Xenopus 
Splenocytes were taken from a Tx animal and FACS analysis of these cells showed 
that 38% were bound by XL-6 (Figure 3.12A). Immunomagnetic separation was then 
performed on the splenocytes, with the anti-ji mAb 8E4, to sort the cells into a non-B 
and a B cell population (As described in Section 3.2.2.3). Flow cytometric testing of 
the non-B cell population showed that 14% were XL-6 positive, whereas 42% were 
positive when tested with the putative anti-thrombocyte mAb XLH-1 (Figure 3.12B). 
This was taken as indirect evidence that XL-6 did not bind to thrombocytes. A dual 
stain was also performed on the non-B cells, using XL-6, detected with an anti-mouse 
PE antibody, followed by the FITC conjugated mAb 1F8 {mh-Xenopus NK cell mAb, 
described in detail in Chapter 4). This dual stain revealed that the XL-6 antigen was 
expressed on approximately one third of 1F8-Iabelled Xenopus NK cells. 
FACS analysis of the enriched B cell population (Figure 3.12C) revealed purity of 
nearly 90% (86% 8E4-positive). 54% of this enriched B cell population were XL-6 
positive. Dual stain analysis using XL-6 and the anti-ji mAb D8 confirmed that the 
XL-6 antigen was present on over half of the B cells. 
3.3.3.9 Dual Stain Testing of Soluble XL-6 on Xenopus Thymocytes 
Dual stain analysis of thymocytes was carried out using soluble XL-6 in conjunction 
with PE-conjugated mouse mAb's to Xenopus cell surface markers (As described in 
Section 3.2.4.7). Figure 3.13 shows that the pan T cell markers detected by the mAb's 
D4-3 and 2B1 (anti-CD5) were expressed on 17% and 54% of thymocytes 
respectively. XL-6 routinely stained around 20% of thymocytes, the majority of which 
co-expressed the markers detected by mAb's D4-3 and 2B1. In addition, 
approximately one quarter of XL-6 positive thymocytes also co-expressed the CD8 
antigen recognised by the mAb F17. 
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3.33.10 Probing Western Blots of Control Spleen Cell Lysates with Phage XL-6 
In order to identify the antigen bound by phage antibody XL-6, Western blots of 
spleen cell lysates were probed with phage antibody XL-6 and wild type phage as a 
control (As in Section 2.2.4,4). Detection was achieved using a mouse anti-M13 
antibody, followed by an HRP-conjugated goat anti-mouse IgG antibody and 
chemiluminescent identification of protein bands. The result (Figure 3.14) shows that 
no specific protein band was identified by XL-6, whereas the wild type phage displays 
some non-specific background staining oiXenopus proteins. Soluble XL-6 was also 
used to probe Western blots oiXenopus spleen cell lysates but failed to identify any 
specific proteins (Data not shown). 
3.4 Discussion 
3.4.1 The Efficiency of Panning on Xenopus NK-Enriched Cells 
The intention of the phage display panning described in this Chapter was to isolate 
phage antibodies to Xenopus NK cells. The method for cloning the scFv library from 
an immunised mouse and for panning the library on Tx Xenopus spleen cells was 
based on the protocol used in Chapter 2 to raise phage antibodies to B3B7 cells. 
Evidence from FACS analysis strongly suggested that, through panning, the ct-NK 
phage library of around 5 x 105 scFv clones became enriched for phage antibodies 
capable of binding to Tx Xenopus splenocytes. RFLP analysis of 48 scFv sequences 
from the panned phage pool revealed 12 different phage scFv's, designated XL-1 to 
XL-12, which were tested individually for their ability to bind to control Xenopus 
spleen cells. Of the twelve phage, only XL-6 displayed a FACS profile indicating 
distinct binding to Xenopus splenocytes. Further testing of XL-6 phage on spleen cells 
from a number of control Xenopus revealed that it consistently bound between 80% 
and 95% of splenocytes. The ability of purified soluble XL-6 scFv to bind the same 
proportion of cells as the phage XL-6 confirmed that the scFv protein, rather than any 
non-specific interactions of the phage particle, was responsible for binding to Xenopus 
cells. 
The ability of XL-6 to bind such a high percentage of splenocytes clearly indicates that 
it is not specific for Xenopus NK cells, which represent less than 10% of splenocytes 
in control Xenopus (See Chapter 4). There are a number of reasons why the panning 
protocol failed to raise phage antibodies specific to Xenopus NK cells. Firstly, the 
library was derived from a mouse immunised with 'NK-enriched' cells from Xenopus 
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rather than a pure population of Xenopus NK cells. This meant that the mouse would 
have become immunised against epitopes expressed on any other contaminating cell 
types, and these specificities would have become incorporated into the phage library. 
In addition, by using whole Xenopus cells for injection rather than cell membrane 
preparations, the mouse would also have become immunised against any intracellular 
epitopes which were exposed following degradation of the cells. Combined with the 
relatively small size of the phage library, these factors would have meant that there 
was a fairly small chance of isolating a phage antibody with a specificity for Xenopus 
NK cells. The library was also panned on mixed cell populations, rather than pure NK 
cells, which again reduced the chances of enriching the library for NK-specific phage. 
However, to isolate a pure population of Xenopus NK cells for immunisation and 
panning would have required the use of cell sorting with an anti-NK mAb and such an 
antibody was not available at the time. In addition, the small number of NK-enriched 
cells obtainable by immunomagnetic depletion from a Tx spleen meant that the 
purification of membranes from these cells for immunisation, which would have 
involved further loss of material, was not considered a viable option. Thus the protocol 
used in this Chapter was thought to give the best chance of raising NK-specific phage 
antibodies. 
Considering the number of different scFv sequences present in the library after three 
rounds of panning, it was predicted that more than one of the twelve phage screened 
would be able to bind Xenopus cells. However, only the FACS trace of spleen cells 
stained with XL-6 phage, which was found to constitute almost a quarter of the panned 
phage pool by RFLP analysis, showed a distinct peak of fluorescence. It is possible 
that the other eleven phage antibodies, which had been selected through panning, were 
low affinity binders and as such did not perform as well in FACS analysis. As 
mentioned in Chapter 2 they may have performed better in different immunoassays, 
such as immunocytochemistry. In addition, the screening of a larger number of panned 
phage may have led to the isolation of other useful, even NK-specific, phage 
antibodies. However, since performing more than one method of screening on a large 
number of phage antibodies would have been very time-consuming, it was decided to 
spend more time investigating the one phage antibody, XL-6, which showed a genuine 
ability to bind to Xenopus cells. 
3.4.2 Further Investigation of the Specificity of XL-6 scFv 
Using flow cytometric analysis, it was shown that XL-6 scFv did not bind to Xenopus 
red blood cells, the Xenopus thymus tumour cell line B 3 B 7 , or the Xenopus kidney 
75 
tumour cell line A6. The inability to bind these three cell types reflects the success of 
negative panning on red blood cells in removing phage which bound general Xenopus 
cell surface epitopes. 
Investigation of control spleen and liver leukocytes by flow cytometry revealed that 
XL-6 typically bound between 75% and 85% of these cells. Dual stain analysis 
showed that XL-6 co-stained virtually all splenocytes which were labelled with T cell 
markers. In contrast, not all splenic B cells were XL-6 positive as dual stain analysis 
with the anti-IgM mAb D8 revealed both XL-6 positive and XL-6 negative B cells. 
The investigation of immunomagnetically sorted Ig-positive and Ig-negative 
populations from Tx spleen confirmed that XL-6 co-stained a major population, 
equivalent to around 50%, of B cells and approximately one third of NK'cells. The Ig-
negative population from Tx spleen were only 14% XL-6 positive whereas 42% were 
labelled with the putative anti-thrombocyte mAb XLH-1. Thus XL-6 appears not to 
label thrombocytes which may explain why PBL, which contains a large proportion of 
thrombocytes ( T L . Horton, pers. comm.), was only 25% XL-6 positive. 
In contrast to the high proportion of peripheral lymphoid cells, especially T cells, that 
were XL-6 positive, only a small proportion, equivalent to around 20%, of thymic 
lymphocytes were XL-6 positive. It is of interest to note that XL-6 did not label the 
thymic tumour cell line B3B7. This cell line has been shown to have an immature 
thymic phenotype as it does not express MHC class II which acts as a differentiation 
marker of thymocytes and is preferentially expressed on mature medullary thymic cells 
(Flajnik et al., 1990; Du Pasquier et al., 1995). The immature nature of B3B7 cells is 
further underlined by its expression of a molecule called CTX, which is a known 
marker of immature, cortical thymocytes (Chretien et al., 1996). Flow cytometric 
analysis has also shown that the immature thymic marker CTX is found on between 
65% and 80% of thymocytes, implying that the mature medullary population of the 
thymus is a minor population of between 20% and 35% (Chretien et al., 1996). Taken 
together this indirect evidence suggests that XL-6 could be binding to a population of 
mature thymocytes. 
Dual stain FACS analysis of thymocytes revealed that XL-6 also co-stained the 
majority of D4-3 positive cells in the thymus, which may be of interest as D4-3 also 
stains mature, peripheral T cell populations (Ibrahim et al., 1991). In addition, the 
small percentage of CD8 positive thymocytes (detected by mAb F17) which co-stain 
with XL-6 may represent single positive mature T cells whereas the CD8 positive 
thymocytes not labelled with XL-6 may be immature, double positive T cells. Also of 
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interest is the ratio of CD8+ to CD8- cells within the XL-6 labelled thymic population 
which is similar to the 1:2 ratio of CD8+ to CD8- (putative CD4+) T cells in the 
periphery (Gravenor et al., 1995). Unfortunately there are currently no markers of 
CD4+ T cells in Xenopus with which to confirm this theory. 
There is a distinct possibility mat XL-6 identifies an amphibian equivalent of a 
mammalian CD45 molecule, also known as the leukocyte common antigen. Although 
the CD45 family as a whole are expressed on all leukocytes, different isoforms are 
expressed on sub-populations of leukocytes according to differences in cell maturation 
and function (Poppema et al., 1996; Aran and Sloan, 1997). The specificity of XL-6 
for a particular CD45 isoform may explain why, despite being leukocyte specific, it 
labels all T cells and varying levels of B and NK cells. Interestingly, it has been shown 
that one isoform of CD45 in mammals, known as CD45RA, identifies a small subset 
(between 15% and 30%) of thymocytes, which are located in the medulla and are 
thought to be committed to entering the periphery as mature T cells (Deans et al., 
1989, Gillitzer and Pilarski, 1990). This bears a striking similarity with the staining 
pattern of XL-6 in the thymus which identifies a small population of thymocytes with a 
'mature' phenotype. 
Studies carried out on leukocyte common antigens in Xenopus have used mAb's which 
appear to identify an epitope common to several isoforms of the putative amphibian 
CD45 as determined by immunoprecipitation experiments (Ohinata et al., 1989; Smith 
and Turpen, 1991). One of these studies, using the putative anti-CD45 mAb CL21, 
showed by flow cytometry that lymphoid cells, but not thrombocytes, from adult 
spleen were over 90% positive and that an equally high percentage (90%) were stained 
in the adult thymus (Smith and Turpen, 1991). This contrasts with the much lower 
level of XL-6 positive cells in the thymus and may reflect the ability of CL21 to bind 
several isoforms of CD45, whereas XL-6 may be showing specificity for a single 
isoform. 
During these studies that involved many Xenopus, it was observed that a minority of 
animals tested with XL-6 showed insignificant levels of XL-6 positive splenocytes and 
some showed no binding at all. It is possible that this relates to variability of the 
extracellular domain of the target antigen and it is of interest to note that mammalian 
CD45 shows considerable variation in this region due to differential splicing (Poppema 
et al., 1996). 
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More definite conclusions as to the nature of the antigen bound by XL-6 were hindered 
by the failure of XL-6 to identify any protein bands in Western blots. This is probably 
due to the fact that XL-6 was raised against cell surface proteins in their native 
conformation. The denatured form of the protein probed in the Western blot may not 
have been recognisable by XL-6. As such, it would be of great interest in the future to 
conduct immunoprecipitation experiments with XL-6 on splenocyte and thymocyte 
lysates. 
78 
Figure 3.1 VH and V L RT-PCR's 
1% agarose gel showing amplification of variable heavy (VH) and variable 
light (VL) chain DNA by RT-PCR. Template RNA was obtained from the 
spleens of mice immunised with an 'NK-enriched' population of Xenopus 
lymphocytes. Lane 1 contains A.Pstl DNA markers. 
V H V L 
« - 4 0 0 b p 
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Figure 3.2 Joining of VH and V L Fragments by SOE-PCR 
1% agarose gel showing the result of an SOE-PCR reaction on VH and V L 
DNA fragments amplified from the 'NK-immunised' mouse. Lane 1 contains 
^Pstl DNA size markers. 
SOE-
P C R 
800bp scFv 
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Figure 3.3 Diversity of scFv Sequences in Library by R F L P Analysis 
10 scFv sequences were reamplified from the unpanned phage library by PCR 
and analysed by gel electrophoresis (A). Following Haelll digestion, scFv 
fragments were run on a 2% agarose gel for analysis of RFLP's (B). Marker in 
lane 1 of both gels is XPstI DNA. 
A ' 1 2 3 4 5 6 7 8 9 10 
800bp scFv 
B. 1 2 3 4 5 6 7 8 9 10 
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Figure 3.4 Flow Cytometric Analysis of Phage During Panning 
During each round of panning, both wild type (WT) and recombinant phage 
were tested by flow cytometry for their ability to bind Tx spleen cells. Phage 
were detected by a rabbit anti-M13 antibody followed by a FITC-conjugated 
anti-rabbit Ig antibody. The percentage of positively stained splenic lymphoid 
cells is indicated in the top-right corner of each histogram. 
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Figure 3.5 RFLP Analysis of Phage scFv Sequences after Three Rounds 
of Panning 
scFv sequences were amplified by PCR and digested with HaelN before 
separation on 2% agarose gels. Different RFLP profiles have been designated I 
to 12. Lane 1 in each gel is APstI DNA marker. 
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Figure 3.6 Flow Cytometric Analysis of Twelve Individual Phage 
Antibodies 
Twelve different recombinant phage, isolated from the library which had been 
panned three times, were designated XL-1 to XL-12 and tested individually by 
flow cytometry for their ability to bind splenocytes from control Xenopus. 
Phage were detected by a rabbit anti-M13 antibody followed by a FITC-
conjugated anti-rabbit Ig antibody. Markers for background staining were set at 
2% using cells incubated with FITC-conjugated anti-rabbit Ig antibody only. 
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Figure 3.7 Confirmation of scFv on Phage XL-6 by Western Blotting 
10 1 0 wild type (WT) and 101 0 XL-6 phage particles were separated by SDS-
PAGE and blotted to nitrocellulose. Blots were probed with an HRP-
conjugated anti-mouse Ig antibody and HRP activity was detected by 
chemiluminescence. 
WT XL-6 
phage phage 
66kDa — 
45kDa 
36kDa 
. . . 
scFv/cpIII fusion 
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Figure 3.8 Confirmation of Soluble XL-6 scFv Production 
Following induction of soluble XL-6 scFv production in E.coli strain JM83, an 
aliquot of osmotic shock fluid was subjected to SDS-PAGE and blotted to 
nitrocellulose. Blots were then probed with an HRP-conjugated anti-mouse Ig 
antibody before detection by chemiluminescence. 
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Figure 3.9 Comparison of Phage and Soluble XL-6 Binding to Control 
Xenopus Spleen Lymphocytes by Flow Cytometry 
Phage expressing surface scFv XL-6 and bacterially produced soluble XL-6 
were both tested by flow cytometry for their ability to bind splenocytes from 
control Xenopus. Phage were detected by a rabbit anti-M 13 antibody followed 
by a FITC-conjugated anti-rabbit Ig antibody whereas soluble scFv's were 
detected directly with a FITC-conjugated anti-mouse Ig antibody. 
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Figure 3.10 Ability of Soluble XL-6 to Bind Diverse Ceil Types from 
Xenopuslaevis 
The specificity of soluble XL-6 was tested by flow cytometry on various 
lymphoid cells from different organs of Xenopus laevis, as well as Xenopus 
peripheral red blood cells and two Xenopus tumour cell lines. The histograms 
shown here are representative of several experiments conducted on one year 
old animals. 
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Figure 3.11 Dual Stain Testing of Soluble XL-6 on Control Splenocytes 
Spleen cells from control Xenopus were dual-labelled by using soluble XL-6 
(detected by FITC) in conjunction with phycoerythrin (PE)-conjugated 
antibodies. The soluble XL-6 (FITC) fluorescence is measured on the X-axis of 
the histogram, while the PE fluorescence is shown on the Y-axis. The results 
shown on these histograms are gated for spleen lymphocytes. 
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Figure 3.12 Single and Dual Stain Analysis of Immunomagneticallv-
Sorted Spleen Populations from Tx Xenopus 
Tx splenocytes were tested by FACS using soluble XL-6 (A) and then 
immunomagnetically sorted with the B cell-specific mAb 8E4. The non-B cell 
population was re-tested with XL-6 and the a-thrombocyte mAb XLH-1. This 
population was also dual stained (B) with the FITC-conjugated ct-NK mAb 1F8 
after staining with XL-6 (detected by PE-conjugated a-mouse Ig). The B cell-
enriched population was re-tested with XL-6 and the a-IgM mAb 8E4, and in a 
dual stain with XL-6 and the PE-conjugated a-IgM mAb D8 (C). 
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Figure 3.13 Dual Stain Testing of Soluble XL-6 on Thymocytes 
Thymocytes from a year-old Xenopus were dual-labelled by staining with 
soluble XL-6 (detected by FITC-conjugated anti-mouse Ig) in conjunction with 
phycoerythrin (PE)-conjugated antibodies. The soluble XL-6 (FITC) 
fluorescence is measured on the X-axis of the histogram, while the PE 
fluorescence is recorded on the Y-axis. The data shown is representative of 
several experiments. 
18% 36% 5% 12% 
PQ U 
10% 5% 
r r m I—FTTTTT1 rTTTTt rt nm ITT1 
Soluble XL-6 Soluble XL-6 
6% 36% 
in 
17% 
rl m rrrrn i i i mi 
Soluble XL-6 
91 
Figure 3.14 XL-6 Phage as a Reagent in a Western Blot 
Protein lysates from control Xenopus splenocytes were separated by SDS-
PAGE and transferred to nitrocellulose before being probed with XL-6 phage. 
Wild type (WT) phage were used in parallel as a control for non-specific 
binding. Bound phage were detected by a rabbit anti-M13 antibody, followed1 
by an HRP-conjugated anti-rabbit antibody. HRP activity was detected using 
chemiluminescence 
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The WT phage control blot shown here is also displayed in Figure 2.11 as 
the experiments were performed at the same time. 
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CHAPTER 4 
Use of Hybridoma Technology to Generate 
Monoclonal Antibodies to Xenopus NK Cells 
This Chapter details the use of hybridoma technology to isolate monoclonal antibodies 
to Xenopus NK cells. Flow cytometric screening of the hybridoma-derived mAb's was 
used to highlight those with a potential NK specificity and further investigation of 
these mAb's on both Xenopus and human cells was carried out by flow cytometry. 
Attempts to define the NK cell surface antigens bound by these mAb's using Western 
blotting and immunoprecipitation are described. 
4.1 Introduction 
4.1.1 Natural Cytotoxicity in Xenopus 
Splenocytes from both control and thymectomised Xenopus, when cultured in growth 
factor supplemented medium (GFM), which contains IL-2 like material (Haynes and 
Cohen, 1993), are able to lyse the MHC-deficient Xenopus thymus tumour cell line 
B 3 B 7 in chromium release assays (Horton et al., 1996). Furthermore, splenocytes from 
Tx animals, which have been shown to lack functional T cells, can be further depleted 
by the immunomagnetic removal of B cells and have been shown to retain their natural 
cytotoxicity (reviewed in Horton et al., 1998a). Thus a non-T, non-B cell population in 
Xenopus is capable of spontaneous cytotoxicity towards B 3 B 7 tumour cells. The ability 
to ki l l tumour targets in a non-MHC dependant fashion strongly suggests that this 
activity is NK-like. 
Despite the evidence for natural cytotoxicity in Xenopus, me NK-like cells responsible 
have yet to be identified by monoclonal antibodies. Chapter 3 described attempts to 
isolate NK-specific phage antibodies from an scFv library cloned from mice 
immunised with NK-enriched Xenopus cells. This Chapter summarises attempts to 
isolate NK-specific mAb's from the same immunised mice using the classical 
hybridoma approach. 
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4.1.2 The Potential Uses of mAb's to Xenopus NK cells 
A mAb which identifies NK cells in Xenopus would be initially useful in studying the 
distribution of these cells in various lymphoid organs. Mammalian NK cells are found 
primarily in the spleen, peripheral blood, liver and gut and it would be of interest to 
compare the distribution of NK cells in Xenopus. In addition, an anti-NK mAb could 
be used to immunomagnetically purify populations of Xenopus NK cells for functional 
characterisation. The use of such purified NK cells in cytotoxicity assays would be 
useful in confhrriing the ability of these cells to lyse the B 3 B 7 tumour target. 
It would also be of interest to test the mAb on different species to find out i f the NK 
antigen is conserved. Although some mAb's are not able to recognise antigen across 
species, there are others such as 5C6, which was raised against catfish NCC, which 
binds specifically to an antigen on human NK cells (Harris et al., 1991). 
Perhaps more revealing from an evolutionary perspective would be the molecular 
characterisation of surface antigens on Xenopus NK cells. An NK-specific mAb could 
be used to identify specific protein antigens through Western blotting or 
immunoprecipitation. This allows purification of the target protein and consequently 
derivation of amino acid sequence information. By comparing the Xenopus NK protein 
sequence with those of NK-related proteins from other species it is possible to find out 
i f the Xenopus protein is a conserved marker of NK cells or a novel cell surface 
marker. 
4.2 Materials and Methods 
4.2.1 General Materials and Methods 
A l l the general materials and methods used in this Chapter are described in Sections 
2.2.1. and 3.3.1. 
4.2.2 Generation and Initial Screening of Hybridoma's 
The generation and initial screening of hybridoma's was carried out by Trudy Horton 
at Durham University. 
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4.2.2.1 Preparation of NK-enriched Cells from Tx Xenopus for Immunisation 
Splenic lymphocytes were isolated from Tx animals, as described in Section 2.2.3.2., 
and incubated with B cell-specific mAb's, including the anti-IgM mAb 8E4 (see 
Appendix 3 for details) together with a cocktail of anti-light chain mAb's (Hsu et al., 
1991) on ice for 30 minutes. Following 3 washes with FACS medium, 5xl0 6 cells in 
80pl HBSS were added to 20pl of MACS microbeads conjugated with goat anti-mouse 
IgG (Miltenyi Biotec). The cells and beads were incubated for 15 minutes at 4°C, and 
the mixture passed over a prewashed Mini-MACS separation column placed in a 
separation unit (magnet). The non-adherent splenocytes, depleted of B cells, eluted 
from the column were then incubated with the thrombocyte-specific mAb XLH-1 (See 
Appendix 3 for details). Following three washes with FACS medium, the 
thrombocytes were removed by magnetic sorting using goat anti-mouse IgM 
microbeads. 
4.2.2.2 Immunisation of Mice with Xenopus 'NK-enriched' Cells 
Two Balb/C mice were given three injections of 8xl0 5 NK-enriched cells, the first in 
complete Freund's adjuvant and the second and third in incomplete Freund's adjuvant, 
into the foot pad over a 10 day period. After 10 days, samples of mouse sera were 
tested by flow cytometry to confirm reactivity to Xenopus splenocytes (Data not 
shown). 
4.2.2.3 Fusion and Selection of Hybridoma's 
Following the 10 day immunisation, the mice were dissected and the enlarged popliteal 
lymph nodes were removed and disrupted to release cells. 8x10 lymph node cells 
were washed twice in PBS and mixed with lx lO 7 P3X63Ag8.653 myeloma cells 
(ECACC). 0.8ml 50% PEG 1500 (in ImM NaOH and wanned to 37°C) was added to 
the cells and incubated for 5 minutes. The cells were spun down at 300g for 10 
minutes at 4°C and resuspended in 50ml RPMI medium, supplemented with 50ng/ml 
pemcillin/streptomycin (Gibco), 50mM mercaptoethanol and 1ml 50x hypoxanthine, 
aminopterin and thymidine (HAT) solution (Gibco). The cells were transferred to 96-
well plates in 150ul aliquots and incubated at 37°C in 5% CO2 for 2 weeks, with one 
change of medium after 5 days. HAT-selected hybridoma's were grown in RPMI 
medium, supplemented with 10% foetal calf serum, 50pg/ml pemcillin/streptomycin 
(Gibco), 50mM mercaptoethanol and 1ml 5Ox hypoxanthine and thymidine (HT) 
solution (Gibco) at 37°C in 5% C0 2 . 
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4.2.2.4 Screening of Hybridoma-Derived mAb's on Xenopus Splenocytes 
Hybridoma supernatants were screened by flow cytometry for their ability to bind 
splenocytes isolated from control and Tx Xenopus. Spleen lymphocytes were isolated 
from Xenopus as described in Section 2.2.3.2 and aliquots of 2 x 105 of these cells 
were transferred to separate wells in a 96-well plate (Becton Dickinson). 50^1 
hybridoma supernatant was applied to a well and the cells incubated on ice for 30 
minutes. The cells were then spun down at 300g for 10 minutes at 4°C before 
removing the supernatant and resuspending the cells in 200ul FACS medium. This 
wash was repeated twice before resuspending the cells in 50ui FITC-conjugated rabbit 
anti-mouse Ig antibody (DAKO), which had been adsorbed on Xenopus serum and 
diluted 1:20, and incubated on ice in the dark for 30 minutes. The cells were washed 
three times in 200ul FACS buffer before resuspending in 500pl FACS buffer and 
analysing on the flow cytometer. As in previous FACS analysis, a sample of cells 
incubated with FITC-conjugated rabbit anti-mouse Ig antibody only was used to set the 
fluorescence background marker to 2%. Hybridoma's of interest were cloned by 
limiting dilution and re-tested by flow cytometry. 
43.3 Flow Cytometric Analysis of Hybridoma-Derived mAb's on Xenopus Cells 
4.2.3.1 Preparation of Lymphoid Cells from Xenopus Spleen, Liver and Gut 
The protocol for preparing lymphoid cells from Xenopus spleen and liver are described 
in Sections 2.2.3.2 and 3.2.4.5 respectively. Preparations of intra-epithelial 
lymphocytes (IEL) from Xenopus gut were carried out according to a protocol devised 
by Rebecca Stewart in our laboratory which is adapted from a method for isolating IEL 
from mice (Mosley and Klein, 1992). Animals were anaesthetised as described in 
Section 2.2.3.2 and the small and large intestines removed and cut longitudinally 
before placing in a 15ml Falcon centrifuge tube containing 5ml APBS. The tube was 
inverted several times to loosen any faecal matter and mucus before allowing the 
intestinal matter to setde. The supernatant was removed and replaced with 5ml APBS 
and the process repeated twice before transferring the gut tissue to a siliconised conical 
flask containing 30ml APBS supplemented with 0. ImM EDTA and 0. lmM DTT. A 
magnetic stirrer was used to agitate the suspension during a 1 hour incubation at RT. 
Following incubation, the supernatant, containing both lymphoid and epithelial cells, 
was collected in a 50ml Falcon tube and placed on ice while the gut tissue was 
resuspended in 30ml APBS and agitated for a further 30 minutes at RT. The second 
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supernatant was collected and combined with the first before spinning down the cells 
at 300g for 10 minutes at 4°C and resuspending in 6ml APBS. The cells were then 
passed through a nylon wool column, which had been made up and sterilised inside a 
10ml plastic syringe (Becton Dickinson). The column was hydrated by adding 5ml 
APBS, before adding the gut cell suspension and collecting the first eluate. A further 
10ml APBS was added and the second eluate collected and combined with the first. 
The purified cells were then layered onto 3ml Ficoll in a 15ml Falcon tube and 
centrifuged at 250g for 5 minutes. The lymphocytes were removed from a tight band 
above the Ficoll, washed, counted and incubated in a 5% C 0 2 atmosphere as described 
in Section 2.2.3.2. 
4.23.2 Single Stain FACS Analysis 
Single stain flow cytometric analysis of cells from Xenopus spleen, liver and gut was 
carried out using hybridoma supernatants exactly as described in Section 4.2.2.4. 
4.2.3.3 Immunomagnetic Separation of NK Cells from Tx Spleen 
Splenic lymphocytes were isolated from Tx animals, as described in Section 2.2.3.2., 
adjusted to 5xl0 6 and incubated with 500ul of the appropriate hybridoma supernatant 
on ice for 30 minutes. Following 3 washes with FACS medium, 5xl0 6 cells in 80^1 
HBSS/1% FCS were added to 20ul of MACS microbeads conjugated with goat anti-
mouse IgG (Miltenyi Biotec). The cells and beads were incubated for 15 minutes at 
4°C, and the mixture passed over a prewashed Mini-MACS separation column placed 
in a separation unit (magnet). The non-adherent splenocytes eluted from the column 
were collected before removal of the column from the magnetic separation unit to 
allow collection of the adherent population. Both non-adherent and adherent 
populations were cultured overnight in tumour medium (As in Section 2.2.3.2) before 
FACS analysis. 
4.2.3.4 Dual Stain FACS Analysis of Immunomagnetically-Separated NK cells 
For dual stain analysis, the immunomagnetically-separated NK cells were first labelled 
with hybridoma supernatant and rabbit anti-mouse Ig FITC antibody (DAKO) as 
described above. The cells were washed three times in FACS buffer containing 1:100 
filter-sterilised normal mouse serum before incubating in the dark on ice for 20 
minutes with 50ul PE-conjugated D12, which is a putative marker of y8 T cells in 
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Xenopus (Ibrahim et al., 1991). Three further washes in FACS buffer were carried out 
before resuspending the cells in 500ul FACS buffer and analysing on the flow 
cytometer. Controls for FITC and PE fluorescence were used to set the background 
markers at 2%, as described in Section 3.2.4.7. 
4.2.4 Chromium Release Assays to Test the Cytotoxicity of Immunomagnetically 
Purified Cells from Tx Spleen 
The chromium release assays described in this Section were carried out by Trudy 
Horton at Durham University. B 3 B 7 tumour targets ( lx lO 6 cells/ml) were incubated 
overnight, as described in Section 2.2.3.1, in tumour medium supplemented with 
100nCi/ml Na 2[ 5 1Cr]04 (Amersham). Following 3 washes in tumour medium, the 
radiolabeled target cells were incubated for 30 minutes to remove initial spontaneous 
release of 5 1Cr, then adjusted to 5xl0 5 cells/ml prior to assay. Immunomagnetically 
sorted populations of Tx spleen cells (described in Section 4.2.3.3), which had been 
cultured in 25% growth factor rich medium (GFM) derived from concanavalin A-
stimulated Xenopus splenocytes, were serially diluted in wells of a 96-well plate. To 
each well was added lOOul 51Cr-labelled targets (5xl0 4 cells) and the plates were 
incubated for 6 hours at 27°C in 5% C0 2 . Following incubation, the cells were 
pelleted by spinning the 96-well plate at 300g for 10 minutes and lOOu! supernatant 
removed and added to 3ml Ecosint scintillation solution (National Diagnostics). 
Radioactivity was detected in each sample using a Packard Tri-Carb analyser. The 
percentage of specific 5 1 Cr release was calculated using the formula (E-C/M-C x 100), 
where E=cpm 5 1 Cr for experimental supernatant, C=cpm for minimum control (ie 
spontaneous release using 100^1 target cells cultured in IOOJAI medium alone) and 
M=cpm for maximum control (ie using lOOpl target cells in lOOul water, freeze-
thawed 3 times). 
4.2.5 Flow Cytometric Analysis of Hybridoma-Derived mAb's on Human 
Peripheral Blood Lymphocytes 
The FACS analysis of human PBL described in this section was performed in 
collaboration with Dr Marco Colonna at the Basel Institute for Immunology in 
Switzerland. 3ml peripheral blood from a healthy donor was layered onto 3ml density 
1.077 Ficoll (Nycomed) and centrifuged at 600g for 20 minutes at 4°C. The 
lymphocytes were removed from a band above the Ficoll and washed twice in PBS. 
For dual stain FACS analysis, aliquots of 3xl0 5 human PBL were probed with the anti-
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Xenopus NK cell mAb 1F8 (detected with a FITC antibody) before the addition of PE-
conjugated mAb's to the human cell surface markers CD3, CD4, CD8, CD14, CD16, 
CD19 or CD56 (Becton-Dickinson). As a control, an aliquot of cells was incubated 
with FITC-conjugated mouse IgG (Becton-Dickinson), followed by PE-conjugated 
mouse IgG (Becton-Dickinson) and used to set the background fluorescence 
parameters on the flow cytometer. Aliquots of 3x105 PBL were transferred to 
individual wells of a 96-well plate and spun down at 300g for 5 minutes at 4°C to 
pellet the cells before discarding the supernatant. 50^1 neat 1F8 hybridoma supernatant 
was added to each cell pellet and incubated on ice for 30 minutes. The cells were then 
washed 3 times in PBS before the addition of 50\d FITC conjugated anti-mouse IgG 
(Becton-Dickinson) and incubation on ice in the dark for 30 minutes. The cells were 
washed 3 times in PBS before resuspending in 20^1 30% normal mouse serum and 
incubating on ice for 20 minutes, l j i l of PE-conjugated anti-human CD marker mAb 
(Becton-Dickinson) was added to the cells and incubated in the dark for 30 minutes on 
ice before 2 final washes. The cells were resuspended in 500^1 PBS and analysed by 
flow cytometry. 
4.2.6 Western Blots of Xenopus Cell Lysates 
Xenopus lymphoid cells were prepared from spleen, liver and gut of both control and 
Tx animals as described above. lxlO 7 cells were resuspended in 100^1 lysis buffer 
(l%NP-40, 150mM NaCl, 50mM Tris HC1 (pH8.0), ImM MgCl2, ImM 
phenylmethane sulphonyl fluoride (PMSF), ljig/ml leupeptin and ljig/ml pepstatin A). 
The cells were lysed on ice for 30 minutes, then spun at 15000rpm for 3 minutes to 
remove insoluble material. 20JJ1 aliquots of the supernatant were added to 4JJ,1 protein 
sample loading buffer and the samples subjected to SDS-PAGE and transferred to 
nitrocellulose (as in Section 2.2.1.4). Nitrocellulose filters were blocked in 5% milk, 
0.02% Tween 20 in TBS (pH7.5) using the same conditions as those described in 
Section 2.2.4.3. 20ml primary antibody (hybridoma supernatant diluted 1:2 in blocking 
buffer) was added to the nitrocellulose and incubated for 2 hours at RT with gentle 
rocking. The filter was then washed twice in blocking buffer before incubating for 2 
hours at RT in HRP-conjugated goat anti-mouse IgG antibody (diluted 1:20000 in 
20ml blocking buffer). Chemiluminescent detection of bands was carried out exactly 
as described in Section 2.2.4.3. 
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4.2.7 Immunoprecipitation Reactions Performed on Xenopus Cell Lysates 
The immunoprecipitation reactions described in this Section were performed in 
collaboration with Dr Louis Du Pasquier at the Basel Institute for Immunology in 
Switzerland. 
4.2.7.1 Metabolic Labelling of Xenopus Cells 
Xenopus lymphoid cells were prepared from spleen and gut of both control and Tx 
animals as described above. Cysteme/methionine-free RPMI medium (Gibco) was 
made isotonic to frog cells by adding 30% distilled water and supplemented with 10% 
foetal calf serum and lOO i^g/ml kanamycin. Xenopus cells were resuspended in 4ml of 
this RPMI medium (6 million cells/ml) in a 50ml Falcon tube and incubated at 27°C in 
5% C0 2 for 20 minutes to 'starve' the cells. Following the 20 minute incubation, 35S 
methionine (Amersham) was added to a final concentration of 0.2mCi/ml and the cells 
incubated at 27°C in 5% C0 2 overnight, with the lid loosened to allow diffusion of 
C0 2. Following overnight incubation, the cells were washed twice in 45ml APBS to 
remove unincorporated 35S methionine. 
4.2.7.2 Immunoprecipitation 
The metabolically labelled cells were resuspended in 6ml lysis buffer (l%NP-40, 
150mM NaCl, 50mM Tris HC1 (pH8.0), ImM MgCl2, ImM phenylmethane sulphonyl 
fluoride (PMSF), l^ig/ml leupeptin and lp.g/ml pepstatin A) and incubated on ice for 
30 minutes. The lysate was pre-cleared by the addition of 200ul protein A sepharose 
beads (made up 1:1 (v/v) in lOmM Tris-HCl (pH7.5), 150mMNaCl, 0.2%NP-40, 
2mM EDTA). Following incubation for 30 minutes at 4°C with rotation, the protein A 
beads were pelleted by centrifugation at 5000 rpm for 10 minutes at 4°C and the 
supernatant divided into 6 eppendorf tubes (equivalent to 4 million radiolabeled cells 
per tube). 
200^1 of 6 different hybridoma supernatants (including one negative and one positive 
control mAb) was added to each tube of pre-cleared lysate. The tubes were capped 
tightly and incubated for 1.5 hours at 4°C with rotation. After incubation, the tubes 
were centrifuged at 14,000 rpm for 15 minutes at 4°C and the supernatant was 
transferred to a new eppendorf tube. 
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The antigen:antibody complexes were captured by the addition of 50pl protein A 
sepharose beads (made up 1:1 (v/v) in lOmM Tris-HCl (pH7.5), 150mM NaCl, 0.2% 
NP-40, 2mM EDTA) followed by incubation, with rotation, for 1.5 hours at 4°C. The 
tubes were then centrifuged at 14,000 rpm for 3 minutes at 4°C to pellet the protein A 
beads and the supernatant was discarded, before resuspending the beads in 1ml lOmM 
Tris-HCl (pH7.5), 150mM NaCl, 0.2% NP-40, 2mM EDTA. The beads were washed 2 
more times in this buffer before 2 washes in 1ml lOmM Tris-HCl (pH7.5), 500mM 
NaCl, 0.2% NP-40, 2mM EDTA followed by 2 washes in 1ml lOmM Tris-HCl 
(pH7.5). 
4.2.7.3 SDS-PAGE and Detection of RadiolabeUed Proteins 
Following the washes, the protein A beads were resuspended in 20ul lx protein 
loading buffer and boiled for 5 minutes, followed by centrifugation for 1 rninute at 
14,000 rpm. The samples were separated by SDS-PAGE (As in Section 2.2.1.4) and 
the gel fixed in 10% acetic acid, 45% methanol for 30 minutes and then equilibrated 
with distilled water for 5 minutes. The gel was placed on a piece of 3MM paper 
(Whatman), wetted with distilled water and covered in cling film prior to vacuum 
drying in a Bio-Rad Slab Dryer for 2 hours. The dried gel was placed in a film cassette 
and, in a dark room, a sheet of X-ray film (Pujifilm) placed on top. The closed film 
cassette was incubated at -70°C overnight before development of the film using a 
Compact X4 X-ray film processor (X-Ograph). If necessary, a second sheet of X-ray 
film was exposed to the gel and incubated at -70°C for longer before developing in the 
same way. 
4.3 Results 
4.3.1 Flow Cytometric Investigation of mAb's to Xenopus NK Cells 
43.1.1 Flow Cytometric Screening of Hybridoma-Derived mAb's on Control and 
Tx Xenopus Spleen 
Following the production of hybridoma's from the mice immunised with Xenopus NK-
enriched cells, hybridoma supernatants were screened by flow cytometry for their 
ability to bind both control and Tx splenocytes (As described in Section 4.2.2.4). The 
histograms in Figure 4.1 show the results for 3 mAbs, designated 1F8, 1G5 and 4D4, 
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on control and Tx spleen. All three bound between 5% and 7% of control splenocytes 
and 17% of Tx splenocytes. These figures were consistent with the expected levels of 
NK cells in the spleen of control and Tx animals. 
4.3.1.2 Flow Cytometric Screening of mAb 1F8 on Different Lymphoid Organs 
from Control and Tx Xenopus 
Monoclonal antibody 1F8, having been identified as a potential marker of Xenopus NK 
cells was tested by flow cytometry on lymphoid cells prepared from the spleen, liver 
and gut IEL of control and Tx Xenopus. The results in Figure 4.2 show that the levels 
of 1F8 positive cells in control spleen, liver and gut were respectively 5%, 11% and 
25%. In Tx animals, these percentages were more than doubled, as the numbers in 
spleen, liver and gut were 14%, 30% and 55% respectively. 
43.1.3 Immunomagnetic Cell Sorting with mAb 1F8 and Dual Stain FACS 
Analysis 
Tx spleen cells were immunomagnetically sorted into lF8-adherent and non-adherent 
populations (As described in Section 4.2.3.3). The adherent population were confirmed 
as being 83% lF8-positive by FACS analysis and the non-adherent population were 
shown to be only 5% lF8-positive (See Figure 4.3). The adherent population were 
used in a dual stain with 1F8 and the PE-conjugated mAb D12, a putative marker of 
Xenopus y5 T cells (Ibrahim et al., 1991), which demonstrated that D12 labelled 
around 90% of lF8-positive cells. 
43.2 Cytotoxicity Assays Using Immunomagnetically Sorted Cell Populations 
from Control and Tx Spleen 
lF8-adherent and non-adherent populations of cells were prepared from control and Tx 
spleen, as described in Section 4.2.3.3. These populations, as well as control and Tx 
spleen samples which had not undergone immunomagnetic separation, were incubated 
in growth factor rich medium prior to use in chromium release assays to test their 
cytotoxicity towards the Xenopus tumour cell line B 3 B 7 (See Section 4.2.4). The 
graphs in Figure 4.4, which show the results of repeated experiments, clearly 
demonstrate that lF8-adherent cells are more effective killers than either the 
unseparated or 1F8 non-adherent populations. 30% killing of the tumour cells by 1F8-
positive cells was possible with an effector:target ratio as low as 3:1. Significantly, the 
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lF8-negative cells showed very low levels of cytotoxicity and unseparated cells 
displayed an intermediate level. 
4.3.3 Dual Stain FACS Analysis of Human PBL using mAb 1F8 
Having verified that mAb 1F8 is a marker of NK cells in Xenopus, flow cytometric 
analysis was used to test the ability of 1F8 to bind human PBL. 1F8 staining was 
detected using a FITC-conjugated anti-mouse IgG antibody before co-staining the cells 
with various PE-conjugated mAb's to human CD markers (As described in Section 
4.2.5). The results shown in Figure 4.5 demonstrate that mAb 1F8 labelled a subset of 
human PBL but did not co-stain with the pan T cell marker CD3, or the helper and 
cytotoxic subsets of T cells identified by the anti-CD4 and anti-CD8 mAb's. Nor did 
the 1F8-Iabelled cells co-express CD56, an NK-specific marker, CD 16, which labels 
NK cells, neutrophils and macrophages, or CD 14, which is specific for monocytes. 
However, the pan B cell marker CD 19 did co-stain with mAb 1F8. 
43.4 Western Blots of Xenopus Lymphoid Lysates Probed with Anti-NK mAb's 
4.3.4.1 A Comparison of mAbs 1F8,4D4,1G5 and D12 in Western Blots of Tx 
Xenopus Spleen and Gut Lysates 
Western blots of cell lysates from Tx spleen and gut were probed with mAb's 1F8 
(IgG2b), 4D4 (IgG2a), 1G5 (IgG2a) and D12 (IgGl), as described in Section 4.2.6. 
The concentrations of these four mAb's were estimated to be equal from FACS 
analysis (T.L.Horton, pers. comm.).Figure 4.6 shows that mAb's 1F8 and 4D4 failed 
to identify any protein bands in the spleen, whereas 1G5, and to a lesser extent D12, 
both reacted with a doublet at 72 to 74 kDa and a larger band at around 84 kDa. In the 
gut, all the mAb's detected a doublet at 72 to 74 kDa, with 1F8 and 4D4 showing the 
weakest staining, D12 slightly stronger staining and 1G5 very strong staining. Tx 
spleen and gut lysates showed no background staining when probed with secondary 
antibody alone. 
4.3.4.2 Western Blots of Xenopus Lymphoid Lysates Probed with mAb 1G5 
Cell lysates from control and Tx animals were separated by SDS-PAGE, blotted to 
nitrocellulose and probed with mAb 1G5, as described in Section 4.2.6. Figure 4.7 
shows that probing Western blots of spleen and gut lysates from control Xenopus with 
mAb 1G5 identified a specific doublet of protein bands at 72 to 74 kDa, with much 
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heavier staining in gut than spleen. The control spleen also exhibited staining of a 
larger protein band of-84 kDa. In Tx animals, the doublet at 72 to 74 kDa was more 
strongly stained than in control animals and was more heavily stained in the gut than in 
spleen or liver. Both Tx liver and Tx spleen lysates, when probed with 1G5, identified 
an additional protein band of around 84 kDa. Spleen, liver and gut lysates showed no 
background staining when probed with secondary antibody alone. The probing of 
lysates of the tumour cell line B 3 B 7 with mAb 1G5 identified no protein bands, 
whereas probing with XT-1 identified bands at 120 to 130 kDa, corresponding to the 
XTLA-1 antigen (Nagata, 1986). 
4.3.5 Immunoprecipitation Reactions Performed on Xenopus Spleen and Gut Cell 
Lysates with mAb's 1F8, 4D4 and 1G5 
Following preparation of lymphoid cells from the spleen and gut of control Xenopus, 
immunoprecipitation reactions were performed with mAb's 1F8, 4D4 and 1G5, as 
described in Section 4.2.7. Positive control samples immunoprecipitated with mAb 
10A9, which identifies IgM heavy (75-80 kDa) and light (25 kDa) chains and mAb 
TBI7, which identifies MHC class I (40-45 kDa) were included for comparison. Also 
included was a negative control using mAb Gabi, which identifies a 55 kDa molecule 
called CTX (Chretien et al., 1996) but which is not expressed in spleen or gut (See 
Appendix 3 for further details of these mAb's). 
The spleen immunoprecipitation results (Figure 4.8) show that bands corresponding to 
MHC class I (40-45 kDa) and IgM heavy chain (75-80kDa) were isolated using mAb's 
TBI7 and 10A9 respectively. The CTX-specific mAb Gabi shows no specific bands, 
but mAb's 4D4, 1G5 and 1F8 possibly identify specific protein bands at 55 to 60 kDa. 
The gut immunoprecipitation reactions with mAb's 4D4, 1G5 and 1F8 show more 
convincing identification of specific protein bands. As in the spleen, mAb's 4D4 and 
1G5 appear to precipitate a protein of ~55 kDa, whereas 1F8 identifies a slightly larger 
protein of-60 kDa. The positive control mAb 10A9 appears to precipitate the IgM 
heavy chain, while the negative control mAb Gabi shows no specific protein bands. 
4.4 Discussion 
4.4.1 The Overlapping Functions of NK and T cells in Xenopus laevis 
In the past, the study of NK cells in Xenopus has been hindered by the lack of mAb's 
which specifically bind to NK cell surface antigens. As such, it has proved difficult to 
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separate the cytotoxic effects of NK cells from those of T cells in control animals. In 
fact it has been shown, using immunomagnetic separation of control splenocytes to 
isolate CD5+,CD8+ T cells, CD5+,CD8- (putative CD4+) T cells and CD5-,CD8- non-
T cells, that all three in-vitro cultured populations kill the tumour target B 3 B 7 (Horton 
et al., 1998b). In-vivo studies in Xenopus, using transplanted MHC-matched tumour 
cells, also suggest an anti-tumour role for T cells. These experiments have 
demonstrated rejection of the tumour cells by adults but not by tadpoles and 
furthermore that the tumour rejection was abrogated by thymectomy, underlining the 
importance of T cells (Robert et al., 1995; Robert et al., 1997). 
Work investigating tumour antigens on Xenopus tumour cell lines has highlighted the 
possible importance of a heat shock protein called gp96 (Robert and Cohen, 1998). 
This protein is expressed on the surface of all known Xenopus tumour cell lines and 
when isolated from the 15/0 tumour cell line has been used successfully to immunise 
against challenge with 15/0 cells, whereas gp96 isolated from non-tumour cells was 
unable to elicit the same anti-tumour response (Robert and Cohen, 1998). These results 
suggest a possible role for heat shock proteins in antigen presentation and/or delivery 
of danger signals to the immune system. The MHC-deficient phenotype of 15/0 cells is 
suggestive of NK cell involvement in this anti-tumour activity but the involvement of T 
cells is not ruled out (Robert and Cohen, 1998). 
4.4.2 Identification of Three Monoclonal Antibodies to Xenopus NK cells 
Given the close functional and developmental relationship of T cells and NK cells, the 
use of Tx animals has been crucial in identifying the putative NK-like population in 
Xenopus (Horton et al., 1996). As such, the attempts made in this Chapter to raise NK-
specific mAb's through hybridoma technology used Tx animals as a source of NK-like 
cells for the immunisation of mice. Furthermore, it was the ability of three mAb's, 
namely 1F8, 4D4 and 1G5, to label a greater number of spleen cells in Tx than control 
animals which facilitated their identification as putative markers of Xenopus NK cells. 
Having identified the three potentially NK-specific antibodies, mAb 1F8 was used in 
FACS analysis to determine the levels of putative NK cells in control and Tx liver and 
gut IEL. As with the results in the spleen, the percentage of positively stained cells was 
higher in Tx than control animals for both liver and gut cells which eradicated the 
possibility that 1F8 was binding to an antigen on thymus-derived T cells. The levels of 
lF8-positive staining in control spleen and liver, which were around 5% and 10% 
respectively, are fairly comparable with the percentages of NK cells found in those 
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organs in mammals. The approximately 25% of control gut IEL which labelled with 
1F8, however, is considerably higher than the frequency of NK cells in human and 
mouse intestine, but is more comparable with the levels of NK cells in the intestine of 
the chicken, which can constitute 50% of BEL (Gobel et al., 1994). 
1F8 was used to immunomagnetically isolate the putative NK cell population from Tx 
spleen which consequently allowed these cells to be used in cytotoxicity assays using 
the allogeneic thymus tumour cell line B 3 B 7 as a target. The ability of l F8-positive 
cells to lyse B 3 B 7 tumour cells far more efficiently than lF8-negative cells confirmed 
this mAb as a marker of Xenopus NK cells. Further confirmation of the ability of 1F8 
to label Xenopus NK cells has been achieved through FACS analysis of 1F8 on 
cultured cells from both control and Tx animals and the demonstration that 1F8 is not 
expressed on T or B cells (Horton et al., manuscript submitted). 
FACS analysis of inmiunomagnetically-purified lF8-positive cells was used to show 
that the antigen bound by mAb D12 was present on the majority of lF8-positive cells. 
The D12 mAb is of interest because it was originally thought to bind to a 36 kDa 
receptor on Xenopus y5 T cells (Ibrahim et al., 1991). The FACS data shown here 
indicate that D12 is also capable of binding to Xenopus NK cells. 
The flow cytometric binding studies of mAb 1F8 on human PBL's revealed an 
interesting anomaly. Whilst it was unable to co-stain human NK or T cells, it appeared 
that 1F8 did bind to human B cells. Any non-specific binding of 1F8 antibody by Fc 
receptors on human B cells was deemed unlikely as the PE and FITC-conjugated 
control mouse IgG antibodies did not show any such binding. Therefore, it appears that 
there are two possibilities to explain why a mAb which is specific for Xenopus NK 
cells should bind to human B cells. Firstly it is conceivable that 1F8 could, by chance, 
cross react in humans with a B cell-specific antigen which is entirely unrelated to the 
original NK-specific antigen in Xenopus. Alternatively, it is possible that 1F8 binds to 
the same antigen in both Xenopus and humans and that the antigen is expressed on 
different cell types in the two species. Further FACS analysis of lymphoid cells from a 
variety of other species may shed some light on the antigen specificity of 1F8 but the 
only definitive answer would come from the molecular characterisation of both the 
Xenopus and human 1F8 antigens. 
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4.4.3 Investigation of the Antigens bound by the Anti-Xenopus NK mAb's 
The data collected from Western blotting experiments using Xenopus lymphoid lysates 
probed with mAb 1G5 suggested a convincing ability of this mAb to specifically bind 
two proteins at 72 and 74 kDa. These proteins were found in both control and, at a 
higher level, in Tx lymphoid lysates and their expression was greatest in gut IEL, 
followed by liver and then spleen. These levels of expression appear to correlate well 
with the percentages of NK cells identified by FACS analysis of these organs as the 
relative numbers of NK cells are highest in the gut, followed by liver and then spleen. 
1G5 also identified a higher molecular weight protein band of around 84 kDa in spleen 
and liver and this variation may reflect alternative splicing of the encoding mRNA or a 
difference in glycosylation of this protein when expressed on NK cells in these organs. 
1F8, 4D4 and D12 were also used to probe Western blots of Xenopus lymphoid lysates 
and were all able to bind the two proteins at 72 and 74 kDa in Tx gut. Of the three 
mAb's, D12 reacted most strongly to gut lysates and was also able to identify the 72, 
74 and 84 kDa bands in Tx spleen whereas 1F8 and 4D4 staining was weak in Tx gut 
and undetectable in Tx spleen. The evidence from these Western blots seems to 
suggest that all four mAb's are capable of binding to the same 72 and 74 kDa antigens 
expressed in Tx gut whereas only mAb's 1G5 and D12 can detect the 72, 74 and 84 
kDa bands, which are expressed at lower levels in spleen and liver. The D12 Western 
blot results reported here disagree with the previously published 36 kDa size of the 
D12 antigen which was determined by immunoprecipitation (Ibrahim et al., 1991). 
The immunoprecipitations carried out with mAb's 1F8, 4D4 and 1G5 on radiolabeled 
spleen and gut lymphoid lysates from control Xenopus do not appear to correlate with 
the Western blotting results. While 4D4 and 1G5 appear to precipitate a protein of 
around 55kDa from spleen and gut, 1F8 precipitates a protein of around 60 kDa from 
spleen and gut. However, it should be noted that these prelirninary 
immunoprecipitation reactions showed a high level of background and all the mAb's 
appeared to precipitate proteins non-specifically at around 55 kDa in the gut. As such, 
it is concluded that the Western blotting results, especially with mAb 1G5, which were 
repeated on more than ten occasions, currently offer a more reliable identification of 
the NK surface antigen. Further work is required to obtain more convincing results 
from immunoprecipitation reactions with these mAb's. 
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Figure 4.1 Identification of Putative anti-NK niAb's 1F8.1G5 and 4D4 
Through Screening on Control and Tnymectomised Xendpus Splenocytes 
Flow cytometric traces comparing the ability of three mAb's, 1F8, 4D4 and 
1G5, to bind control and Tx Xenopus splenocytes. Bound mAb's were detected 
using a FITC-conjugated anti-mouse Ig antibody. 
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Figure 4.2 Flow Cytometric Testing of mAb 1F8 on Lymphoid Cells 
from Various Organs of Control and Tx Xenopus 
Flow cytometric traces are shown which demonstrate the ability of mAb 1F8 to 
bind spleen, liver and gut lymphoid cells from both control and Tx Xenopus. 
As in the previous figure, the bound mAb was detected using a FITC-
conjugated anti-mouse Ig antibody. 
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Figure 4.3 Immunomagnetic Separation of Cells from Tx Spleen with 
mAb 1F8 and Dual Stain Analysis of 1F8-Enriched Cells 
The first trace (A) shows the binding of 1F8 to Tx spleen cells prior to 
immunomagnetic separation. Following separation of the splenocytes into 1F8 
non-adherent and 1F8 adherent populations, the cells were re-tested by flow 
cytometry with mAb 1F8 (B and C). The lF8-adherent cells were also used in a 
dual stain with 1F8 in conjunction with the PE-conjugated mAb D12 (D). 
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Figure 4.4 Cytotoxicity Assays to Test the Ability of IF8-Adherenfc 1F8-
Non-Adherent and Unseparated Cells from Control and Tx Spleen to Ki l l 
the Tumour Target B^ B? 
Following irnmiinomagnetic separation of spleen cells with mAb 1F8, the 1F8-
adherent, non-adherent and unseparated populations were each tested for their 
ability to lyse B 3B 7 cells in chromium release assays. The percentage of B 3 B 7 
cells lysed is shown at different effectontarget (E:T) ratios and the data (with 
mean ± standard errors) from three experiments each on control and Tx spleen 
are plotted. 
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Figure 4.5 Dual Stain FACS Analysis of mAb 1F8 on Human PBL 
Human PBL were probed with mAb 1F8 (detected with FITC-conjugated anti-
mouse Ig) in conjunction with PE-conjugated mAb's to human CD3 (A), CD56 
(B), CD4 (C), CD8 (D), CD 16 (E), CD 14 (F), CD 19 (G), or no PE-mAb (H). 
Also included was a control sample incubated with mouse IgG-FITC and 
mouse IgG-PE (I). FITC-labelled cells are detected on the X-axis and PE-
labelled cells on the Y-axis. 
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Figure 4.6 A Comparison of Western Blots of Tx Spleen and Gut 
Lvsates Probed with mAb's 1F8. 4D4,1GS and D12 
Western blots of spleen (S) and gut (G) lysates from Tx Xenopus probed with 
mAb's 1F8, 4D4, 1G5 and D12 and, as a control, with secondary antibody 
alone (2°). Molecular weight markers are shown for each blot. 
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Figure 4.7 Western Blots of Xenopus Cell Lysates Probed with mAb 1G5 
Western blots of spleen (S) and gut (G) lysates from control Xenopus and liver 
(L), spleen (S) and gut (G) lysates from thymectomised Xenopus probed with 
mAb 1G5 and, as a control, with secondary antibody alone (2°). B 3 B 7 cell 
lysates were probed with mAb's 1G5 and XT-1, which is known to react with a 
protein of 120-130 kDa. Molecular weight markers are shown for each blot. 
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Figure 4.8 lmmunoprecipitat ion Reactions Carried out on Cell Lysates 
from Control Xenopus Spleen and Gut 
Autoradiograms showing proteins immunoprecipitated with mAbs 1F8, 4D4 
and 1G5 following SDS-PAGE under reducing conditions (arrows indicate 
specific proteins). Positive control samples immunoprecipitated with mAb 
10A9, which identifies IgM heavy (75-80 kDa) and light (25 kDa) chains and 
mAb TB17, which identifies MHC class I (40-45 kDa) are included for 
comparison. Also included is a negative control using mAb Gabi, which 
identifies a molecule called CTX (55kDa) which is not expressed in spleen or 
gut. Molecular weight markers and their sizes in kilodaltons are shown. 
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CHAPTER 5 
Cloning Strategies for the Isolation of Xenopus NK 
Receptor Genes 
Following on from the identification o f N K cells in Xenopus, as described in Chapter 
4, the principal aim o f this Chapter was to isolate genes encoding Xenopus N K 
receptor proteins. Two strategies were used, the first being the screening o f a Tx 
Xenopus gut cDNA expression library with one o f the NK-specific mAb's described in 
Chapter 4. The second strategy was to design degenerate PCR primers to conserved 
sequences o f mammalian N K receptors and use them to amplify D N A encoding N K 
receptors f rom Xenopus. 
5.1 Introduction 
5.1.1 The Benefit of Studying N K Receptor Evolution 
The studies of mammalian N K receptors, reviewed in Chapter 1, have revealed a 
number of receptor families, some o f which are not conserved f rom rodents to humans. 
This has made diff icult the identification of receptors which are o f fundamental 
importance to the function o f all N K cells. It would therefore be useful to characterise 
N K receptors from more distantly related vertebrate species to f ind out which receptors 
are conserved through vertebrate evolution. The identification o f antibodies, class I and 
n M H C and T cell receptors in lower vertebrates (reviewed in Horton and Ratcliffe, 
1996) has underlined the fundamental importance o f these molecules in the immune 
systems of all vertebrate species. The recent discovery of bona fide N K cells in 
Xenopus laevis, as described in Chapter 4, now offers an opportunity to study and 
characterise amphibian N K cell receptors. 
5.1.2 The Use of mAb's to Isolate Specific cDNA's from Bacteriophage Lambda 
Expression Libraries 
The mAb's described in Chapter 4, which identify Xenopus N K cells, offer a direct 
means of isolating cDNA's encoding Xenopus N K cell surface proteins. By isolating 
mRNA from Xenopus NK-enriched lymphocytes, reverse transcribing to cDNA and 
cloning into bacteriophage lambda vectors, i t is possible to express a library o f 
Xenopus cDNA's as proteins and probe these proteins wi th the NK-specific mAb's. 
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Since each cDNA-containing phage can be grown as an individual plaque on a lawn of 
bacteria, any which express proteins identified by the NK-specific mAb can be isolated 
and the cDNA sequence derived. One feature o f the mti-Xenopus N K cell mAb 1G5 is 
that i t reacts strongly with denatured proteins in Western blot experiments (See Figure 
4.6), suggesting that it binds to a sequential, rather than a conformational, epitope. 
Therefore i f the Xenopus cDNA's are not expressed in their native conformation, 
which is often the case wi th eukaryotic proteins expressed in bacterial systems 
(Sambrook et al., 1989), the polypeptide antigen should still be identified by this mAb. 
Furthermore, the Western blot reaction wi th mAb 1G5 was strongest in the gut IEL of 
Tx animals, suggesting that the level of antigen is elevated in this organ. As such, it 
was decided to clone a cDNA expression library f rom the gut IEL o f a Tx animal and 
probe i t wi th the mAb 1G5. 
5.1.3 The Isolation of DNA Encoding Xenopus N K Receptor Proteins by P C R 
Amplification 
Many proteins have conserved stretches o f amino acids which are often inherently 
linked to their specific function. By identifying conserved motifs in the amino acid 
sequences o f N K receptors in different species, i t is possible to design PCR primers to 
specifically amplify D N A encoding these N K receptors. I f the motifs are conserved 
enough through evolution, specific D N A sequences f rom highly divergent species, 
such as Xenopus and humans, can be amplified wi th the same PCR primers. 
One of the difficulties of identifying targets for NK-specific PCR amplifications in 
Xenopus is that nearly all o f the sequence information for N K receptor proteins has 
been isolated f rom mammalian species. So even i f an amino acid sequence is 
conserved from rodent to human, there can be no certainty mat i t w i l l also be 
conserved in lower vertebrate species, such as Xenopus. However, wi th more sequence 
information from non-mammalian species gradually becoming available, opportunities 
are beginning to arise for the PCR amplification o f N K receptor transcripts f rom lower 
vertebrates such as Xenopus. 
5.2 Materials and Methods 
5.2.1 General Materials and Methods 
A l l the general materials and methods used in this Chapter are described in Sections 
2.2.1. and 3.3.1. 
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5.2.2 Isolation of mRNA from Tx Xenopus Gut I E L 
IEL were prepared from the gut of a Tx animal (as described in Section 4.2.3.1) and 
total RNA was purified from these cells (as described in Section 2.2.2.4). mRNA was 
isolated from the total RNA using an Oligotex™ mRNA Miniprep Ki t (Qiagen) which 
works by capturing the poly-A tail o f mRNA molecules on Oligotex particles, which 
have poly-T oligonucleotides covalently linked to their surface. 
Total RNA was resuspended in 500^1 lOmM Tris-HCl (pH 7.5), 0.5M NaCl, I m M 
EDTA, 0 .1% SDS in an eppendorf tube and 15|jl Oligotex particles (10% w/v in 
lOmM Tris HC1 (pH 7.5), 0.5M NaCl, I m M EDTA, 0 . 1 % SDS) were added before 
heating for 3 minutes at 60°C to disrupt the secondary structure of the RNA. The tube 
was incubated at RT for 10 minutes to allow hybridisation of the mRNA to the oligo-
dT on the Oligotex particles. The Oligotex particles were pelleted by centrifugation for 
2 minutes at 15,000 rpm and the supernatant (containing non-messenger RNA) 
removed and saved. The pellet was washed by resuspending in 400|il lOmM Tris HC1 
(pH 7.5), 150mM NaCl, I m M EDTA, pipetting onto a small spin column (Qiagen) and 
centrifuging for 1 minute at 15,000 rpm. The flow-through was discarded and the wash 
step repeated. 20^1 elution buffer (5mM Tris HC1 pH7.5), pre-heated to 70°C, was 
applied to the column before centrifugation at 15,000 rpm for 1 minute and collection 
of the f low through. This elution step was repeated and the eluates combined. 
5.2.3 P C R Amplification of Xenopus (3-a c tin DNA from purified mRNA 
Two cDNA amplification reactions were performed, one using the purified mRNA as a 
template and the other using the RNA left behind following removal of the mRNA 
(non-mRNA). The following components were added to two nuclease-free eppendorf 
tubes: 
mRNA Reaction Non-mRNA Reaction 
5x First strand buffer (Gibco) 4^1 5x First strand buffer 4M1 
40 units RNase inhibitor (Promega) l j i l 40 units RNase inhibitor l f i l 
lOmM dNTP's (Gibco) 2^d lOmM dNTP's 2 | i l 
I O O J I M Oligo dT primer (Gibco) l u l lOOpM Ohgo dT primer l j i l 
0.1M DTT (Gibco) 2^1 0 . 1 M D T T 2f i l 
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200 units Superscript I I Reverse 
Transcriptase (Gibco) 
Nuclease-free water (Promega) 
lOngmRNA 
TOTAL 
8^1 
20vl 
200 units Superscript I I Reverse 
Transcriptase 
Nuclease-free water 
lOng non-mRNA 
TOTAL 
9^1 
20^1 
The tubes were incubated at 37°C for 1 hour. Two PCR reactions were then performed 
using an aliquot of each cDNA amplification. The sequences of the primers for the 
amplification of a 541bp fragment of |3-actin D N A (Prof C. Secombes; pers. comm.) 
were as follows: 
(3-ActFor 5' ATC GTG GGG CGC CCC AGG CAC C 3' 
P-ActRev 5' CTC CTT A A T GTC A C G CAC GAT TTC 3' 
PCR reactions were performed as follows in eppendorf tubes: 
1 Ox PCR buffer (Boehringer Mannheim) 3 u l 
lOmM dNTP's 1(J 
lOOng cDNA 4^1 
100nM p-ActFor (Synthesised by M W G Biotech) 1 \A 
100(iM P-ActRev (Synthesised by M W G Biotech) Ipl 
2.5 units Taq polymerase (Boehringer Mannheim) 0.5^1 
Water 19.5ul 
TOTAL 30^1 
The tubes were heated in a Thermal Cycler (Perkin Elmer) as follows: 
92°C 3 minutes (Denaturation step) 
92°C 1 minute |^ (Denaturation step) 
50°C 1 minute r x 3 0 (Annealing step) 
72°C 1 minute J (Elongation step) 
72°C 7 minutes (Elongation step) 
lOpil o f each completed PCR reaction was analysed by agarose gel electrophoresis, as 
described in Section 2.2.1.3. 
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5.2.4 Construction of the Tx Xenopus Gut cDNA Library 
The amplification of cDNA f rom the Tx Xenopus gut mRNA was carried out using the 
ZAP-cDNA® Synthesis K i t (Stratagene) and all components, except for the mRNA, 
were supplied. 
5.2.4.1 Bacterial Strains 
The strains of E.coli used in the construction and manipulation o f the cDNA library 
were as follows: 
X L 1-Blue MRF ' A(mcrA) 183 A(mcrCB-hsdSMR-mrr) 173 endA 1 supEMthi-1 
recA 1 gyrA96 relA 1 lac [F ' proAB lac? ZAM\5 TnlO (Tef ) ] 
SOLR e 14-(McrA-) A(mcrCB-hsdSMR-mrr) 171 sbcC recB recJ uvrC 
umuC::Tn5 (Kan') lacgyrA96 relAl thi-\ endAX XR [F 'proAB 
lacF ZAM15] Su-
5.2.4.2 First Strand cDNA Synthesis 
The primer used for the amplification o f first strand cDNA, called the linker-primer, is 
described in Appendix 4. The following components were assembled in a nuclease-
free eppendorf tube: 
400ngXe«o/n /5mRNA 37.5^1 
lOx First strand buffer 5JJ1 
lOmMdNTP's 3ul 
2.8jig Linker-primer 2j.il 
40 units RNase inhibitor l j i l 
The tube was incubated at RT for 10 minutes to allow the linker-primer to anneal 
before the addition o f 1.5JJ1 Moloney murine leukaemia virus reverse transcriptase ( 5 0 
units/ul). The first strand synthesis reaction was incubated at 37°C for l hour. 
5.2.4 J Second Strand cDNA Synthesis 
The following components were added to the first strand reaction tube: 
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lOx Second strand buffer 
lOmM dNTP's 
20jil 
6{il 
l l l j j 
lini 
200^1 
Water 
E.coli RNase H (1.5 units/^1) 
E.coli D N A polymerase I (9 units/|il) 
TOTAL 
The tube was incubated for 2.5 hours at 16°C 
5.2.4.4 Blunting of cDNA Termini, Ligation of EcoRI Adapters and 
Phosphorylation of Cohesive Ends 
The following components were added to the second strand synthesis reaction to create 
blunt-ended cDNA tennini: 
2.5mM dNTP's 23^1 
Pfu D N A polymerase (2.5 units/nl) 2JJ1 
The blunting reaction was carried out at 72°C for 30 minutes. Following completion o f 
the reaction, 200fj l phenol-chloroform (1:1 v/v) was added and the tube vortexed 
before centrifugation at 15,000 rpm for 2 minutes. The upper aqueous layer, containing 
the cDNA, was transferred to a new eppendorf tube and an equal volume of 
chloroform was added. The tube was again centrifuged at 15,000 rpm for 2 minutes 
and the upper aqueous layer transferred to a new tube and the following were added: 
3 M sodium acetate 20^1 
100% ethanol 400^1 
The tube was incubated at -20°C overnight to allow the cDNA to precipitate and then 
centrifuged at 15,000 rpm for 60 minutes at 4°C. The supernatant was discarded and 
the D N A pellet washed by adding 500jol 70% (v/v) ethanol and centrifuging at 15,000 
rpm for 2 minutes. The supernatant was removed and the pellet allowed to air dry for 2 
minutes at RT. The pellet was resuspended in 9JJJ o f EcoRI adapters (See Appendix 4) 
and the following components added: 
1 Ox Ligase buffer 1 
lOmM Adenosine triphosphate (ATP) Ijol 
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T4 D N A Ligase (4 units/pi) 
The ligation reaction was incubated at 4°C for 2 days before heat inactivating the 
ligase enzyme by incubation at 70°C for 30 minutes. 
Following ligation o f the EcoRI adapters to the ends o f the cDNA molecules, the 
cohesive ends were phosphorylated by the addition o f the following components: 
lOx Ligase buffer l u l 
lOmM Adenosine triphosphate 2pl 
Water 6pJ 
T4 Polynucleotide kinase (10 units/pl) 1 p i 
The tube was incubated at 37°C for 30 minutes, then at 70°C for 30 minutes to heat 
inactivate the kinase enzyme. 
5.2.4.5 Xhol Digestion of cDNA 
The cDNA was digested wi th the restriction endonuclease Xhol at the site contained 
within the linker-primer to give each cDNA molecule an. Xhol and an EcoRI cohesive 
end. The following components were added to the phosphorylated cDNA from Section 
5.2.4.4: 
Xhol buffer 28pJ 
Xhol (40 units/ul) 3 p i 
The reaction was incubated for 1.5 hours at 37°C before the addition of 5 p i lOxSTE 
buffer (1M NaCl, 200mM Tris HC1 (pH 7.5), lOOmM EDTA) and 125pl 100% 
ethanol. The tube was placed at -20°C overnight to precipitate the cDNA, before 
centrifugation at 15,000rpm for 60 minutes at 4°C. The supernatant was discarded and 
the pellet resuspended in 14ul lxSTE buffer and 3.5pJ column loading dye (50% v/v 
glycerol, 10% v/v lOx STE buffer, 40% w/v bromophenol blue) was added. 
5.2.4.6 Size Fractionation of cDNA 
cDNA was size fractionated by passing it through a Sepharose CL-2B column and 
eluting progressive fractions f rom the column. The column was prepared by adding 
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Sepharose CL-2B resin on top of a cotton plug in the tip of a sterile 1ml plastic pipette 
(Greiner). The resin was left to pack down and form a column before being washed by 
the addition of 10ml lxSTE buffer. As the last of the lxSTE buffer entered the 
column, the cDNA was loaded on top and allowed to migrate through the column. 
When the leading edge of the dye reached the -0.4ml gradation on the pipette, fractions 
were collected from the column in eppendorf tubes i n aliquots of around lOOpl (3 
drops). 8ul of each fraction was removed and saved for electrophoretic analysis while 
an equal volume o f phenol-chloroform (1:1 v/v) was added to the remainder. Each tube 
was vortexed and centrifuged at 15,000 rpm for 2 minutes. The upper aqueous layer, 
containing the cDNA, was transferred to a new eppendorf tube and an equal volume o f 
chloroform was added. The tube was again vortexed and centrifuged at 15,000 rpm for 
2 minutes and the upper aqueous layer transferred to a new tube and 2 volumes o f 
100% ethanol were added. The tube was incubated at -20°C overnight, centrifuged at 
15,000 rpm for 60 minutes at 4°C and the D N A pellet washed by the addition of 200jJ 
80% (v/v) ethanol. Following a further centrifugation at 15,000 rpm for 2 minutes, the 
supernatant was removed and the pellet resuspended in 3.5^1 sterile water and stored at 
-20°C. 
5.2.4.7 Electrophoretic Analysis of cDNA Fractions 
A 5% polyacrylamide gel was poured using the Bio-Rad Mini-Gel apparatus as 
described in Section 2.2.1.3. Each 8^il cDNA fraction was added to 2ul 5x D N A 
loading buffer (See Section 2.2.1.1) and loaded on the gel before electrophoresis at 
100V for 1.5 hours. Gels were removed f rom the electrophoresis apparatus and stained 
using a silver stain kit (Bio-Rad). Gels were fixed by incubating in 50ml 40% (v/v) 
methanol for 30 minutes, followed by 15 minutes in two changes o f 50ml 10% (v/v) 
ethanol. Following fixation, the gels were incubated in 50ml oxidising solution (Bio-
Rad), containing potassium dichromate and nitric acid, for 5 minutes before 3 washes 
in 50ml sterile, distilled water. The gels were then incubated in 50ml silver reagent 
(Bio-Rad), containing silver nitrate, for 20 minutes before washing once in 50ml 
sterile, distilled water. 50ml developing solution (Bio-Rad), containing sodium 
carbonate and paraformaldehyde, was added to the gels until the D N A bands became 
visible, at which point 5% (v/v) acetic acid was added to stop the reaction. 
5.2.4.8 Ligation of cDNA into the Phage Lambda Lni-Zap X R Vector 
cDNA was ligated into the Uni-ZAP XR vector (Appendix 5), which had been 
digested with EcoRl and Xhol, in a 5jxl reaction volume as follows: 
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Uni-ZAP X R Vector 
cDNA 
lOx Ligase buffer 
lOmMATP 
2.5^ 1 
0.5^ 1 
0.5nl 
T4 D N A Ligase (4 units/^il) 0.5^1 
The ligation reaction was incubated at 4°C for two days. 
5.2.4.9 Packaging of the Uni-Zap X R Vector DNA into Lambda Phage Particles 
and Quantification of Phage Numbers by Titering 
A Gigapack HI Gold packaging extract (Stratagene) was removed from -80°C storage 
and placed on dry ice. The extract was then removed f rom dry ice, allowed to thaw and 
4jol o f the ligation reaction added immediately. The tube was incubated at RT for 2 
hours before the addition o f 500^1 SM buffer (0.1M NaCl, 8mM MgSCy7H 2 0 , 50mM 
Tris HC1 (pH 7.5), 0.01% (w/v) gelatin) and 20^1 chloroform. The completed 
packaging reaction was then stored at 4°C. 
XLl-b lue M R F ' E.coli cells were cultured overnight at 30°C in 10ml 2xYT medium 
(See Section 2.2.2.2), supplemented with lOmM M g S 0 4 and 0.2% (w/v) maltose, 
before being resuspended at an OD 6 0o o f 0.5 in lOmM MgS0 4 . A serial dilution o f the 
packaged phage was performed down to a final dilution o f 10"6. l u l aliquots o f the 
10", 10 5 and 10 - 6 dilution's were each added to 200^1 XLl -b lue cells and incubated at 
37°C for 15 minutes. 3 universal tubes, each containing 3ml 2xYT soft agar which had 
been melted and cooled to 48°C, were supplemented wi th 2.5mM IPTG and 5mg/ml 5-
bromo-4-chloro-3-indoyl-B-D-galactopyranoside (X-gal). Following the 15 minute 
incubation at 37°C, each 200^1 aliquot of XLl -b lue cells was added to a tube of soft 
agar which was consequently poured onto a 2xYT agar plate. The plates were 
incubated for 8 hours at 37°C before counting the respective numbers o f white and 
blue plaque forming units. 
5.2.4.10 Amplification of the Uni-Zap X R Library in Phage Lambda 
XLl-b lue M R F ' E.coli cells were cultured overnight at 30°C in 10ml 2xYT medium, 
supplemented with lOmM MgSC>4 and 0.2% (w/v) maltose, before being resuspended 
at an OD<5oo o f 0.5 in lOmM MgS0 4 . 500JJ1 o f the phage packaging reaction from 
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Section 5.2.4.9 was added to 1ml XLl-b lue cells and incubated at 37°C for 15 minutes. 
The XLl-b lue cells were then added to 30ml 2xYT soft agar, which had been melted 
and cooled to 48°C, and poured on to a 21x2 l c m square 2xYT agar plate and 
incubated at 37°C for 8 hours. The plate was then overlaid wi th 50ml SM buffer and 
incubated overnight at 4°C before transferring the SM buffer, into which the phage had 
diffused, to a 50ml Falcon tube. The tube was centrifuged at 4,000 rpm for 10 minutes 
to pellet the cell debris and the supernatant divided into 1ml aliquots, which were 
supplemented wi th 7% dimethyl sulphoxide (DMSO) and stored at -80°C. One aliquot 
was titred, as described in Section 5.2.4.9. 
5.2.5 In vivo Excision of cDNA-Containing Plasmid's from the Uni-ZAP X R cDNA 
Library in Phage Lambda 
In-vivo excision o f the pBluescript phagemid (Stratagene) f rom the Uni-Zap X R vector 
was achieved by co-infection wi th ExAssist helper phage (Stratagene). Separate 10ml 
cultures o f XLl -b lue M R F ' and SOLR E.coli cells in 2xYT medium, supplemented 
wi th lOmM M g S 0 4 and 0.2% (w/v) maltose, were grown overnight at 30°C. Each 
culture was centrifuged at 4,000 rpm for 10 minutes and the cells resuspended at an 
OD60<) of 0.5 in lOmM M g S 0 4 and stored on ice. The following were added to a 50ml 
Falcon tube: 
107 plaque forming units (pfu) Uni-ZAP X R lambda phage library 
125ul XLl-b lue cells (at an O D 6 0 0 o f 0.5 in lOmM M g S 0 4 ) 
10 9 p fu ExAssist helper phage (Stratagene) 
The tube was incubated at 37°C for 15 minutes before the addition o f 20ml 2xYT 
medium. The tube was shaken at 37°C for 3 hours and then heated to 70°C for 20 
minutes before being centrifuged at 4,000 rpm for 10 minutes, l u l o f the supernatant 
was added to 200pJ SOLR cells in an eppendorf tube and incubated at 37°C for 15 
minutes. lOOul was then spread, wi th a sterile glass spreader, on the surface o f a 2xYT 
agar plate, which had been supplemented wi th 50u,g/ml ampicillin. The plate was 
incubated overnight at 37°C and the cells harvested by adding 5ml 2xYT medium and 
scraping the colonies with a sterile glass spreader. The 2xYT medium was then 
transferred to a 15ml Falcon tube and centrifuged at 4,000 rpm for 10 minutes to pellet 
the cells. The supernatant was discarded and the cells resuspended in 500ul 2xYT 
medium. A 50ul aliquot was removed for the isolation o f plasmid D N A (As described 
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in Section 2.2.1.3), while the remainder was supplemented with 500jil 80% (v/v) 
glycerol and stored at -80°C. 
5.2.6 P C R Amplification of Xenopus P-actin DNA from the Excised cDNA Library 
Following the preparation of excised plasmid D N A (Section 5.2.5), a PCR reaction 
was performed to amplify Xenopus p-actin DNA: 
The tube was heated in a Thermal Cycler (Perkin Elmer) as described in Section 5.2.3. 
lOjol of each completed PCR reaction was analysed by agarose gel electrophoresis, as 
described in Section 2.2.1.3. 
5.2.7 Screening the Uni-ZAP X R Lambda Phage Expression Library with mAb's 
5.2.7.1 Primary Screening 
4 x l 0 5 p fu o f the Tx Xenopus gut cDNA library in phage lambda were plated out on a 
21x21cm 2xYT agar plate as described in Section 5.2.4.10. The plate was incubated at 
42°C for 4 hours before 4 sheets of 10x10cm nitrocellulose (Schleicher and Schuell), 
which had been pre-wetted in lOmM IPTG, were placed side by side on the agar plate. 
The plate was incubated for a further 4 hours at 37°C before transferring each 
nitrocellulose filter to a shallow tray containing 50ml TBS (See Section 2.2.1.1). After 
5 minutes incubation at RT on a rocker platform, the TBS was poured o f f and replaced 
with 50ml blocking solution (5% non fat dried milk (Marvel), 0.05 % Tween 20 in 
TBS) and the filters incubated with rocking for a further 30 minutes. After the 30 
minute incubation, the blocking solution in each tray was replaced with 10ml mAb 
1G5 hybridoma supernatant (diluted 1:2 in blocking solution) and the trays incubated 
for 2 hours. Following incubation, the filters were washed 3 times in 50ml blocking 
lOx PCR buffer (Boehringer Mannheim) 
lOmMdNTP's 
lOOng Excised plasmid D N A 
lOOpM p-ActFor 
lOOfjM P-ActRev 
2.5 units Taq polymerase (Boehringer Mannheim) 
Water 
3| i l 
l |0 l 
IJJI 
l j i l 
0.5(il 
22.5(il 
30|il TOTAL 
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solution before the addition o f 10ml HRP-conjugated anti-mouse IgG antibody (diluted 
1:20,000 in blocking solution). The filters were incubated for a further hour at RT on 
the rocker platform before washing 3 times in TBS. Chemiluminescent detection o f 
bound antibodies was carried out as described in Section 2.2.4.3. Plaques 
corresponding to positive results on the nitrocellulose filters were isolated by pressing 
down on the appropriate area of agar wi th a cut o f f pipette tip. The plug was 
transferred to an eppendorf tube containing 500(jJ SM buffer and left overnight at 4°C 
to allow diffusion of phage into the buffer. The titre of phage in the buffer was 
determined using the technique described in Section 5.2.4.9. 
5.2.7.2 Secondary Screening 
Approximately 100 p fu of each phage carried forward from the primary round of 
screening was plated on 2xYT as described in Section 5.2.4.9. Following incubation at 
42°C for 4 hours, each plate was overlaid with a 5x5cm nitrocellulose filter, which had 
been pre-wetted with lOmM IPTG. The remainder of the screening process was carried 
out as in Section 5.2.7.1, except that the filters were incubated in 10ml buffer volumes. 
5.2.8 Sequencing and Analysis of cDNA Clones from the Excised cDNA Library 
The excised D N A library in E.coli SOLR was plated on to a 2xYT agar plate f rom the 
40% glycerol stock at -80°C and the plate incubated at 37°C overnight. Individual 
colonies were picked with a sterilised nichrome wire, transferred to 5ml 2xYT medium 
containing 50(ig/ml ampicillin and cultured overnight at 37°C. Overnight bacterial 
cultures were consequently used for the preparation of plasmid DNA, as described in 
Section 2.2.1.3. 
5' to 3' sequencing of cDNA inserts f rom individual plasmid's was carried out using 
the M l 3 reverse primer (Stratagene) on a 373 Stretch™ or 377 Prism™ automated 
DN A sequencer (Applied Biosystems). Analysis o f cDNA sequences was performed 
using a web site (http://www.ncbi.nlm.nih.gov/BLAST) run by the US National Centre 
for Biotechnology Information (NCBI). cDNA sequences were entered and compared 
to either D N A or protein sequence databases using the BLAST (Basic Local Alignment 
Search Tool) algorithm (Altschul et al., 1990). BLASTN searches were used to 
directly compare the cDNA sequence with the D N A database whereas BLASTX 
searches compared the 6-frame conceptual translation of the cDNA to the protein 
database. 
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5.2.9 Attempts to Isolate DNA Encoding Xenopus N K Receptor Proteins by P C R 
Amplification 
5.2.9.1 Bacterial Strain 
The strain o fE.co l i used in the cloning o f PCR products was as follows: 
TOP10 F-, mcrA A(mrr-hsdRMS-mcrBC) <}>80/acZAM15 MacX74 deoR recAX 
araD139 A(ara-leu) 7697 galU galK. rpsh (Str*) endAl nupG 
5.2.92 Alignment of N K Receptor Protein Amino Acid Sequences 
N K receptor amino acid sequences were obtained from the N C B I Entrez database 
(http://www3.ncbi.nmi.nih.gov/htbin-post/Entrez) and gapped alignments were 
performed using the MegAlign program, which is part o f the LaserGene software 
package (DNASTAR Inc.). Conserved motifs within the N K receptor protein NKRP-1 
were found by aligning amino sequences f rom different species (See Figure 5.6). 
These motifs were consequently used to derive the PCR primers NK-F and N K - R 
(Figure 5.7). 
5.2.93 R T - P C R Reactions to Amplify NKRP-1 DNA from Xenopus Spleen R N A 
A spleen was dissected from a control Xenopus, as described in Section 2.2.3.2, and 
total RNA prepared f rom the spleen (as in Section 2.2.2.4). In order to remove 
contaminating genomic DNA, the fol lowing components were added to 14jil Xenopus 
spleen RNA in a nuclease-free eppendorf: 
5x First strand buffer (Gibco) 4^1 
2 units RNase-free DNase I (Promega) 2 j i l 
The tube was incubated at RT for 15 minutes before heating to 65°C for 10 minutes. 
Two cDNA amplification reactions were then performed on the RNA, one of which 
was a control reaction conducted in the absence o f the reverse transcriptase enzyme: 
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Test Reaction Control Reaction 
20ng RNA lOji l 20ng RNA lOjxl 
5x First strand buffer (Gibco) 2(xl 5x First strand buffer 2 j i l 
40 units RNase inhibitor (Promega)l}il 40 units RNase inhibitor l jol 
lOmM dNTP's (Gibco) 2nl lOmM dNTP's 2 j i l 
lOOuM Oligo dT primer (Gibco) l f i l IOOJJM Oligo dT primer l j i l 
0 . 1 M D T T (Gibco) 2 j i l 0.1M DTT 2jxl 
200 units Superscript I I Reverse Nuclease-free water l f i l 
Transcriptase (Gibco) 1^1 TOTAL 20jxl 
Nuclease-free water (Promega) l j i l 
TOTAL 20jol 
The reactions were incubated at 37°C for 1.5 hours and then each was used in a PCR 
reaction with the NKR-P1 primers NK-F and NK-R (synthesised by M W G Biotech): 
cDNA 4 | i l 
lOmM dNTP's (Gibco) l | i l 
1 OOjxM NK-F primer 1 |_il 
1 OOfiM NK-R primer 1 f i l 
lOx Expand™ buffer (Boehringer Mannheim) 5jol 
Expand™ polymerase mixture (Boehringer Mannheim) 0.5ul 
Water 37.5jil 
TOTAL 50|il 
The tubes were heated in a Thermal Cycler (Perkin Elmer) as follows: 
95°C 
95°C 
50°C 
72°C 
72°C 
3 minutes 
1 minute 
1 minute 
1 minute 
7 minutes 
y x 3 o 
(Denaturation step) 
(Denaturation step) 
(Annealing step) 
(Elongation step) 
(Elongation step) 
lOjul o f each completed PCR reaction was analysed by agarose gel electrophoresis, as 
described in Section 2.2.1.3. 
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5.2.9.4 Cloning and Sequencing of P C R Products 
PCR products were purified following agarose electrophoresis by silica fines, as 
described in Section 2.2.1.3. The PCR products were cloned into the pCR® vector 
(Invitrogen) using a TOPO™ TA cloning kit (Invitrogen). 4ul PCR product was added 
to l p l pCR vector and incubated for 5 minutes at RT. l u l o f the supplied 6x stop 
solution was added and the tube incubated for a further 10 seconds at RT before being 
placed on ice. 2ul of the reaction was added to a vial o f TOP 10 E.coli cells 
(Invitrogen) and incubated on ice for 30 minutes. The cells were subjected to heat 
shock by incubating at 42°C for 30 seconds and then placing immediately on ice. 
Following the heat shock, 250ul N E medium (See Section 2.2.2.2) was added to the 
cells and the tube shaken horizontally for 30 minutes at 37°C. 50ul was then plated 
onto a 2xYT agar plate, which had been supplemented with 50ug/ml ampicillin, 
40p,g/ml X-gal and 0. I m M IPTG, and the plate was incubated overnight at 37°C. 
White colonies were picked f rom the 2xYT agar plate with a sterilised nichrome wire, 
transferred to 5ml 2xYT medium containing 50ug/ml ampicillin and cultured overnight 
at 37°C. Overnight bacterial cultures were consequently used for the preparation o f 
plasmid DNA, as described in Section 2.2.1.3. Bi-directional sequencing of cDNA 
inserts f rom individual plasmid's was carried out using the universal M13 forward (-
20) and reverse (-40) primers (Invitrogen) on a 373 Stretch™ or 377 Prism™ 
automated D N A sequencer (Applied Biosystems). Analysis o f cDNA sequences was 
performed as described in Section 5.2.8. 
5.3 Results 
53.1 R T - P C R Amplification of p-actin DNA from Tx Xenopus Gut mRNA 
Following preparation o f mRNA f rom the total RNA isolated f rom Tx Xenopus gut 
IEL, an RT-PCR reaction was performed to amplify (3-actin D N A (As described in 
Section 5.2.3). The same RT-PCR was performed on both the mRNA and the RNA left 
behind following removal o f the mRNA. The result (Figure 5.1) shows amplification 
of a 541bp D N A fragment, which is the correct size for (3-actin D N A (Prof C. 
Secombes; pers. comm.), in the mRNA lane but not in the non-mRNA lane. This result 
suggested that intact mRNA had been isolated from the total RNA prepared f rom gut 
IEL. 
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53.2 Construction of Tx Xenopus Gut cDNA Library in Phage Lambda 
5.3.2.1 Size Fractionation of cDNA Molecules 
Double stranded cDNA was synthesised from Tx Xenopus gut mRNA and size 
fractionated by passing through a sepharose column, as described in Section 5.2.4. The 
cDNA fractions collected from the column were analysed by polyacrylamide gel 
electrophoresis and the DNA visualised by silver staining (See Section 5.2.4.7). The 
two gels displayed in Figure 5.2 show that the largest cDNA fragments were present in 
fractions 4, 5 and 6, whereas later fractions (7 to 12) show progressively smaller 
fragments of cDNA. 
5.3.2.2 Cloning of cDNA Fractions into the Phage Lambda Uni-Zap XR Vector 
Equal amounts of cDNA fractions 4, 5 and 6 were ligated into the Uni-Zap XR Vector 
as described in Section 5.2.4.8. Following packaging of the ligation reaction into phage 
lambda particles, the phage were titred using blue-white selection to determine how 
many contained cDNA inserts. 3xl0 5 white plaques (containing cDNA inserts) and 
lxlO 4 blue plaques (no inserts) were counted. The library was amplified and stored at 
-80°C. 
5.3.2.3 PCR Amplification of p-actin DNA from the Tx Xenopus cDNA Library 
In order to verify that Xenopus cDNA inserts had been successfully cloned, an aliquot 
of the phage lambda library was converted in an in vivo excision reaction to a plasmid 
library (As described in Section 5.2.5). The plasmid cDNA library was then used as a 
template in a PCR reaction to amplify P-actin DNA (See Section 5.2.6). Figure 5.3 
shows that the 541bp P-actin DNA was successfully amplified from the cDNA library. 
5.3.3 Screening of Tx Xenopus Gut cDNA Library in Phage Lambda with anti-
Xenopus NK mAb 1G5 
Proteins expressed by the Tx Xenopus gut cDNA library in phage lambda were 
screened with mAb 1G5, as described in Section 5.2.7. The primary round of screening 
(Figure 5.4) highlighted three potentially positive plaques, denoted A, B and C, which 
were subjected to a secondary round of screening with mAb 1G5. The second round of 
screening (Figure 5.5) showed no positive reactions to cDNA's expressed by plaques 
A, B or C. 
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5.3.4 Sequencing of 5 Tx Xenopus Gut cDNA's from the Excised Plasmid cDNA 
Library 
Five cDNA inserts, denotedXenl toXen5, from individual excised plasmid's were 
sequenced in a 5' to 3' direction and the deduced amino acid sequences compared to a 
protein database using the BLAST algorithm (See Section 5.2.8). One of the five 
sequences (Xen4) resulted from the re-cloning of vector DNA whereas the other four 
showed significant similarity to known mouse or human proteins (Table 5.1). The most 
significant result was the cDNA Xen3 which showed 92% identity to a 208 amino acid 
sequence found in a human GTP-binding protein (Data not shown). Of the other 
cDNA's, Xenl showed similarity to the murine protein Keapl, a possible suppressor of 
the transcription factor Nrf2 (Itoh et al., 1999), Xenl was similar to a human protein 
called OS-9, which is over-expressed in osteosarcomas (Kimura et al., 1998) and Xen5 
showed homology to a mouse protein called Bim, a novel member of the Bcl-2 family 
that promotes apoptosis (O'Connor et al., 1998). 
5.3.5 Attempts to Amplify DNA Encoding NK Receptors from Xenopus spleen 
RNA by RT-PCR 
5.3.5.1 Alignment of IN KR-PI Amino Acid Sequences 
The only NK receptor for which non-mammalian homologous sequences could be 
found on the NCBI database was NKR-P1. These homologous sequences were both 
cDNA's and were cloned from the Japanese flounder {Paralichthys olivaceus) and the 
chicken {Gallus gallus). When translated to amino acid sequence they showed 
significant homology to mammalian NKR-P1 amino acid sequences from mouse, rat 
and human (See Figure 5.6). 
5.3.5.2 Design of PCR Primers for the Amplification of NKR-P1 DNA 
Two short regions which showed a high level of homology between the 5 aligned 
amino acid sequences were chosen for the design of PCR primers (See Figure 5.6). 
The flounder and chicken cDNA regions encoding these sequences were compared and 
in the case of one region were found to be identical (Figure 5.7). This sequence was 
thus chosen as the forward PCR primer (NK-F). The flounder and chicken cDNA 
sequences for the second region were not identical and differences between the two 
were incorporated into the reverse PCR primer (NK-R) as degenerate bases (Figure 
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5.7). Based on the flounder and chicken cDNA sequences, the predicted size of the 
DNA fragment amplified by NK-F and NK-R would be between 150 and 180 bp. 
5.3.53 RT-PCR with Primers NK-F and NK-R on Xenopus Control Spleen RNA 
Two RT-PCR reactions were performed on control Xenopus spleen RNA with primers 
NK-F and NK-R (Described in Section 5.2.9.3). One of these was carried out in the 
absence of reverse transcriptase as a control for amplification from contaminating 
genomic DNA. This control sample showed no DNA bands when examined by agarose 
electrophoresis, whereas the sample in which reverse transcriptase was included 
showed amplification of 2 bands at around 180 and 450 base pairs (Figure 5.8). This 
suggested that amplification from mRNA rather than genomic DNA had taken place. 
53.5.4 Sequencing and Analysis of PCR Products 
Both the 180 and 450 base pair PCR products were cloned and sequenced, as 
described in Section 5.2.9.4. The 180 base pair fragment contained the NK-F primer 
sequence at one end but the NK-R primer sequence was not found. The 450 base pair 
product contained neither the NK-F or NK-R primer sequences but did contain a poly-
T region, probably transcribed from the poly-A tail of an mRNA molecule. 
Unfortunately, neither sequence showed significant homology to nucleic acid or 
protein sequences contained within the NCBI database when entered into the BLAST 
algorithm. 
5.4 Discussion 
5.4.1 Screening the Xenopus cDNA Expression Library with an Anti-NK mAb 
The first strategy for isolating a cDNA encoding a Xenopus NK cell surface protein 
was to screen a cDNA expression library cloned from the gut IEL of a Tx animal with 
the anti-NK mAb 1G5. This strategy of immunological screening has been used 
successfully in the molecular cloning of MHC class I cDNA from Xenopus (Flajnik et 
ai, 1991). A library of 3x105 recombinants was constructed from the Tx gut IEL 
mRNA. PCR with primers specific for P-actin DNA were able to amplify a correctly 
sized band from the cloned library. In addition, 5 cDNA's from the library were 
sequenced and 4 were found to be Xenopus cDNA's with similarity to 4 different 
mouse or human sequences. This evidence was taken as an indication that the library 
contained a diverse selection of Xenopus cDNA sequences. Primary screening of the 
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expression library with mAb 1G5 revealed three putative positive clones which were 
isolated and subjected to a further round of screening with 1G5. Unfortunately, none 
of the clones were true positives and a repeated attempt to isolate clones by screening 
with 1G5 was unsuccessful. 
There are several possible reasons for the failure of this strategy to clone a cDNA 
encoding aXenopus NK cell surface protein. Firstly, the library size of 3x105 may 
have been too small to contain the cDNA encoding the 1G5 antigen. Although the 
library was enriched for larger cDNA molecules which roughly approximated to the 
size of the protein identified by Western blotting (See Figure 4.6) by size fractionation, 
it is possible that rare mRNA transcripts, which can be present at a frequency of 1 per 
cell (Toole et al., 1984; Wood et al., 1984), were not represented. In this respect it is 
worth noting that the successful cloning oiXenopus MHC class I cDNA (Flajnik et al., 
1991) resulted from the screening of a library of 6xl0 6 recombinants. The factor which 
limited the size of this library was the number of IEL which could be obtained from a 
Tx animal and hence the amount of mRNA which could be used for cDNA library 
construction. The ZAP-cDNA® Synthesis Kit (Stratagene) is designed for cDNA 
amplification from 5jig of mRNA, whereas the amount of total RNA obtainable from 
the gut IEL was around 20^g (Data not shown), of which 1-5% (0.2 - lug) would be 
expected to be mRNA. Although RNA from several organs or even several animals 
could have been combined in order to obtain enough mRNA, it was thought that this 
would have introduced an increased number of mRNA transcripts from non-NK cells 
and reduced the frequency of NK-specific transcripts in the library. 
A second explanation for the failure of this method is that the correct cDNA clone was 
present in the library but was not expressed in a form which could be recognised by 
mAb 1G5. Although, 1G5 reacted very strongly to Western blots of denatured Tx gut 
protein, it is possible that when the cDNA-encoded antigen was expressed in bacteria 
it no longer contained the epitope to which 1G5 reacted. The initial amplification of 
cDNA from the 3' end of mRNA molecules with an oligo-dT primer tends to favour 
the production of C-terminal polypeptides which 1G5 may fail to recognise if its 
epitope is found in the N-terrninus of the protein. Alternatively, 1G5 may react with a 
carbohydrate moiety which would not be present when the protein is expressed in 
E.coli, as glycosylation of proteins does not occur in bacteria. However, the high level 
of specificity of mAb 1G5 for NK cells mXenopus, suggests that it is not simply 
binding to a carbohydrate antigen. With respect to the problem of eukaryotic protein 
expression in bacteria, it is desirable to screen bacterial expression libraries with 
polyclonal antisera which react to several epitopes on the target antigen, thus 
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increasing the chances of identifying a positive clone (Sambrook et al., 1989). 
Polyclonal antisera were used in the cloning of Xenopus MHC class I by this strategy 
(Flajnik et al., 1991) but unfortunately a polyclonal antiserum raised against the 1G5 
antigen was not available for this study. 
Given the reasons for the failure of this strategy, any future attempts to clone cDNA's 
for Xenopus NK cell surface proteins by immunological screening of cDNA expression 
libraries will require certain improvements. Firstly, the frequency of the desired clone 
in the cDNA library can be increased by employing immunomagnetic separation (as 
described in Section 4.2.3.3) to obtain highly enriched populations of NK cells prior to 
the preparation of mRNA. In order to obtain sufficient mRNA for the construction of a 
representative library it may be necessary to combine NK-enriched cells from several 
organs or even from several animals. Secondly, the cDNA could be initially amplified 
with a combination of oligo-dT and random primers so as not to favour too heavily the 
production of C-terminal polypeptides. Thirdly, and perhaps most importantly, 
screening the library with polyclonal antisera raised against the purified Xenopus NK 
antigen would increase the chances of identifying a positive clone despite some of the 
problems of bacterial expression described above. As an alternative to this third 
improvement, the Xenopus cDNA library could be expressed in a eukaryotic host, such 
as a yeast, insect or mammalian cell, to overcome some of the difficulties of bacterial 
protein expression. The eukaryotic expression library could then be screened by flow 
cytometry using the original m\x-Xenopus NK mAb's. 
5.4.2 Attempts to Isolate NKR-P1 DNA from Xenopus by RT-PCR 
The isolation of DNA encoding a Xenopus NKR-P1 homologue by RT-PCR relies 
upon the identification of conserved sequences in NKR-P1 proteins from several 
species. As mentioned earlier, NKR-P1 was the only NK receptor for which sequence 
homology was found in non-mammalian organisms, namely the Japanese flounder and 
the chicken. Although these sequences were not highly homologous, they did contain 
short amino acid motifs which appeared to be quite highly conserved and these were 
chosen for the design of the PCR primers NK-F and NK-R. The ability of these 
primers to amplify two PCR products, one of which was at the expected 180 base pah-
size, from control Xenopus spleen RNA initially suggested that the strategy may have 
been successful. However, sequencing and analysis of these products revealed no 
significant homology to any known DNA or protein sequences. The NK-F primer was 
found at one end of the 180 base pair sequence but the NK-R primer sequence could 
not be found, suggesting that an NKR-P1 homologue had not been amplified. The 
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larger 450 base pair PCR product contained a poly-T region but neither the NK-F or 
NK-R primers could be found within this PCR product. 
The failure of the PCR strategy to isolate a Xenopus NK receptor homologue may 
reflect the use of the chicken and flounder cDNA sequences to design PCR primers: 
Although the conceptual translations of these sequences were found to show homology 
to regions of mammalian NKR-P1, there has been no verification that these cDNA's 
actually encode NKR-P1 homologues. However, the design of PCR primers based on 
the mammalian sequences would have required the use of highly degenerate primer 
sequences which would have decreased the chance of amplifying a specific product. 
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Figure 5.1 Amplification of fi-actin DNA from Tx Xenopus Gut mRN A 
by RT-PCR 
1% agarose gel showing the amplification of 6-actin DNA from Tx Xenopus 
gut mRNA in an RT-PCR reaction. As a control reaction, the same RT-PCR 
was performed on RNA left behind after the removal of mRNA. Lane 1 
contains APstI DNA markers. 
mRNA non-mRNA 
541 base pair 
B-actin DNA 
-4 Primers 
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Figure 5.2 Size Fractionation of Tx Xenopus Gut cDNA 
2 silver-stained polyacrylamide gels showing aliquots of Xenopus gut cDNA 
following size fractionation on a sepharose column. Progressively-eluted 
fractions from the column are indicated (1 to 12) as are the DNA size markers 
^Hindlll and APstl. 
mindl l l 1 2 3 4 5 6 A.PstI 
I T 
• _ 1200 
• _ 1100 _ J 
Large (>1 kb) 
DNA fragments 
600 
80(1 
11 12 XHindiII XPstI 7 10 8 
5 
11000 
4500 
120(1 
800 
M M ) 
; 
Large (greater than 1 kilobase) DNA fragments are indicated. 
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Figure 5.3 Amplification of B-actin DNA by PCR from the Xenopus Gut 
cDNA Library 
Having excised the cDN A library as plasmids from the bacteriophage lambda 
vector, the plasmid library was used as a template in a PCR reaction to amplify 
B-actin DNA. Lane 1 contains APstI DNA size markers. 
541 base pair 
B-actin DNA 
Primers 
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Figure 5.4 Primary Screening of Xenopus Gut cDN A Expression Library 
with anti-NK mAb 1G5 
The Tx Xenopus gut cDNA library in the lambda ZAP vector was plated out on 
a bacterial lawn and the cDNA-encoded proteins were expressed, transferred to 
nitrocellulose filters and consequently probed with mAb 1G5. Four filters, each 
of which has corresponds to around lxlO 5 cDNA-containing lambda plaques, 
are shown with arrows highlighting putative positives. The circles indicate 
marks made on the nitrocellulose for orientation. 
r 
0 
B 
o 
o 
c 
, J L. J 
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Figure 5.5 Secondary Screening of Xenopus Gut cDNA Expression 
Library with anti-NK mAb 1G5 
Bacteriophage isolated from the primary screen with 1G5 (designated A,B and 
C in Figure 5.4) were individually plated out and re-screened with 1G5. The 
circles indicate marks made on the nitrocellulose for orientation. 
O 
B 
• 
i 
o 
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Table 5.1 Sequencing Results for 5 Random cDNA's from the Tx Xenopus 
Gut Library 
cDNA's from 5 randomly isolated plasmids were sequenced from the 5' end 
and the sequences entered into BLAST searches to allow comparison with 
DNA and protein sequence databases. BLASTN searches were used to directly 
compare the cDNA sequence with the DNA sequence database whereas 
BLASTX searches compared the 6-frame conceptual translation of the cDNA 
to the protein database. The degree of similarity is indicated by the score and E -
values, with a high score signifying similarity found over a long stretch of 
amino acids or bases and a low E-value indicating a low probability of a match 
being found by chance. 
cDNA BLAST 
search 
Similarity Found Accession 
Number 
Score E-value 
Xen\ BLASTX Mouse Keapl protein AB020063 79 2x10''5 
Xen2 BLASTX Human OS-9 precursor protein AB002806 62 3xl0"y 
Xen3 BLASTX Human GTP-binding protein AF120334 405 lxlO"1 1 3 
XenA BLASTN Bluescript vector DNA X52324 1223 0 
Xen5 BLASTX Mouse BimEL protein AF032459 66 1x10"" 
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Figure 5.6 Sequence Aii2nment of NKR-P1 Proteins from Various 
Vertebrate Species 
Aligned amino acid sequences are shown for NKR-P1 receptor proteins from 
mouse, rat and human. Also included are NKR-P1 homologous sequences 
translated from cDNA's cloned from the Japanese Flounder {Paralichthys 
olivaceus) and the chicken {Gallus gallus). The one-letter amino acid code is 
used and consensus sequences (found in at least two species) are contained in 
shaded boxes. The sequences used for the design of forward and reverse PCR 
primers are highlighted. 
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Figure 5.7 Design of Degenerate Primers to Amplify NKR-P1 DNA 
The derivation of the NKR-P1 primers from chicken and flounder cDNA 
sequences which have homology to mammalian NKR-P1 receptors. The amino 
acid and DNA sequences for each organism are aligned and the primers 
designed from these sequences are shown. Brackets indicate bases excluded 
from the primer sequences. Note that the NK-reverse primer is anti-parallel to 
the chicken/flounder DNA sequence. 
Flounder/Chicken W K W V D N S 
(amino acid) 
Flounder/Chicken 5' TGG AAA TGG GTG GAC AAC TClA 3' 
(DNA) C 
NK-F (forward primer) 5' TGG AAA TGG GTG GAC AAC TC 3' 
(20-mer) 
Flounder/Chicken 
(amino acid) 
Flounder/Chicken 
(DNA) 
NK-R (reverse primer) 
(16-mer) 
R/W I/V C Q M/K A/E 
5' ClGG ATC TGT CAG ATA GA T 
G C AG 
3' CC TAG AC A GTC TAT CT 
C G TC G 
3' 
5' 
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Figure 5.8 RT-PCR Reaction to Amplify NKR-P1 DNA from control 
Xenopus spleen RNA 
1% agarose gel showing 2 RT-PCR reactions performed on Xenopus spleen 
RNA, using degenerate primers designed to amplify NKR-P1 DNA. The 
reverse transcriptase enzyme was omitted from the reaction shown in lane A to 
act as a control for the amplification of products from contaminating genomic 
DNA. Lane B contains the RT-PCR reaction in which reverse transcriptase was 
included and the possible products of specific amplification with the NKR-P1 
primers are indicated. The DNA marker in the left hand lane is APstl. 
A B 
520bp 
470bp -450 bp product 
340bp 
2G0bp 
20()bp 180 bp product 
Primers 
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CHAPTER 6 
Conclusions and Future Work 
The aim of the work described in this Thesis was to raise antibodies to Xenopus NK 
cells with a view to the molecular characterisation of NK cell surface antigens. The 
main benefits of studying NK cell surface antigens in a comparative model such as 
Xenopus are twofold. Firstly, the identification of NK receptor proteins which are 
highly conserved through vertebrate evolution underlines their fundamental importance 
in the function of all NK cells. Secondly, the study of NK cell surface antigens in a 
lower vertebrate such as Xenopus may provide evidence for or against the idea that NK 
cells are the evolutionary forerunners of CTL as proposed recently (Janeway, 1989). 
Before any attempts to raise mti-Xenopus NK cell antibodies by phage display were 
made, the technique was developed in Chapter 2 for the isolation of recombinant 
antibodies to novel cell surface antigens expressed by the Xenopus tumour cell line 
B 3 B 7 . This use of the phage display technique differed from previously published 
examples of phage display in several ways. Firstly, the majority of published examples 
have used large naive or "in-vitro engineered' libraries, containing as many as 1010 
different recombinant antibody fragments (reviewed in Sheets et al., 1998). Secondly, 
many papers have concentrated on the optimisation of phage display for the isolation 
of antibodies to known, characterised antigens (for example see Nissim et al., 1994). 
In addition, large amounts of purified antigen, typically 10-lOOug, have been used for 
phage panning in conjunction with a sensitive screening method such as enzyme-linked 
immunosorbent assay (ELISA) for the detection of bound phage (Krebber et al., 1997; 
Sheets el al., 1998). In contrast, the protocol in Chapter 2 used panning of a relatively 
small, immune phage library (10s clones) on whole, live cells to enrich for phage 
which bound to unknown antigens on the cell surface. In this case the levels of surface 
antigen expressed by the cells would have been significantly lower than the amount of 
purified antigen used in previously published reports (for example see Krebber et al., 
1997). Additionally, flow cytometry, rather than ELISA, was used to screen phage for 
novel cell binding properties and this has only been described in a minority of 
publications (Siegel and Silberstein, 1994; De Kruif et al., 1995; Palmer et al., 1997). 
The ability of this cell based panning and screening strategy to isolate a phage 
antibody, XLB-5, which bound the target cell B 3 B 7 was demonstrated by several lines 
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of evidence, including FACS data, RFLP analysis of scFv DNA sequences and the 
monitoring of phage elution titres during panning. The confirmation of scFv/cpin 
fusion protein expression by this phage antibody, using Western blotting, indicated 
that specific binding was occurring through surface scFv. Phage antibody XLB-5 was 
found to label approximately two-thirds of T cells, B cells and red blood cells which 
meant that its target antigen was common to many Xenopus cell types. However, as no 
such pattern of binding has been reported for other mti-Xenopus mAb's it appeal s that 
XLB-5 is specific for a novel antigenic determinant. 
Following on from the optimisation of phage display through panning on the B 3 B 7 
tumour cell line, attempts were made in Chapter 3 to isolate phage display antibodies 
specific for Xenopus NK cells. Since the a-B 3 B 7 antibody XLB-5 cross-reacted with 
several Xenopus cell types, an area which required improvement in order to raise an 
NK-specific phage antibody was the specificity of the phage selected by panning. 
Unfortunately, the relatively small size (5xl0 5) of the phage library and the lack of a 
purified population of Xenopus NK cells for panning meant that an NK-specific mAb 
was not isolated. However, the phage antibody XL-6 which was isolated through 
panning did show specificity for Xenopus lymphocytes, which constituted an 
improvement on the level of specificity achieved in Chapter 2. Another major 
development was the production of soluble XL-6 scFv from bacteria, which showed 
the same specificity for Xenopus lymphocytes as the phage-displayed XL-6 scFv. 
Flow cytometric testing of soluble XL-6 scFv on diverse lymphoid populations from 
Xenopus suggested that it may bind to an amphibian equivalent of the leukocyte 
common antigen CD45. Particularly interesting was the ability of XL-6 to identify a 
small population of thymocytes which were thought to represent mature T cells. This 
finding may be indicative of binding to an isoform of CD45 known as CD45RA which, 
in mammals, identifies a small subset of thymocytes which are located in the medulla 
and are thought to be committed to entering the periphery as mature T cells (Deans et 
al., 1989; Gillitzer and Pilarski, 1990). Although mh-Xenopus class I I antibodies 
preferentially stain medullary thymocytes (Flajnik et al., 1990), there are few markers 
which differentiate thymocytes in Xenopus and it would therefore be of interest to 
investigate the antigen bound by XL-6. Firstly, in order to determine whether the XL-6 
positive thymocytes are mature in phenotype, it would be of interest to co-stain thymic 
lymphocytes with XL-6 and an anti-CTX mAb, which identifies an immature 
population of Xenopus thymocytes (Chretien et al., 1996), and examine the cells by 
flow cytometry. If, as predicted, XL-6 identifies a mature thymic population, the two 
antibodies should not co-stain the same thymocytes. Secondly, despite the failure of 
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Western blotting with soluble or phage-displayed XL-6 to identify any specific 
proteins, it may be possible to use soluble XL-6 to immunoprecipitate the target 
antigen using techniques described previously (Sanna et al., 1995; Sawyer et al., 
1997). Determination of the molecular weight of the antigen by this method would 
help resolve whether or not XL-6 is binding to an amphibian equivalent of the CD45 
receptor. 
In Chapter 4, the use of hybridoma technology to isolate 3 Xenopus NK-specific 
mAb's was described. FACS analysis of the mAb's 1F8, 4D4 and 1G5 demonstrated 
binding to a small proportion (5-10%) of spleen lymphocytes in control Xenopus and a 
higher proportion (15-20%) of spleen lymphocytes in Tx animals. Following 
immunomagnetic separation, lF8-positive spleen cells from control and Tx animals 
were shown to be effective killers of the thymus tumour cell line B 3 B 7 . Further 
evidence from irnmunohistochemistry and more detailed FACS analysis has confirmed 
that 1F8 identifies a population of non-T, non-B lymphocytes which are similar in 
distribution, morphology and function to mammalian NK cells (Horton et al., 
manuscript submitted). 
One finding of interest resulted from the flow cytometric testing of 1F8 on human 
PBL, which suggested that this mAb has a specificity for human B cells. This perhaps 
indicates that the antigen bound by mAb 1F8 is a conserved molecule of importance to 
the immune systems of many species. As such, it would be interesting to use FACS 
analysis to test mAb's 1F8, 4D4 and 1G5 on lymphoid populations from other lower 
vertebrate and mammalian species. Another possibility, i f the binding of 1F8 to human 
B cells is confirmed, would be to test this mAb on a human B cell line, such as an 
Epstein Barr virus transformed cell line. I f 1F8 is shown to bind by flow cytometry, 
such a cell line could provide a useful source of mRNA and protein for the molecular 
characterisation of the human 1F8 antigen. 
Having established ihaX Xenopus NK cells were identified by the mAb's 1F8, 4D4 and 
1G5, the surface antigens bound by these mAb's were investigated in Chapter 4 by 
Western blotting and immunoprecipitation. The results achieved through Western 
blotting demonstrated that all three mAb's could identify a doublet of protein bands at 
72 and 74 kDa, whereas immunoprecipitations indicated that the three mAb's bound to 
proteins of between 55 and 60 kDa. The significance of these results is not yet known 
although the Western blotting results were repeated on more than ten occasions, 
whereas the immunoprecipitations identified a number of non-specific protein bands 
and were not repeated. Further immunoprecipitation experiments on enriched NK cell 
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populations from Xenopus may help to clarify the true molecular weights of these 
antigens. 
Irnmunoprecipitation with the mh-Xenopus NK mAb's could also offer a means of 
isolating sufficient antigen for amino acid sequencing. The sequences obtained could 
be used to design degenerate PCR primers with which to amplify the encoding cDNA 
sequence from Xenopus. An alternative route to gaining cDNA sequence information 
was attempted in Chapter 5 by immunoscreening a lambda expression library with 
mAb 1G5. The library was constructed from the gut of a Tx animal which, through 
Western blotting experiments, was known to express a high level of the 1G5 antigen. 
Unfortunately the initial attempts at screening the library with 1G5 failed to identify 
any positive clones. As discussed in Chapter 5, improvements in the expression of 
Xenopus cDNA's and perhaps the use of polyclonal antibodies rai sed against the 1G5 
antigen could permit cloning of the appropriate cDNA. 
Chapter 5 also described an attempt to clone a. Xenopus homologue of the mammalian 
NK cell surface receptor NKR-P1 by RT-PCR. Although an NKR-P1 homologue was 
not identified, attempts to amplify homologues of other mammalian NK receptor 
cDNA's with degenerate PCR primers may be worthwhile. In particular, the CD94 
molecule is thought to be invariant (Lazetic et al., 1996) and thus may be a good target 
for PCR amplification. Another possible target is the signal transducing molecule 
DAP-12 which appears to be closely linked to NK cell activation (Lanier et al., 
1998c). 
To summarise, the work described in this Thesis demonstrates firstly that phage 
display technology is capable of raising phage antibodies to novel, unknown epitopes 
on whole, live cells. These phage antibodies and the soluble scFv molecules derived 
from them were able to identify distinct lymphoid populations in Xenopus using single 
and dual stain FACS analysis. Secondly, hybridoma technology was used to isolate 
three monoclonal antibodies which were shown to be specific for Xenopus NK cells. 
These antibodies offer a means of identifying and characterising Xenopus NK cell 
surface antigens which could eventually shed light on NK cell evolution and also the 
evolutionary relationship between NK and T cells. 
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Appendix 1 
PCR Primers for the Amplification and Combination of Mouse 
VL and VH Antibody Regions 
V L Primers 
The VL forward and reverse primer sets are made by mixing the volumes (in jil) of 
each oligonucleotide indicated under 'Mix ' to give the concentrations shown. The 
variable regions are indicated in capital letters (degenerate bases are denoted as 
follows: R = A or G; Y = C or T; M = A or C; K = G or T; S = C or G; W = A or T; H 
= A or C or T; B = C or G or T; V = A or C or G; D = A or G or T) and the sequence 
encoding the 4 amino acid tag detected by the a-FLAG mAb is underlined. Al l 
oligonucleotide sequences are taken from Krebber et al, 1997. 
Primer VL Forward Mix Cone (nM) 
LB1 pccateeceeactacaaaGAYATCCAGCTGACTCAGCC 1 1.6 
LB2 pccategcpeactacaaaGAYATTGTTCTCWCCCAGTC 2 3.1 
LB3 gccatggcgeactacaaaGAYATTGTGMTMACTCAGTC 5 7.8 
LB4 gccatgeceeactacaaaGAYATTGTGYTRACACAGTC 3.5 5.4 
LB5 pccateecEeactacaaaGAYATTGTRATGACMCAGTC 4 6.2 
LB6 pccateeceeactacaaaGAYATTMAGATRAMCCAGTC 7 10.9 
LB7 pccateeceeactacaaaGAYATTCAGATGAYDCAGTC 6 9.3 
LB8 gccatggcEeactacaaaGAYATYCAGATGACACAGAC 1.5 2.3 
LB9 gccateecaeactacaaaGAYATTGTTCTCAWCCAGTC 2 3.1 
LB 10 eccateeceeactacaaaGAYATTGWGCTSACCCAATC 3.5 5.4 
LB11 gccateecseactacaaaGAYATTSTRATGACCCARTC 8 12.4 
LB 12 pccatepcpeactacaaaGAYRTTKTGATGACCCARAC 8 12.4 
LB13 pccatepceeactacaaaGAYATTGTGATGACBCAGKC 6 9.3 
LB14 gccatggcggactacaaaGAYATTGTGATAACYCAGGA 2 3.1 
LB 15 gccatgeceaactacaaaGAYATTGTGATGACCCAGWT 2 3.1 
LB16 gccateecEeactacaaaGAYATTGTGATGACACAACC 1 1.6 
LB17 gccateeceeactacaaaGAYATTTTGCTGACTCAGTC 1 1.6 
gccateeceeactacaaaGATGCTGTTGTGACTCAGGAATC 1 1.6 
Primer VL Reverse Mix Cone (nM) 
LF1 ggagccgccgccgcc(agaaccaccaccacc)2ACG 1 l ' l G A l" r i CC AGCTTGG 1 23.5 
LF2 ggagccgccgccgcc(agaaccaccaccacc)2ACGTl t i ATTTCCAGCTTGG 1 23.5 
LF4 ggagccgccgccgcc(agaaccaccaccacc)2ACGl 1 l"l ATTTCCAACTTTG 1 23.5 
LF5 ggagccgccgccgcc(agaaccaccaccacc)2ACG l n CAGCTCCAGCTTGG 1 23.5 
LFX. ggagccgccgccgcc(agaaccaccaccacc)2ACCTAGGACAGTCAGTTTGG 0.25 5.9 
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VH Primers 
The VH forward and reverse primer sets are made by mixing the volumes (in f j l ) of 
each oligonucleotide indicated under 'Mix ' to give the concentrations shown. The 
variable regions are indicated in capital letters (degenerate bases are denoted as 
follows: R = A or G; Y = C or T; M = A or C; K = G or T; S = C or G; W = A or T; H 
= A or C or T; B = C or G or T; V = A or C or G; D = A or G or T) and the Sfil 
restriction sites within the V H reverse primers are underlined and in bold. A l l 
oligonucleotide sequences are taken from Krebber et al., 1997. 
Primer VH Forward Mix Cone. (nM) 
HB1 ggcggcggcggctccggtggtggtggatccGAKGTRMAGCTTCAGGAGTC 4 7.6 
HB2 ggcggcggcggctccggtggtggtggatccGAGGTBCAGCTBCAGCAGTC 4 7.6 
HB3 ggcggcggcggctccggtggtggtggatccCAGGTGCAGCTGAAGSASTC 3 5.7 
HB4 ggcggcggcggctccggtggtggtggatccGAGGTCCARCTGCAACARTC 4 7.6 
HB5 ggcggcggcggctccggtggtggtggatccCAGGTYCAGCTBCAGCARTC 7 13.2 
HB6 ggcggcggcggctccggtggtggtggatccCAGGTYCARCTGCAGCAGTC 2 3.8 
HB7 ggcggcggcggctccggtggtggtggatccCAGGTCCACGTGAAGCAGTC 1 1.9 
HB8 ggcggcggcggctccggtggtggtggatccGAGGTGAASSTGGTGGAATC 2 3.8 
HB9 ggcggcggcggctccggtggtggtggatccGAVGTGAWGYTGGTGGAGTC 5 9.5 
HB10 ggcggcggcggctccggtggtggtggatccGAGGTGCAGSKGGTGGAGTC 2 3.8 
HB11 ggcggcggcggctccggtggtggtggatccGAKGTGCAMCTGGTGGAGTC 2 3.8 
HB12 ggcggcggcggctccggtggtggtggatccGAGGTGAAGCTGATGGARTC 2 3.8 
HBO ggcggcggcggctccggtggtggtggatccGAGGTGCARCTTGTTGAGTC 1 1.9 
HB14 ggcggcggcggctccggtggtggtggatccGARGTRAAGCTTCTCGAGTC 2 3.8 
HB15 ggcggcggcggctccggtggtggtggatccGAAGTGAARSTTGAGGAGTC 2 3.8 
HB16 ggcggcggcggctccggtggtggtggatccCAGGTTACTCTRAAAGWGTSTG 5 9.5 
HB17 ggcggcggcggctccggtggtggtggatccCAGGTCCAACTVCAGCARCC 3.5 6.6 
HB18 ggcggcggcggctccggtggtggtggatccGATGTGAACTTGGAAGTGTC 0.7 1.3 
HB19 ggcggcggcggctccggtggtggtggatccGAGGTGAAGGTCATCGAGTC 0.7 1.3 
Primer VH Reverse Mix Cone. (|iM) 
HF1 ggaattcggcccccgaggcCGAGGAAACGGTGACCGTGGT 1 25 
HF2 ggaattcggcccccgaggcCGAGGAGACTGTGAGAGTGGT 1 25 
HF3 ggaattcggcccccgagjjcCGCAGAGACAGTGACCAGAGT 1 25 
HF4 ggaattcggcccccgaggcCGAGGAGACGGTGACTGAGGT 1 25 
Joining Primers 
The primers used to combine VH and V L regions by SOE-PCR are shown below, with 
the Sfil site shown underlined in bold type and the sequence encoding the 4 amino acid 
FLAG tag is underlined (Krebber et al., 1997) 
ScBack ttaclcgcggcccagccggccatggcggactacaaaG (lOO^M) 
ScFor ggaattcggcccccgag (lOO^M) 
151 
Appendix 2 
Phagemid Vectors for the Production of Phage-Displayed and 
Soluble scFv Molecules 
pAKlOO 
The pAKlOO vector used for the cloning and expression of scFv molecules on the surface 
of bacteriophage M l 3 is shown, with the position of the scFv DNA insertion indicated 
(diagram taken from Krebber et al., 1997). The following features of the plasmid are 
denoted: 
ColEl: E.coli origin of replication 
tHP: terminator sequence 
pelB: leader sequence 
myc: tag recognised by a-myc mAb 
gill250-406- truncated M l 3 gene HI 
f ] ori: phage origin of replication 
Lad: LacI repressor gene 
Lac p/o: Lac promoter/operator 
tet: tetracycline resistance cassette 
*: amber codon 
tlpp: downstream terminator sequence 
S f i l S f l l 
L a d H ' hf» \\ Lac p/o tf^T^jaB»^t^jaWil| 
EcoRl 
pAK100 6425 bp 
PAK400 
The pAK400 vector used for the expression of soluble scFv molecules has the following 
adaptations from pAKlOO (diagram from Krebber et al., 1997): 
S f l l S f i l 
SOT7q10 I I pAK400 —\ L a c p/o Hpa«Btf^i^»' f»: -«r^H6 h is 1 
H i n d l l l 
SDT7glO: altered Shine Dalgarno sequence for increased expression 
6 his: poly-histidine tag for purification of scFv molecules 
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Appendix 3 
Monoclonal Antibodies to markers on Xenopus Cells 
The following anti-Xenopus mAb's were used during the course of these studies. 
Asterisks indicate purified mAb's which have been conjugated to phycoerythrin. 
Antibody Isotype Dilution Antigen Cell Specificity Reference 
Used (MW when reduced) 
2B1 * IgGl 1:100 CD5 Pan T cell Jurgens et al., 
(FACS) (71-82kDa) marker 1995 
D4-3 * IgGl 1:200 Putative a(3 TCR Pan T cell Ibrahim et al., 
(FACS) (40kDa & 60kDa) marker 1991 
F17* IgM 1:200 CD8 T cell subset Ibrahim et al., 
(FACS) (30kDa) 1991 
D12 * IgGl 1:200 Putative y8 TCR Putative 78 T Ibrahim et al., 
(FACS) (36 kDa) cells 1991 
XT-1 IgG2 1:2 XTLA-1 T cell subset Nagata, 1986 
(Western) (120kDa) 
8E4 IgG 1:30 IgM Pan B cell Langeberg 
(MACS) (25kDa & 75kDa) marker et al., 1987 
D8 * IgG3 1:100 IgM Pan B cell Jurgens et al., 
(FACS) (25kDa & 75kDa) marker 1995 
10A9 IgG 1:5 IgM Pan B cell Du Pasquier & 
(IP) (25kDa & 75kDa) marker Hsu, 1983 
X71 IgG 1:5 CTX Immature Chretien et al., 
(IP) (55kDa) thymocyte 1996 
TB17 IgG 1:5 Class I M H C Al l Xenopus Flajnik et al., 
(IP) (40-45kDa) cells 1991 
XLH-1 IgM 1:4 Not characterised Thrombocyte Horton 
(FACS) (unpublished) 
Abbreviations used in this table: 
FACS: Fluorescence Activated Cell Sorting 
MACS: Magnetically Activated Cell Sorting 
IP: Immunoprecipitation 
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Appendix 4 
Oligonucleotides Used in cDNA Library Construction 
Linker-primer 
The following oligonucleotide, supplied by Stratagene, was used to synthesise first 
strand cDNA from mRNA templates. The 'GAGA' sequence is designed to protect the 
Xhol restriction site which is used for the directional cloning of cDNA's into the Uni-
ZAP XR vector. The poly dT sequence anneals to the poly-A tail of mRNA molecules 
and initiates DNA synthesis. 
5' GAGAGAGAGAGAGAGAGAGAACTAGTCTCGAGTTTTTTTTTTTTTTTTTT 3' 
'GAGA' sequence Xhol poly dT 
EcoRI Adapters 
The EcoRI adapters, consisting of the 9- and 13-mer oligonucleotides shown below, 
are ligated onto the blunt ends of the cDNA molecules to give them EcoRI cohesive 
ends (underlined). These oligonucleotides were also supplied by Stratagene. 
5' AATTCGGCACGAG 3' 
3' GCCGTGCTC 5' 
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Appendix 5 
The Uni-ZAP XR cDNA Expression Vector 
The Uni-ZAP XR Vector (Stratagene) is supplied double digested with Xhol and 
EcoRI for directional cloning of cDNA inserts of up to 10 kilobases. cDNA inserts are 
cloned into the P-galactosidase gene, allowing blue-white colour selection of 
recombinants. Inserts which are in frame with the lacZ sequence can be expressed as 
fusion proteins and detected by antibody screening. 
p-Galactosidase ^ 
C> C\l <£) 
E 3 3 
LU 3* _l CO 
LA 
§ 
® 
8.? S SjjsES. 
< c l 3 s: 3 i£ wzxaT 
x£i? icBcn co — - •- ~~ cd xx co eo co </> 
— £ 
I f 
1U 
«* O XiS 
ct&57 (nin5) ] 
Lambda ZAP II vector 
In-vivo excision of the pBluescript phagemid (Stratagene) from the Uni-Zap XR vector 
can be achieved in SOLR E.coli (Stratagene) following co-infection with ExAssist 
helper phage (Stratagene). 
Wasl134 
Ssp I 445 
Ssp\22 Ssp I 2850 
Aiae 333 Xmn I 2845 
Sea I 2526 
Pvu1503 
Pvu II532 PVul2416 
KpnI 657 
pBluescript SK (+/-) 0) 
Sac I 759 phagemid vector 
2958 bp 
Pvu II 977 
All information and diagrams taken from Stratagene internet site (http://www.stratagene.com) 
155 
References 
Afonso, L.C.C., Scharton, T.M., Vieira, L.Q., Wysocka, M. , Trinchieri, G. and Scott, 
P. (1994). The adjuvant effect of interleukin-12 in a vaccine against Leishmania major. 
Science, 263, 235-237 
Altin, J.G. and Sloan, E.K. (1997). The role of CD45 and CD45-associated molecules 
in T cell activation. Immunol. Cell Biol, 75, 430-435 
Altschul, S.F., Gish, W., Miller, W., Myers, E.W. and Lipman, D.J. (1990). Basic 
local alignment search tool. J. Mol. Biol. 215, 403-410 
Anegon, I . , Cuturi, M.C., Trinchieri, G. and Perussia, B. (1988). Interaction of Fc 
receptor (CD 16) ligands induces transcription of interleukin-2 receptors (CD25) and 
lymphokine genes and expression of their products in human natural killer cells. J. 
Exp Med, 167, 452-472 
Arase, H., Arase, N. and Saito, T. (1996). Interferon-y production by natural killer 
(NK) cells and NK1.1+ T cells upon NKR-P1 cross-linking. J. Exp. Med., 183, 2391-
2396 
Arase, N. , Arase, H., Park, S.Y., Ohno, H., Ra, C. and Saito, T. (1997). Association 
with FcR-y is essential for activation signal through NKR-P1 (CD161) in natural killer 
(NK) cells andNKl . l+ T cells. J. Exp. Med, 186, 1957-1963 
Arora, D.J.S. and Houde, M. (1988). Purified glycoproteins of influenza virus 
stimulate cell-mediated cytotoxicity in vivo. Nat. Immun. Cell Growth Regul., 7, 287-
296 
Barbas, C.F., Kang, A.S., Lerner, R.A. and Benkovic, S.J. (1991). Assembly of 
combinatorial antibody libraries on phage surfaces: the gene in site. Proc. Natl. Acad. 
Sci. USA, 88, 7978-7982 
Barlozzari, T., Reynolds, C.W. and Herberman, R.B. (1983). In vivo role of natural 
killer cells: involvement of large granular lymphocytes in the clearance of tumour cells 
in anti-asialo GMl-treated rats. J. Immunol., 131, 1024-1027 
156 
Beckerman, K.P., Rogers, G.W., Corbett, J.A., Schreiber, R.D., McDaniel, M.L. and 
Unanue, E.R. (1993). Release of nitric oxide during T cell independent pathway of 
macrophage activation. J. Immunol., 150, 888-895 
Bezouska, K., Yuen, C-T., O'Brien, J., Childs, R.A., Chai, W., Lawson, A.M., Drbal, 
K., Fiserova, A., Pospisil, M . and Feizi, T. (1994). Oligosaccharide ligands for NKR-
Pl protein activate NK cells and cytotoxicity. Nature, 372, 150-157 
Biassoni, R., Cantoni, C , Falco, M. , Verdiani, S., Bottino, C , Vitale, M. , Conte, R., 
Poggi, A., Moretta, A., Moretta, L. (1996). The human leukocyte antigen (HLA)-C-
specific "activatory" or "inhibitory" natural killer cell receptors display highly 
homologous extracellular domains but differ in their transmembrane and 
intracytoplasmic portions. J. Exp. Med., 183, 645-650 
Biassoni, R., Pessino, A., Bottino, C , Pende, D., Moretta, L. and Moretta, A. (1999). 
The murine homologue of the human NKp46, a triggering receptor involved in the 
induction of natural cytotoxicity. Eur. J. Immunol., 29, 1014-1020 
Binstadt, B.A., Brumbaugh, K.M., Dick, C.J., Scharenberg, A.M., Williams, B.L., 
Colonna, M. , Lanier, L.L., Kinet, J-P., Abraham, R.T. andLeibson, P.J. (1996). 
Sequential involvement of Lck and SHP-1 with MHC-recognising receptors on NK 
cells inhibits FcR-initiated tyrosine kinase activation. Immunity, 5, 629-638 
Biron, C.A., Turgiss, L.R. and Welsh, R.M. (1983). Increase in NK cell number and 
turnover rate during acute viral infection. J. Immunol., 131, 1539-1545 
Biron, C.A., Byron, K.S. and Sullivan, J.S. (1989). Severe herpes virus infections in an 
adolescent without natural killer cells. N. Eng. J. Med., 320, 1731-1735 
Braud, V.M., Allen, D.S.J., O'Callaghan, C.A., Soderstrom, K., D'Andrea, A., Ogg, 
G.S., Lazetic, S., Young, N.T., Bell, J.I., Phillips, J.H. and McMichael, A.J. (1998a). 
HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature, 391, 
795-799 
Braud, V.M., Allan, D.S.J., Wilson, D. and McMichael, A.J. (1998b). Tap- and 
tapasin-dependent HLA-E surface expression correlates with the binding of an MHC 
class I leader peptide. Curr. Biol., 8, 1-10 
157 
Brennan, J., Mager, D., Jefferies, W. and Takei, F. (1994). Expression of different 
members of the Ly-49 family defines distinct natural killer cell subsets and cell 
adhesion properties. J. Exp. Med., 180, 2287-2295 
Brown, M.G., Fulmek, S., Matsumoto, K., Cho, R., Lyons, P.A., Levy, E.R., Scalzo, 
A.A. and Yokoyama, W.M. (1997). A 2-Mb YAC contig and physical map of the 
natural killer gene complex on mouse chromosome 6. Genomics, 42, 16-25 
Brutkiewicz, R.R. and Welsh, R.M. (1995). Major histocompatibility complex class I 
antigens and the control of viral infections by natural killer cells. J. Virol., 69, 3967-
3971 
Bukowski, J.F., Warner, J.F., Dennert, G. and Welsh, R.M. (1985). Adoptive transfer 
studies demonstrating the antiviral effect of natural killer cells in vivo. J. Exp. Med., 
161, 40-52 
Burshtyn, D.N., Scharenberg, A.M., Wagtmann, N. , Rajagopalan, S., Berrada, K., Yi, 
T., Kinet, J-P and Long, E.O. (1996). Recruitment of tyrosine phosphatase HCP by the 
killer cell inhibitory receptor. Immunity, 4, 77-85 
Campbell, K.S., Dessing, M., Lopez-Botet, M., Cella, M. and Colonna, M. (1996). 
Tyrosine phosphorylation of a human killer inhibitory receptor recruits protein tyrosine 
phosphatase 1C. J. Exp. Med, 184, 93-100 
Campbell, K.S. and Giorda, R. (1997). The cytoplasmic domain of ratNKR-Pl 
receptor interacts with the N-terminal domain of p56 l c k via cysteine residues. Eur. J. 
Immunol., 27, 72-77 
Cantoni, C, Verdiani, S., Falco, M. , Pessino, A., Cilli, M. , Conte, R., Pende, D., 
Ponte, M., Mikaelson, M.S., Moretta, L., Biassoni, R. (1998). p49, a putative HLA 
class I-specific inhibitory NK receptor belonging to the immunoglobulin superfamily. 
Eur. J. Immunol., 28, 1980-1990 
Cantoni, C , Bottino, C , Vitale, M., Pessino, A., Augugliaro, R., Malaspina, A., 
Parolini, S., Moretta, L., Moretta, A. and Biassoni, R. (1999). NKp44, a triggering 
receptor involved in tumour cell lysis by activated human natural killer cells, is a novel 
member of the irmnunoglobulin superfamily. J. Exp. Med, 189, 787-796 
158 
Casali, P., Sissons, J.G.P., Buchmeier, N.J., and Oldstone, M.B.A. (1981). In vitro 
generation of human cytotoxic lymphocytes by viral glycoproteins induce nonspecific 
cell-mediated cytotoxicity without the release of interferon. J. Exp. Med., 154, 840-
855 
Chadwick, B.S., Sambhara, S.R., Sasakura, Y. and Miller, R.G. (1992) Effect of class I 
MHC binding peptides on recognition by natural killer cells. J. Immunol, 149, 3150-
3156 
Chambers, W.H., Vujanovic, N.L., DeLeo, A.B., Olszowy, M.W., Herberman, R.B. 
and Hiserodt, J.C. (1989). Monoclonal antibody to a triggering structure expressed on 
rat natural killer cells and adherent lymphokine-activated killer cells. J. Exp. Med., 
169, 1373-1389 
Chan, P-Y. and Takei, F. (1989). Molecular cloning and characterisation of a novel 
murine T cell surface antigen, YE 1/48. J. Immunol, 142, 1727-1736 
Chretien, I . , Robert, J., Marcuz, A., Garcia-Sanch, J.A., Courtet, M. and Du Pasquier, 
L. (1996). CTX, a novel molecule specifically expressed on the surface of cortical 
thymocytes in Xenopus. Eur. J. Immunol, 26, 780-791 
Clackson, T., Hoogenboom, H.R., Griffiths, A.D. and Winter, G. (1991). Making 
antibody fragments using phage display libraries. Nature, 352, 624-628 
Cooper, E.L. (1969). Specific tissue graft rejection in earthworms. Science, 166, 1414 
Cossarizza, A., Cooper, E.L., Suzuki, M.M., Slavioli, S., Capri, M. , Gri, G., Quaglino, 
D. and Franceschi, C. (1996). Earthworm leukocytes that are not phagocytic and cross-
react with several human epitopes can ki l l human tumour-cell lines. Experimental Cell 
Research, 224, 174-182 
De Bruin, R., Spelt, K., Mol, J., Koes, R. and Quattrocchio, F. (1999). Selection of 
mgh-affinity phage antibodies from phage display libraries. Nat. Biotechnol, 17, 397-
399 
De Kruif, J., Terstappen , L., Boel, E. and Logtenberg, T. (1995). Rapid selection of 
cell subpopulation-specific human monoclonal antibodies from a synthetic phage 
antibody library. Proc. Natl. Acad. Sci. USA, 92, 3938-3942 
159 
Deans, J.P., Shaw, J., Pearse, M.J. and Pilarski, L.M. (1989). CD45R as a primary 
signal transducer stimulating IL-2 and JL-2R mRNA synthesis by CD3-4-8 
thymocytes. J. Immunol., 143, 2425-2430 
Dianzani, C , Zarcone, D., Pistoia, V., Grossi, C.E., Piled, A., Massaia, M. and 
Ferrarini, M. (1989). CD8+ CDl lb+ peripheral blood lymphocytes contain 
lymphokine-activated killer cell precursors. Eur. J. Immunol., 19, 1037-1044 
Dohring, C , Scheidegger, D., Samaridis, J., Cella, M. and Colonna, M. (1996a). A 
human killer inhibitory receptor specific for HLA-A. J. Immunol., 156, 3098-3101 
Dohring, C , Samaridis, J. and Colonna, M. (1996b). Alternatively spliced forms of 
human natural killer inhibitory receptors. Immunogenetics, 44, 227-230 
Du Pasquier, L. and Hsu, E. (1983). Immunoglobulin expression in diploid and 
polyploid interspecies hybrids of Xenopus: evidence for allelic exclusion. Eur. J. 
Immunol., 13, 585-590 
Du Pasquier, L., Schwager, J. and Flajnik, M.F. (1989). The immune system of 
Xenopus. Annu. Rev. Immunol., 7, 251-275 
Du Pasquier, L. and Robert, J. (1992). In vitro growth of thymic tumour cell lines from 
Xenopus. Devel. Immun., 2, 295-307 
Du Pasquier, L., Courtet, M . and Robert, J. (1995). A Xenopus lymphoid tumour cell 
line with complete Ig genes rearrangements and T cell characteristics. Molecular 
Immunology, 32, 583-593 
Evans, D.L., Jaso-Friedmann, L., Smith, E.E. Jr., John, A.S., Koren, H.S. and Harris, 
D.T. (1988) Identification of a putative antigen receptor on fish nonspecific cytotoxic 
cells with monoclonal antibodies. J. Immunol., 141, 324-332 
Evans, D.L. and Cooper, E.L. (1990). Natural killer cells in ectothermic vertebrates. 
Bioscience, 40, 745-750 
Evans, D.L., Leary, J.H. 3 r d and Jaso-Friedmann, L. (1998). Nonspecific cytotoxic cell 
receptor protein-1: a novel (predicted) type in membrane receptor on the teleost 
160 
equivalent of natural killer cells recognises conventional antigen. Cell. Immunol., 187, 
19-26 
Flajnik, M., Ferrone, S., Cohen, N . and Du Pasquier, L. (1990). Evolution of the 
MHC: Antigenicity and unusual tissue distribution of Xenopus (frog) class I I 
molecules. Molecular Immunology, 27, 451-462 
Flajnik, M., Canel, C, Kramer, J. and Kasahara, M. (1991). Evolution of the major 
histocompatibility complex: Molecular cloning of major histocompatibility complex 
class I from the amphibian Xenopus. Proc. Natl. Acad. Sci. USA, 88, 537-541 
Fry, A., Lanier, L.L. and Weiss, A. (1996). Phosphotyrosines in the KTR motif of 
NFKB1 are required for negative signalling and for association with PTP1C. J. Exp. 
Med, 184, 295-300. 
Garcia-Penarrubia, P., Koster, F T., Kelley, R.O., MacDowell, T.D. and Bankhurst, 
A D . (1989). Antibactericidal activity of human natural killer cells. J. Exp. Med, 169, 
99-113 
Ghoneum, M. , Cooper, E.L. and Sadek, I . (1990). Variability of natural killer cell 
activity in anuran amphibians. Dev. Comp. Immunol., 14, 359-365 
Gillitzer, R. and Pilarski, L.M. (1990). In situ localisation of CD45 isoforms in the 
human thymus indicates a medullary location for the thymic generative lineage. J. 
Immunol., 144, 66-74 
Giorda, R, Rudert, W.A., Vavassori, C , Chambers, W.H., Hiserodt, J.C. and Trucco, 
M. (1990). NKR-P1, a signal transduction molecule on natural killer cells. Science, 
249, 1298-1300 
Glesch, I.E.A. and Kaufmann, S.H.E. (1991). Mechanisms involved in mycobacterial 
growth inhibition by gamma interferon-activated bone marrow macrophages: role of 
reactive nitrogen intermediates. Infect. Immun., 59, 3213-3218 
Gobel, T.W.F., Chen, C-L. H., Shrimpf, J., Grossi, C.E., Bemot, A., Bucy, R.P., 
Auffray, C. and Cooper, M.D. (1994). Characterisation of avian natural killer cells and 
their intracellular CD3 complex. Eur. J. Immunol., 24, 1685-1691 
161 
Gravenor, I . , Horton, T.L., Ritchie, P., Flint, E. and Horton J.D. (1995). Ontogeny and 
thymus-dependence of T cell surface antigens in Xenopus: flow cytometric studies on 
monoclonal antibody-stained thymus and spleen. Dev. Comp. Immunol., 19, 507-523 
Griffiths, A.D. and Duncan, A.R. (1998). Strategies for selection of antibodies by 
phage display. Curr. Opin. Biotech., 9, 102-108 
Griggs, N.D. and Smith, R.A. (1994). Natural killer cell activity against uninfected and 
Salmonella typhimurium-mfected murine fibroblast L929 cells. Nat. Immun., 13, 42-48 
Harfast, B., Orvell, C , Alsheikhly, A., Andersson, T., Perlmann, P and Norrby, E. 
(1980). The role of viral glycoproteins in mumps virus-dependent lymphocyte-
mediated cytotoxicity in vitro. Scand. J. Immunol., 11, 391-400 
Harel-Bellan, A., Quillet, A., Marchiol, C , DeMars, R., Tursz, T. and Fradelizi, D. 
(1986). Natural killer susceptibility of human cells may be regulated by genes in the 
HLA region on chromosome 6. Proc. Natl. Acad. Set USA, 83, 5688-5692 
Harlow, E. and Lane, D. (1988) In Antibodies: A laboratory manual. New York, Cold 
Spring Harbour Laboratory. 
Harris, D. T., Jaso-Friedmann, L., Devlin, R.B., Koren, H.S. and Evans, D.L. (1991). 
Identification of an evolutionarily conserved, function-associated molecule on human 
natural killer cells. Proc. Natl. Acad. Sci. USA, 88, 3009-3013 
Hatcher, F.M. and Kuhn, R.E. (1982). Destruction of Trypanosoma cruzi by natural 
killer cells. Science, 218, 295-296 
Hauser, W.E. and Tsai, V. (1986). Acute toxoplasma infection of mice induces spleen 
cells that are cytotoxic for T. gondii in vitro. J. Immunol., 136, 313-319 
Haynes, L. and Cohen, N. (1993). Further characterisation of an interleukin-2 like 
cytokine produced by Xenopus laevis T lymphocytes. Devel. Immunol., 3, 231-238 
Hidore, M.R. and Murphy. J.W. (1989). Murine natural killer cell interactions with a 
fungal target, Cryptococcus neoformans. Infect. Immun., 57, 1990-1997 
162 
Hogan, P.G., Hapel, A.J., Doe, W.F. (1985). Lymphokine-activated killer cell activity 
in human intestinal mucosa. J. Immunol., 135, 1731-1738 
Hoogenboom, H.R., Griffiths, A.D., Johnson, K.S., Chiswell, D.J., Hudson, P. and 
Winter, G. (1991). Multi-subunit proteins on the surface of filamentous phage: 
methodologies for displaying antibody (Fab) heavy and light chains. Nucleic Acids 
Res., 19, 4133-4137 
Horton, J.D. and Manning, M.J. (1972). Response to skin allografts in Xenopus laevis 
following thymectomy at early stages of lymphoid organ maturation. Transplantation, 
14, 141-154 
Horton, J.D. (1994). Amphibians. In: Turner, R.J., ed. Immunology: A Comparative 
Approach. Chichester: Wiley, pp 101-136 
Horton, J.D. and Ratcliffe, N . (1996). Evolution of immunity. In: Roitt, I .M., Brostoff, 
J. and Male, D.K. ed. Immunology 4th ed. London: Times Mirror; Chapter 15. 
Horton, T.L., Ritchie, P., Watson, M.D. and Horton, J.D. (1996). NK-like activity 
against allogeneic tumour cells demonstrated in the spleen of control and 
thymectomisedXe«o/7M.s. Immunol. Cell Biol., 74, 365-373 
Horton, J.D., Horton, T.L., Dzialo, R., Gravenor, I . , Minter, R., Ritchie, P., Gartland, 
L., Watson, M.D. and Cooper, M.D. (1998a). T-cell and natural killer cell 
development in thymectomised Xenopus. Immunological Reviews, 166, 245-258 
Horton, T.L., Ritchie, P., Watson, M.D. and Horton, J.D. (1998b) Natural cytotoxicity 
towards allogeneic tumour targets in Xenopus mediated by diverse splenocyte 
populations. Developmental and Comparative Immunology, 22, 217-230 
Horton, R.M., Hunt, H.D., Ho, S.N., Pullen, J.K. and Pease, L.R. (1989). Engineering 
hybrid genes without the use of restriction enzymes: gene splicing by overlap 
extension. Gene, 77, 61-68 
Houchins, J.P., Yabe, T., McSherry, C. and Bach, F.H. (1991). DNA sequence 
analysis of NKG2, a family of related cDNA clones encoding type I I integral 
membrane proteins on human natural killer cells. J. Exp. Med., 173, 1017-1020 
163 
Houchins, J.P., Lanier, L.L., Niemi, E.C., Phillips, J.H. and Ryan, J.C. (1997). Natural 
killer cell cytolytic activity is inhibited by NKG2-A and activated by NKG2-C. J. 
Immunol., 158, 3603-3609 
Hsu, E., Lefkovits, I . , Flajnik, M. and Du Pasquier, L. (1991). Light chain 
heterogeneity in the amphibian Xenopus. Molecular Immunology, 28, 985-994 
Huse, W.D., Sastry, L., Iverson, S.A., Kang, A.S., Alting-Mees, M., Burton, D.R., 
Benkovic, S.J. and Lerner, R. (1989). Generation of a large combinatorial library of 
the immunoglobulin repertoire in phage lambda. Science, 246, 1275-1281 
Ibrahim, B., Gartland, L.A., Kishimoto, T., Dzialo, R., Kubagawa, H., Bucy, R.P. and 
Cooper, M.D. (1991). Analysis of T cell development in Xenopus. Fed. Proc, 5, 7651 
Itoh, K., Wakabayashi, N. , Katoh, Y., Ishii, T., Igarashi, K., Engel, J.D. and 
Yamamoto, M. (1999). Keapl represses nuclear activation of antioxidant responsive 
elements by Nrf2 through binding to the ammo-terminal Neh2 domain. Genes Dev., 
13, 76-86 
Janeway, C.A. (1989). A primitive immune system. Nature, 341, 106 
Jaso-Friedmann, L., Leary, J.H. 3 r d and Evans, D.L. (1997). NCCRP-1: A novel 
receptor protein sequenced from teleost nonspecific cytotoxic cells. Mol. Immunol., 
34, 955-965 
Joag, S., Zychlinsky, A. and Young, J.D. (1989). Mechanisms of lymphocyte-mediated 
lysis. J. Cell Biochem., 39, 239-252 
Jurgens, J.B., Gartland, L.A., Du Pasquier, L., Horton, J.D., Gobel, T.W. and Cooper, 
M.D. (1995). Identification of a candidate CD5 homologue in the amphibian Xenopus 
laevis. J Immunol. 155, 4218-4223 
Kabat, E.A., Wu, T.T., Reid-Miller, M. , Perry, H.M., Gottesman, K.S. and Foeller, C. 
(1991). Sequences of Proteins of Immunological Interest. 5 t h ed. US Department of 
Health and Human Services, Public Service, NTH, Washington. 
164 
Karupiah, G., Xie, Q-W., Buller, R.M.L., Nathan, C , Duarte, C. and MacMicking, 
J.D. (1993). Inhibition of viral replication by interferon gamma-induced nitric oxide 
synthase. Science, 261, 1445-1448 
Katagiri, C. and Tochinai, S. (1987). Ontogeny of thymus-dependent immune 
responses and lymphoid cell differentiation in Xenopus laevis. Develop. Growth and 
Differ., 29, 297-305 
Katz, P., Yeager, H. Jr., Whalen, G., Evans, M. , Swartz, R.P. and Roecklein, J. (1990). 
Natural killer cell-mediated lysis of Mycobacterium avium complex-infected 
monocytes. J. Clin. Immunol., 10, 71-77 
Kettleborough, C.A., Saldanha, J., Ansell, K.H. and Bendig, M.M. (1993). 
Optimisation of primers for cloning libraries of mouse immunoglobuUn genes using 
the polymerase chain reaction. Eur. J. Immunol., 23, 206-211 
Kimura, Y., Nakazawa, M. and Yamada, M. (1998). Cloning and characterization of 
three isoforms of OS-9 cDNA and expression of the OS-9 gene in various human 
tumor cell lines. J. Biochem (Tokyo), 123, 876-882 
Klimpel, G.R., Niesel, D.W. and Klimpel, K.D. (1986). Natural cytotoxic effector cell 
activity against Shigella/7ejc«m-infected HeLa cells. J. Immunol, 136, 1081-1086 
Kobayashi, M., Fitz, L., Ryan, M. , Hewick, R.M., Clark, S.C., Chan, S., Loudon, R , 
Sherman, F., Perussia, B. and Trinchieri, G. (1989). Identification and purification of 
natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects 
on human lymphocytes. J. Exp. Med., 170, 827-846 
Kos, F.J. and Engleman, E.G. (1995). Requirement for natural killer cells in the 
induction of cytotoxic T cells. J. Immunol., 155, 578-584 
Krebber, A., Bornhauser, S., Burmester, J., Honegger, A., Willuda, J., Bossard, H.R. 
and Pluckthun. (1997). Reliable cloning of functional antibody variable domains from 
hybridomas and spleen cell repertoires employing a reengineered phage display 
system. J. Immunol. Methods, 201, 35-55 
Kummer, J.A., Kamp, A.M., Tadema, T.M., Vos, W., Meijer, C.J.L.M. and Hack, C.E. 
(1995). Localization and identification of granzymes A and B-expressing cells in 
165 
normal human lymphoid tissue and peripheral blood. Clin. Exp. Immunol., 100, 164-
172 
Kurosawa, S., Harada, M , Matsuzaki, G., Shinorniya, Y., Terao, H. and Kobayashi, 
N. (1995). Early-appearing tumour-infiltrating natural killer cells play a crucial role in 
the generation of anti-tumour T lymphocytes. Immunology, 85, 338-346 
Langeberg, L., Ruben, L.N., Clothier, R.H. and Shiigi, S. (1987). The characterization 
of the toad splenocytes which bind mouse anti-human IL-2 receptor antibody. 
Immunol. Lett., 16, 43-48 
Lanier, L.L., Phillips, J.H., Hackett, J., Tutt, M. and Kumar, V. (1986a). Natural killer 
cells: Definition of a cell type rather than a function. J.Immunol., 137, 2735-2739 
Lanier, L.L., Le, A.M., Civin, C.I., Loken, M.R. and Phillips, J.H. (1986b). The 
relationship of CD 16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human 
peripheral blood NK cells and cytotoxic T lymphocytes. J. Immunol, 136, 4480-4486 
Lanier, L.L., Corliss, B. and Phillips, J.H. (1997). Arousal and inhibition of human NK 
cells. Immunol. Rev., 155, 145-154 
Lanier, L.L., Yu, G. and Phillips, J.H. (1991). Analysis of FcyRIII (CD16) membrane 
expression and association with CD3C, and FceRI-y by site-directed mutation. J. 
Immunol., 146, 1571-1576 
Lanier, L.L., Chang, C. and Phillips, J.H. (1994). Human NKR-P1A: a disulphide 
linked homodimer of the C-type lectin superfamily expressed by a subset of NK and T 
lymphocytes. J. Immunol., 153, 2417-2428 
Lanier, L.L. (1998a). NK cell receptors. Annu. Rev. Immunol., 16, 359-393 
Lanier, L.L. (1998b). Follow the leader: NK cell receptors for classical and 
nonclassical MHC class I . Cell, 92, 705-707 
Lanier, L.L., Corliss, B.C., Wu, J., Leong, C. and Phillips, J.H. (1998c). 
Immunoreceptor DAP 12 bearing a tyrosine-based activation motif is involved in 
activating NK cells. Nature, 391, 703-707 
166 
Lazetic, S., Chang, C, Houchins, J.P., Lanier, L.L. and Phillips, J.H. (1996). Human 
NK cell receptors involved in MHC class I recognition are disulphide-linked 
heterodimers of CD94 andNKG2 subunits. J. Immunol., 157, 1312-1321 
Litwin, V., Gumperz, J., Parham, P., Phillips, J.H. and Lanier, L.L. (1994). NKB1: an 
NK cell receptor involved in the recognition of polymorphic HLA-B molecules. J. 
Exp. Med., 180, 537-543 
Ljunggren, H-G. and Karre, K. (1990), In search of the 'missing self: MHC molecules 
and NK cell recognition. Immunol. Today, 11, 237-244 
Long, E.O. and Wagtmann, N. (1997). Natural killer cell receptors. Curr. Opin. 
Immunol., 9, 344-350 
MacFarlane, M. , Manzoor, A., Srinivasula, S.M., Fernandes-Alnemri, T., Cohen, G.M. 
and Alnemri, E.S. (1997). Identification and molecular cloning of two novel receptors 
for the cytotoxic ligand TRAIL. J. Biol. Chem., 41, 25417-25420 
Manetti, R., Parronchi, P., Giudizi, M.G., Piccinni, M-P, Maggi, E., Trinchieri, G and 
Romagnani, S. (1993). Natural killer cell stimulatory factor (NKSF/IL-12) induces 
Thl-type specific immune responses and inhibits the development of IL-4 producing 
Th cells. J. Exp. Med, 111, 1199-1204 
Marks, J.D., Hoogenboom, H.R., Bonnert, T.P., McCafferty, J., Griffiths, A.D. and 
Winter, G. (1991). By-passing immunisation: human antibodies from V-gene libraries 
displayed on phage. J. Mol. Biol., 222, 581-597 
Mason, L.H., Ortaldo, J.R., Young, H.A., Kumar, K., Bennett, M. and Anderson, S.K. 
(1995). Cloning and functional characteristics of murine LGL-1: a member of the Ly-
49 gene family (Ly-49G2). J. Exp. Med, 182, 293-304 
Mason, L.H., Anderson, S.K., Yokoyama, W.M., Smith, H.R.C., Winkler-Pickett, R. 
and Ortaldo, J R. (1996). The Ly-49D receptor activates murine natural killer cells. J. 
Exp. Med, 184, 2119-2128 
167 
McCafferty, J., Griffiths, A.D., Winter, G. and Chiswell, D.J. (1990). Phage 
antibodies: filamentous phage displaying antibody variable domains. Nature, 348, 552-
554 
Mingari, M.C., Ponte, M., Cantoni, C , Vitale, C , Schiavetti, F., Bertone, S., Bellomo, 
R., Cappai, A.T. and Biassoni, R. (1997). HLA-class I-specific inhibitory receptors in 
human cytolytic T lymphocytes: molecular characterisation, distribution in lymphoid 
tissues, and co-expression by individual T cells. Int. Immunol., 9, 485-491 
Moretta, A., Bottino, C , Pende, D., Tripodi, G., Tambussi, G., Viale, O., Orengo, A., 
Barbaresi, M. , Merli, A., Ciccone, E. and Moretta, L. (1990). Identification of four 
subsets of human CD3-CD16+ natural killer (NK) cells by the expression of clonally 
distributed functional surface molecules: correlation between subset assignment of NK 
clones and ability to mediate specific alloantigen recognition. J. Exp. Med., 172, 1589-
1598 
Moretta, A., Vitale, M., Bottino, C , Orengo, A.M., Morelli, L., Augugliaro, R., 
Barbaresi, M. , Ciccone, E. and Moretta, L. (1993). p58 molecules as putative receptors 
for major histocompatibility complex (MHC) class I molecules in human natural killer 
(NK) cells. Anti-p58 antibodies reconstitute lysis of MHC class I-protected cells in NK 
clones displaying different specificities. J. Exp. Med., 178, 597-604 
Moretta, A., Sivori, S., Vitale, M., Pende, D., Morelli, L., Augugliaro, R., Bottino, C. 
and Moretta, L (1995). Existence of both inhibitory (p58) and activatory (p50) 
receptors for HLA-C molecules in human natural killer cells. J. Exp. Med., 182, 875-
884 
Mosley, R.L. and Klein, J.R. (1992). A rapid method for isolating murine intestine 
intraepithelial lymphocytes with high yield and purity. J. Immunol. Methods, 156, 19-
26 
Nagata. S (1986) Development of T lymphocytes mXenopus laevis: appearance of the 
antigen recognised by an anti-thymocyte mouse monoclonal antibody. Devel. Biol., 
114, 389-394 
168 
Nakamura, M.C., Niemi, E.C., Fisher, M.J., Shultz, L.D., Seaman, W.E. and Ryan, 
J.C. (1997). Mouse Ly-49A interrupts early signalling events in NK cell cytotoxicity 
and functionally associates with the SHP-1 tyrosine phosphatase. J. Exp. Med., 185, 
673-684 
Nathan, C. (1992) Nitric oxide as a secretory product of mammalian cells. FASEB J., 
6, 3051-3064 
Nissim, A., Hoogenboom, H.R., Tomlinson, I .M., Flynn, G., Midgley, C , Lane, D. 
and Winter, G. (1994). Antibody fragments from a 'single pot' phage display library as 
immunochemical reagents. EMBO J., 13, 692-698 
O'Connor, L., Strasser, A., O'Reilly, L.A., Hausmann, G., Adams, J.M., Cory, S. and 
Huang, D.C. (1998). Bim: a novel member of the Bcl-2 family that promotes 
apoptosis. EMBO J., 17, 384-395 
Ohinata, H., Tochinai, S. and Katagiri, C. (1989). Ontogeny and distribution of 
leukocyte common antigen bearing cells during early development of Xenopus laevis. 
Development, 107, 445-452 
Ohlen, C , Kling, G., Hoglund, P., Hansson, M., Scangos, G., Bieberich, C, Jay, G. 
and Karre, K. (1989). Prevention of allogeneic bone marrow graft rejection by H-2 
transgene in donor mice. Science, 246, 666-668 
0rum, H., Andersen, P.S., 0ster, A., Johansen, L.K., Riise, E., Bjernvad, M., 
Svendsen, I . And Engberg, J. (1993). Efficient method for constructing comprehensive 
murine Fab antibody libraries displayed on phage. Nucleic Acids Res., 21, 4491-4498 
Oshimi, Y., Oda, S., Honda, Y., Nagata, S. and Miyazaki, S. (1996). Involvement of 
Fas ligand and Fas-mediated pathway in the cytotoxicity of human natural killer cells. 
J. Immunol., 157, 2909-2915 
Ozer, H., Strelkauskas, A.J., Callery, R.T., and Schlossman, S.F. (1979). The 
functional dissection of human peripheral blood null cells with respect to cytotoxicity 
and natural killing. Eur. J. Immunol., 9, 112-118 
169 
Palmer, D.B., George, A.J.T. and Ritter, M.A. (1997). Selection of antibodies to cell 
surface determinants on mouse thymic epithelial cells using a phage display library. 
Immunology, 91, 473-478 
Pende, D., Biassoni, R., Cantoni, C., Verdiani, S., Falco, M. , Di Donato, C , Accame, 
O., Bottino, C, Moretta, A. and Moretta, L. (1996). The natural killer cell receptor 
specific for HLA-A allotypes : a novel member of the p58/p70 family of inhibitory 
receptors that is characterised by three immunoglobulm-like domains and is expressed 
as a 140-kD disulphide-linked dimer. J. Exp. Med, 184, 505-518 
Perussia, B., Trinchieri, G., Jackson, A., Warner, N.L., Faust, J., Rumpold, H., Kraft, 
D. and Lanier, L.L. (1984). The Fc receptor for IgG on human natural killer cells, 
phenotypic, functional, and comparative studies with monoclonal antibodies. J. 
Immunol., 133, 180-189 
Pessino, A., Sivori, S., Bottino, C , Malaspina, A., Morelli, L., Moretta, L., Biassoni, 
R. and Moretta, A. (1998). Molecular cloning of NKp46: a novel member of the 
immunoglobulin superfamily involved in triggering of natural cytotoxicity. J. Exp. 
Med, 188, 953-960 
Phillips, J.H., Chang, C. and Lanier, L.L. (1991). Platelet-induced expression of 
FcyRni (CD16) on human monocyte. Eur. J. Immunol., 21, 895-899 
Plytycz, B. and Bigaj, J. (1983). Amphibian lymphoid organs: A review. Folia biol, 
31, 225-240 
Ponte, M., Cantoni, C , Biassoni, R., Tradori-Cappai, A., Bentivoglio, G., Vitale, C , 
Bertone, S., Moretta, A., Moretta, L. and Mingari, M.C. (1999). Inhibitory receptors 
sensing HLA-G1 molecules in pregnancy: decidua-associated natural killer cells 
express L1R-1 and CD94/NKG2A and acquire p49, an HLA-G1 -specific receptor. 
Proc. Natl. Acad. Sci. USA, 96, 5674-5679 
Poppema, S., Lai, R., Visser, L. and Yan, X.J. (1996). CD45 (leucocyte common 
antigen) expression in T and B lymphocyte subsets. Leuk. Lymphoma, 20, 217-222 
Prescott, L.M., Harley, J.P. and Klein, D.A. (1990). Bacteriophages. In: Microbiology. 
Dubuque: Wm. C. Brown, Chapter 15 
170 
Pross, H.F. and Lotzova, E. (1993). Role of natural killer cells in cancer. Nat. Immun., 
12, 279-292 
Quillet, A., Presse, F., Marchiol-Fournigault, C , Harel-Bellan, A., Benbunan, M. , 
Ploegh, H. and Fradelizi, D. (1988). Increased resistance to non-MHC-restricted 
cytotoxicity related to HLA A,B expression. Direct demonstration using beta 2-
microglobulin-transfected Daudi cells. J. Immunol., 141, 17-20 
Rafferty, K.A. (1969). Mass culture of amphibian cells: methods and observations 
concerning stability of cell type. In Biology of Amphibian Tumours, ed. M. Mizell. 
Springer-Verlag, New York, pp. 52-81 
Riccardi, C , Santoni, A., Barlozzari, T., Pucetti, P. and Herberman, R.B. (1980). In 
vivo natural reactivity of mice against tumour cells. Int. J. Cancer, 25, 475-486 
Ritz, J., Schmidt, R.E., Michon, J., Hercend, T. and Schlossman, S.F. (1988). 
Characterisation of functional surface structures on human natural killer cells. Adv. 
Immunol, 42, 181-211 
Robert, J., Guiet, C. and Du Pasquier, L. (1995) Ontogeny of the aUoimmune response 
against a transplanted tumour in Xenopus laevis. Differentiation, 59, 135-144 
Robert, J., Guiet, C , Cohen, N . and Du Pasquier, L. (1997). Effects of thymectomy 
and tolerance induction on tumour immunity in adult Xenopus laevis. Int. J. Cancer, 
70, 330-334 
Robert, J. and Cohen, N. (1998). Evolution of immune surveillance and tumour 
immunity: studies in Xenopus. Immunol Rev., 166, 231-243 
Robertson, M.J. and Ritz, J. (1990). Biology and clinical relevance of human natural 
killer cells. Blood, 76, 2421-2438 
Rojo, S., Burshtyn, D.N., Long, E.O. and Wagtmann, N. (1997). Type I 
transmembrane receptor with inhibitory function in mouse mast cells and NK cells. J. 
Immunol, 158, 9-12 
Rolink, A. and Melchers, F. (1993). Generation and regeneration of cells of the B-
lymphocyte lineage. Curr. Opin. Immunol, 5, 207-217 
171 
Rolstad, B., Vaage, J.T., Naper, C , Lambracht, D., Wonigeit, K., Joly, E. and Butcher, 
E.W. (1997). Positive and negative MHC class I recognition by rat NK cells. Immunol 
Rev., 155, 91-104 
Romagnani, S. (1992). Induction of TH1 and TH2 responses: a key role for the 
'natural' immune response. Immunol. Today, 13, 379-381 
Rosenberg, E.B., Herberman, R.B., Levine, P.H., Halterman, R.H., McCoy, J.L. and 
Wunderlich, J.R. (1972). Lymphocyte cytotoxicity reactions to leukaemia-associated 
antigens in identical twins. Int. J. Cancer, 9, 648-658 
Ryan, R.C., Niemi, E.C., Goldfien, R.D., Hiserodt, J.C. and Seaman, W.E. (1991). 
NKR-P1, an activating molecule on rat natural killer cells, stimulates phosphoinositide 
turnover and a rise in intracellular calcium. J. Immunol., 147, 3244-3250 
Salcedo, T.W., Kurosaki, T., Kanakaraj, P., Ravetch, J.V. and Perussia, B. (1993). 
Physical and functional association of p56 l c k with FcyRIIIA (CD 16) in natural killer 
cells. J. Exp. Med, 111, 1475-1480 
Sambrook, J., Fritsch, E.F. and Maniatis, T. (1989) In: Molecular Cloning: A 
Laboratory Manual 2nd ed. New York: Cold Spring Harbour Laboratory Press, 
Chapter 12. 
Sanna, P.P., Williamson, R.A., De Logu, A., Bloom, F.E. and Burton, D.R. (1995). 
Directed selection of recombinant human monoclonal antibodies to herpes simplex 
virus glycoproteins from phage display libraries. Proc. Natl. Acad. Sci. USA., 92, 
6439-6443 
Santoli, D., Trinchieri, G. and Koprowski, H. (1978). Cell-mediated cytotoxicity in 
humans against virus-infected target cells. I I . Interferon induction and activation of 
natural killer cells. J. Immunol., 121, 532-538 
Sawyer, C , Embleton, J. and Dean, C. (1997). Methodology for selection of human 
antibodies to membrane proteins from a phage display library. J. Immunol. Methods, 
204, 193-203. 
172 
Scharton, T.M. and Scott, P. (1993). Natural killer cells are a source of interferon 
gamma that drives differentiation of CD4+ T cell subsets and induces early resistance 
to Leishmania major of mice. J. Exp. Med., 178, 567-577 
Schier, R, McCall, A., Adams, G.P., Marshall, K.W., Merritt, H., Yim, M., Crawford, 
R.S., Weiner, L.M., Marks, C. and Marks, J.D. (1996). Isolation of picomolar affinity 
anti-c-erbB-2 single chain Fv by molecular evolution of the complementarity 
detennining regions in the centre of the antibody binding site. J. Mol. Biol., 263, 551-
567 
Selvakumar, A., Steffens, U. and Dupont, B. (1997). Polymorphism and domain 
variability of human killer cell inhibitory receptors. Immunol. Rev., 155, 183-196 
Sheets, M.D., Amersdorfer, P., Finnern, R., Sargent, P., Lindqvist, E., Schier, R., 
Hemingsen, G., Wong, C, Gerhart, J.C. and Marks, J.D. (1998). Efficient construction 
of a large nonimmune phage antibody library: The production of Mgh-affinity human 
single chain antibodies to protein antigens. Proc. Natl. Acad. Sci. USA., 95, 6157-6162 
Sherif, M. and Elridi, R. (1992). Natural cytotoxic-cell activity in the snake 
Psammophis sibilans. Immunobiology, 184, 348-358 
Shimizu, Y. and DeMars, R. (1989). Demonstration by class I gene transfer that 
reduced susceptibility of human cells to natural killer cell-mediated lysis is inversely 
correlated with HLA class I antigen expression. Eur. J. Immunol., 19, 447-451 
Siegel, D.L. and Silberstein, L.E. (1994). Expression and characterization of 
recombinant anti-Rh(D) antibodies on filamentous phage: a model system for isolating 
human red blood cell antibodies by repertoire cloning. Blood, 83, 2334-2344 
Silver, E.T., Elliott, J.F. and Kane, K.P. (1996). Alternatively spliced Ly-49D and H 
transcripts are found in EL-2 activated NK cells. Immunogenetics, 44, 478-482 
Sivori, S., Vitale, M., Morelli, L., Sanseverino, L., Augugliaro, R., Bottino, C , 
Moretta, L. and Moretta, A. (1997). p46, a novel natural killer cell-specific surface 
molecule that mediates cell activation. J. Exp. Med., 186, 1129-1136 
173 
Skerra, A. and Pluckthun, A. (1988). Assembly of a functional immunoglobulin Fv 
fragment in Escherichia coli. Science, 240, 1038-1041 
Smith, H.R.C., Karlhofer, F.M. and Yokoyama, W.M. (1994). Ly-49 multigene family 
exressed by IL-2-activated NK cells. J. Immunol., 153, 1068-1079 
Smith, K.A. (1988). Inteleukin-2: Inception, impact and implications. Science, 240, 
1169 
Smith, P.B. and Turpen, J.B. (1991). Expression of a leukocyte-specific antigen during 
ontogeny in Xenopus laevis. Developmental Immunology, 1, 295-307 
Snapper, C M . , Rasa, F.R., Moorman, M.A., Jin, L., Shanebeck, K., Klinman, D.M., 
Kehry, M.R., Mond, J.J. and Maliszewski, C.R. (1996). IFN-gamma is a potent 
inducer of Ig secretion by sort-purified murine B cells activated through the mlg, but 
not the CD40 signalling pathway. Int. Immunol., 8, 877-885 
Stoneman, E.R., Bennett, M., An, J., Chesnut, K.A., Scheerer, J.B., Siciliano, M.J., 
Kumar, V. and Matthew, P. A. (1995). Cloning and characterisation of 5E6 (Ly-49C), a 
receptor molecule expressed on a subset of murine natural killer cells. J. Exp. 
Med, 182, 305-314 
Storkus, W.J., Howell, D.N., Salter, R.D., Dawson, J.R. and Cresswell, P. (1987). NK 
susceptibility varies inversely with target cell class I HLA antigen expression. J. 
Immunol., 138, 1657-1659 
Storkus, W.J., Alexander, J., Payne, J.A., Dawson, J.R. and Cresswell, P. (1989). 
Reversal of natural killing susceptibility in target cells expressing transfected class I 
HLA genes. Proc. Natl. Acad. Sci. USA, 86, 2361-2364 
Suzuki, M.M. and Cooper, E.L. (1995). Allogeneic lolling by earthworm effector cells. 
Nat. Immun., 14, 9-11 
Timonen, T., Ortaldo, J. and Herberman, RB. (1981). Characteristics of human large 
granular lymphocytes and relationship to natural killer and K cells. J. Exp. Med., 153, 
569-582 
174 
Toole, J.J., Knopf, J.L., Wozney, J.M., Sultzman, L.A., Buecker, J.L., Pittman, D.D., 
Kaufman, R.J., Brown, E., Shoemaker, C , Orr, E.C., Amphlett, G.W., Foster, W.B., 
Coe, M.L., Knutson, G.J., Fass, D.N. and Hewick, R.M. (1984). Molecular cloning of 
a cDNA encoding human antihaemophilic factor. Nature, 312, 342-347 
Trinchieri, G. (1989). Biology of natural killer cells. Adv. Immunol., 47, 187-376 
Trinchieri, G. and Scott, P. (1995). Natural killer cells in host-parasite interactions. 
Curr. Opin. Immunol., 7, 34-40 
Tripp, C.S., Gately, M.K., Hakimi, J., Ling, P. and Unanue, E.R. (1994). 
Neutralisation of IL-12 decreases resistance to Listeria in SCID and CB-17 mice. J. 
Immunol., 152, 1883-1887 
Turner, J.M., Brodsky, M.H., Irving, B.A., Levin, S.D., Perhnutter, R.M. and Liftman, 
D.R. (1990). Interaction of the unique N-terminal region of tyrosine kinase p56 l c k with 
cytoplasmic domains of CD4 and CD8 is mediated by cysteine motifs. Cell, 60, 755-
765 
Valiante, N.M. and Parham, P. (1996). NK cells and CTL: Opposite sides of the same 
coin. In Molecular Basis ofNK Cell Recognition and Function ed. L. Moretta. Karger, 
Basel, 64, pp 146-163 
Valiante, N.M., Phillips, J.H., Lanier, L.L. and Parham, P. (1996). Killer cell 
inhibitory receptor recognition of human leukocyte antigen (HLA) class I blocks 
formation of a pp36/PLC-y signalling complex in human natural killer (NK) cells. J. 
Exp. Med, 184, 2243-2250 
Vaughan, T.J., Williams, A.J., Pritchard, K , Osbourn, J.K., Pope, A.R., Earnshaw, 
J.C., McCafferty, J., Hodits, R.A., Wilton, J. and Johnson, K. (1996). Human 
antibodies with sub-nanomolar affinities isolated from a large non-immunised phage 
display library. Nat. Biotechnol, 14, 309-314 
Vitale, M., Bottino, C , Sivori, S., Sanseverino, L., Castriconi, R., Marcenaro, E., 
Augugliaro, R., Moretta, L. and Moretta, A. (1998). NKp44, a novel triggering surface 
molecule specifically expressed by activated natural killer cells, is involved in non-
major histocompatibility complex-restricted tumour cell lysis. J. Exp. Med., 187, 2065-
2072 
175 
Vivier, E. and Daeron, M. (1997). Immunoreceptor tyrosine-based inhibitory motifs. 
Immunol. Today, 18, 286-291 
Vujanovic, NX., Yasamura, S., Hirabayashi, H., Lin, W-C, Watkins, S., Herberman, 
R.B. and Whiteside, T.L. (1994). Antitumour activities of subsets of human D e -
activated natural killer cells in solid tissues. J. Immunol, 154, 281-289 
Vujanovic, N.L., Basse, P., Herberman, R.B. and Whiteside, T.L. (1996). Antitumour 
function of natural killer cells and control of metastases. Methods (Companion 
Methods Enzymol), 9, 394-408 
Wang, L.L., Mehta, I.K., LeBlanc, P.A. and Yokoyama, W.M. (1997). Mouse natural 
killer cells express gp49Bl, a structural homologue of human killer cell inhibitory 
receptors. J. Immunol, 158, 13-17 
Watters, J.M., Telleman, P. and Junghans, R.P. (1997). An optimised method for cell-
based phage display panning. Immunotechnology, 3, 21-29 
Welsh, R.M. (1986). Regulation of virus infections by natural killer cells: A review. 
Nat. Immun. Cell Growth Regul. 5, 169-199 
Whiteside, T.L. and Herberman R.B. (1992). Extravasation of antitumour effector 
cells. Invasion Metastasis, 12, 128-146 
Whiteside, T.L. and Herberman, R.B. (1994). Role of natural killer cells in health an 
disease. Clin. Diag. Lab. Immunol, 1, 125-133 
Whiteside, T.L. and Herberman, R.B. (1995). The role of natural killer cells in 
immune surveillance of cancer. Curr. Opin. Immunol, 7, 704-710 
Whiteside, T.L., Vujanovic, N.L. and Herberman; R.B. (1998). Natural killer cells and 
tumour therapy. Current Topics in Microbiology and Immunology, 212, 107-117 
Wiertz, E.J.H.J., Mukherjee, S. and Ploegh, H.L. (1997). Viruses use stealth 
technology to escape from the host immune system. Mol. Med. Today, 3, 116-123 
176 
Wilder, J.A., Koh, C.Y. and Yuan, D. (1996). The role of NK cells during in vivo 
antigen-specific antibody responses. J. Immunol., 156, 146-152 
Wiley, S.R., Schooley, K., Smolak, P.J., Din, W.S., Huang, CP., Nicholl, J.K., 
Sutherland, G.R., Smith, T.D., Rauch, C. and Smith, C.A. (1995). Identification and 
characterisation of a new member of the TNF family that induces apoptosis. Immunity, 
3, 673-682 
Winter, G. and Milstein, C. (1991). Man-made antibodies. Nature, 349, 293-299 
Winter, G., Griffiths, A.D., Hawkins, R.E. and Hoogenboom, H.R. (1994). Making 
antibodies by phage display technology. Ann. Rev. Immunol., 12, 433-455 
Wood, W.I., Capon, D.J., Simonsen, C.C., Eaton, D.L., Gitschier, J., Keyt, B., 
Seeburg, P.H., Smith, D.H., Hollingshead, P., Wion, K.L., Delwart, E., Tuddenham, 
E.G.D., Vehar, G.A. and Lawn, R.M. (1984). Expression of active human factor VHI 
from recombinant DNA clones. Nature, 312, 330-337 
Young, J.D-E. (1989). Killing of target cells by lymphocytes: a mechanistic view. 
Physiol. Rev., 69, 250-314 
Zhou, H., Fisher, R.J. and Papas, T.S. (1994). Optimisation of primer sequences for 
mouse scFv repertoire display library construction. Nucleic Acids Res., 22, 888-889 
